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Abstract 
Early cortical injury has been attributed to the consequential effects of various factors, 
such as alcohol, drug addiction, smoking, and inadequate nutrient intakes during periods 
of pregnancy and lactation, or delivery of infants by forceps, and premature deliveries. 
These are only a few examples of circumstances, or "injury", that may result in disorders 
ranging from mild learning difficulties to aggressive behavior. 
Injury to the cortex during the early years of development has been known to result in 
poor behavioral outcome into adulthood. Presently, the most common form of treatment 
includes a pharmacological agent, which may be accompanied with behavioral 
modification therapies supported by families. As an alternative form of therapy towards 
the treatment of early cortical injury, choline and a vitamin and mineral supplement (EM 
Power+) were used to determine the possibilities of nutrition intervention in an animal 
model. The injuries were incurred by aspiration lesion at days three, (Exp.l) and four, 
(Exp.2) and lesions were localized to the midline medial frontal cortex in some rats, 
while a different group of rats received lesions in the posterior parietal cortex. The pre-
and postnatal choline treated animals showed favorable results for the medial frontal 
lesions, and the postnatal vitamin supplement treated animals showed favorable results 
for treatment in both medial frontal and posterior parietal lesions. All animals were tested 
in adulthood indicating that nutrition intervention is very beneficial for alleviating some 
of the functional deficits commonly seen from early cortical injury. 
iv 
Acknowledgements 
Firstly, I would like to thank my supervisor, Bryan Kolb for accepting an alien 
from the field of Nutrition into the field of Psychology and Neuroscience. Bryan was 
very supportive for me both personally and professionally, giving me the flexibility 
required to adapt to an overwhelming situation initially, which became an extraordinarily 
rewarding career path as completion became evident. 
I'd also like to thank Rob Sutherland for support personally, as well as with any 
technical services required. 
A number of people in the Kolb and Whishaw group have been extremely helpful 
towards the completion of these experiments. Robbin Gibb, for her talent of dissection of 
fresh brain tissue for Western Blot analysis- a technique learned with many years of 
dissection. Morgan Day, for her talent with the actual Western Blot analysis- a technique 
requiring experience. Greg Silasi, Dawn Danka, and Grazyna Gorney for assistance with 
perfusions, histology, and anatomy. Preston Williams for help with the Morris water task 
and Statsview 5. Omar Gharbawi, Bogdan Gorney, and Claudia Gonzalez for help with 
behavioral and technical assistance. Paul Whishaw for his expertise in the incorporation 
of movies into powerpoint presentations. 
David Hardy, the formulator of the vitamin supplement, I would also like to thank 
for managing last minute requests for more supplemented rat feed, and for spending time 
discussing nutritional aspects of the supplement with me, as well as for providing 
samples for me to experience the benefits. 
V 
The moral support and understanding of my temporary disappearance from family 
William and Maxine Halliwell, Richard, Pamela, Kevin, Zachery, Bradly, and Meg'n 
Celeste Halliwell is unquestionably thankful. And last, but not least, I thank my mother 
Caroline Christiansen for her support of keeping me at her home, but also for being 
bipolar. 
vi 
Table of Contents Page 
Title page i 
Signature page ii 
Abstract Hi 
Acknowledgments iv 
List of Figures ix 
List of Tables xiii 
Chapter 1. General Introduction 1 
Brain Plasticity 4 
Development of the vertebrate central nervous system 7 
Critical periods for recovery from brain injury 
during development 13 
The frontal cortex: Function in humans and in rats 15 
Functions of the parietal cortex in humans and in rats 23 
Choline treatment 28 
Vitamin and mineral supplement treatment 30 
Chapter 2. General Organization of the Thesis Experiments 36 
Behavioral measures 36 
Chapter 3. Experiment 1 43 
Experiment 1A 44 
Method 45 
vii 
Results 53 
Experiment IB 70 
Method 71 
Results 72 
Discussion 86 
Chapter 4. Experiment 2 91 
Experiment 2A 93 
Method 94 
Results 101 
Experiment 2B 115 
Method 116 
Results 116 
Discussion 129 
Chapter 5. General Discussion 133 
Molecular actions of the choline and 
vitamin/mineral supplement 134 
Behavioral effects of the choline and vitamin treatments 145 
Anatomical effects of treatments 145 
Cognitive effects of the treatments in cognitive functioning 147 
Broader implications of using dietary treatments 
for behavioral disorders 148 
viii 
Chapter 6. Epilogue 154 
Chapter 7. Appendixes 162 
Appendix A 163 
Appendix B 172 
Appendix C 173 
Appendix D 176 
Appendix E 181 
Chapter 8. References 186 
ix 
List o f Figures 
Fig. 1. Example of measures of dendrites, axons, and spines 6 
demonstrating neural growth. 
Fig. 2. Cortical plasticity of the developing rat brain. 7 
Fig. 3. Development of the central nervous system. 9 
Fig. 4. Cell lineage model. 10 
Fig. 5. Summary of cerebral cortical development. 11 
Fig. 6. Lateral migration. 12 
Fig. 7. Open Field Apparatus. 37 
Fig. 8. Morris Water Task Maze. 39 
Fig. 9. Tray Reaching Apparatus. 40 
Fig. 10. Attention Shift Maze. 42 
Fig. 11. Zilles (1995) Lateral, central, and medial regions measured 
across five planes for cortical thickness. 49 
Fig. 12. Frontal cortical lesions of the choline treated animals. 54 
Fig. 13. Cortical thickness for each of five planes measured in animals 
with frontal lesion treated with choline 58 
Fig. 14. Mean cortical thickness for the five planes measured in animals 
with frontal lesions treated with choline. 58 
Fig. 15. Mean horizontal activity of animals with frontal lesions 
treated with choline. 61 
Fig. 16. Mean distance in open field activity of animals with frontal 
lesions treated with choline. 61 
Fig. 17. Morris water task latency sums for frontal lesion choline treated 
animals. 62 
Fig. 18. Morris water task latency over the five-day trial period. 
Animals had frontal lesions and choline treatment. 63 
X 
Fig. 19. Probe trials of Morris water task for frontal lesion animals treated 
with choline. 64 
Fig. 20. Summary of tray reaching task for frontal lesion choline treated group. 65 
Fig. 21. Summary of all dimensions measured in the attention shift task. 
Animals had frontal lesions and choline treatment. 69 
Fig. 22. Posterior parietal cortical lesions of the choline treated animals. 73 
Fig. 23. Cortical thickness for each of five planes measured in animals 
with parietal lesions treated with choline. 76 
Fig. 24. Mean cortical thickness for the five planes measured in animals 
with parietal lesions treated with choline. 76 
Fig. 25. Mean horizontal activity of parietal lesion animals 
treated with choline. 79 
Fig. 26. Mean distance in open field task of parietal lesion animals 
treated with choline. 79 
Fig. 27. Morris water task latency sums of animals with parietal lesions 
treated with choline. 80 
Fig. 28. Morris water task latency over the five-day trial period. 81 
Fig. 29. Probe trials of Morris water task for parietal lesion animals 
treated with choline. 82 
Fig. 30. Summary of tray reaching task for parietal lesion choline treated group. 83 
Fig. 31. Summary of all dimensions measured in the attention shift task. 
Animals had parietal lesions and choline treatment. 85 
Fig. 32. Flowchart of subjects in the vitamin supplement experiment. 92 
Fig. 33. Zilles (1995) Lateral central, and medial regions measured across five 
planes for cortical thickness. 100 
Fig. 34. Frontal cortical lesions in animals treated with the vitamin supplement. 102 
Fig. 35. Mean cortical thickness for the five planes measured in animals 
with frontal lesions treated with the vitamin supplement. 107 
xi 
Fig. 36. Cortical thickness for each of five planes measured in animals with 
frontal lesions treated with the vitamin supplement. 
Fig. 37. Mean horizontal activity in open field task of frontal lesion animals 
treated with the vitamin and mineral supplement. 
Fig. 38. Mean distance of frontal lesion animals treated with the vitamin 
and mineral supplement. 
Fig. 39. Morris water task latency over five-day training period. Animals 
had frontal lesions and treated with the supplement. 
Fig. 40. Morris water task latency sums of frontal lesion animals treated with 
the vitamin supplement. 
Fig. 41. Probe trials of frontal lesion animals treated with the 
vitamin supplement. 
Fig. 42. Summary of tray reaching task of frontal lesion animals treated 
with the vitamin supplement. 
Fig. 43. Parietal lesions of the vitamin supplement treated group. 
Fig. 44. The caudate putamen in parietal lesion brains. 
Fig. 45. Cortical thickness for each of five planes measured in animals 
with parietal lesions treated with the vitamin supplement. 
Fig. 46. Mean cortical thickness for the five planes measured in animals 
with parietal lesions treated with the vitamin supplement. 
Fig. 47. Mean horizontal activity in open field of parietal lesion animals 
treated with the supplement. 
Fig. 48. Mean distance in open field of parietal lesion animals treated 
with the supplement. 
Fig. 49. Morris water task latency over five-day training period. Animals 
had parietal lesions and treated with the supplement. 
Fig. 50. Morris water task latency sums of parietal lesion animals treated 
with the supplement. 
Fig. 51. Probe Morris water task trials for parietal lesion animals treated 
with the supplement. 
xii 
Fig. 52. Summary of tray reaching task of parietal lesion animals treated 
with the supplement. 128 
Fig. 53. The interconversion of nutrients required for energy metabolism. 158 
Fig. 54. Nutrients required for drug metabolism. 160 
Fig. 55. Anatomical areas of the rat frontal cortex. 164 
Fig. 56. Lateral, medial, and dorsal views of the rat brain. 166 
Fig. 57. Comparisons of Zilles and Kreig's areas of the rat brain. 168 
Fig. 58. Anatomical areas of the posterior regions of the brain in the rat. 170 
Fig. 59. Anatomical areas of the temporal and occipital areas of the rat cortex. 170 
Fig. 60. Proteins analyzed by western blot technique. 174 
Fig. 61. Mean horizontal activity in the open field task of the second-generation 
supplement treated animals. 183 
Fig. 62. Mean distance for second generation supplement treated animals. 183 
Fig. 63. Mean latency of second generation supplement treated animals. 184 
Fig. 64. Summary of tray reaching task for the second-generation supplement 
treated animals. 185 
xiii 
List o f Tables 
Table 1. Summary of effects of medial frontal and orbital frontal lesions in rats. 22 
Table 2. Summary of the effects of posterior parietal lesions in rats. 27 
Table 3. Number of rats used in Experiment 1 A. 45 
Table 4.(Exp. 1 A) Brain weight for choline treated cresyl violet preparations. 55 
Table 5.(Exp. 1 A) Brain weight for choline treated Golgi preparations. 56 
Table 6.(Exp. 1 A) Mean measures of thalamic width. 59 
Table 7. Number of rats used in Experiment IB. 71 
Table 8.(Exp. IB) Brain weight for choline cresyl violet preparations. 74 
Table 9.(Exp. IB) Brain weight for choline Golgi preparations. 75 
Table 10.(Exp. IB) Mean measures of thalamic width. 77 
Table 11. Number of rats used in Experiment 2A. 94 
Table 12.(Exp.2A) Brain weight for cresyl violet preparations. 104 
Table 13 .(Exp.2A) Brain weight for Golgi preparations. 104 
Table 14.(Exp.2A) Mean measures of thalamic width. 108 
Table 15. Number of rats used in Experiment 2B. 116 
Table 16.(Exp. 2B) Brain weight for cresyl violet preparations. 119 
Table 17.(Exp. 2B) Brain weight for Golgi preparations. 120 
Table 18.(Exp. 2B) Mean measures of thalamic width. 122 
Table 19. Nomenclature of equivalent cortical areas. 171 
Table 20. Summary of statistical analysis for western blot. 175 
Table 21. Nutritional analysis of the base diet composition in the 
vitamin supplemented diet. 176 
xiv 
Table 22. Mineral content of vitamin supplemented diet. 176 
Table 23. Nutritional analysis of the standard diet composition 
in the control diet. 177 
Table 24. Mineral content of control standard diet. 178 
Table 25. Base nutrient profiles of the control and vitamin supplement diets. 178 
Table 26. Vitamin supplement. Serving size is 8 Capsules. (Label Claim) 180 
Table 27. Number of second-generation supplement treated animals. 181 
1 
1. General Introduction 
Infant malnutrition has been observed worldwide, enabling nutritionists to study 
the consequences of inadequate dietary intakes during critical periods of growth and 
development. Malnutrition during the critical periods of brain development has been 
reported to result in irreversible functional deficits that impair the learning capacities of 
these individuals, as discussed by Lewis (1990), and Heuther (1990). 
Protein-energy malnutrition in infancy has been reported to alter amino acid 
profiles, which adversely affect brain development, either through protein accretion, or 
neurotransmitter formation (Huether, 1990). According to Lewis (1990), prenatal 
malnutrition affects the proliferation and enlargement of brain cells, whereas malnutrition 
during the postnatal period can reduce the number of cells necessary for growth and 
development. 
Early cortical injury includes a number of consequential effects from factors such 
as alcohol, drug addiction, smoking, and inadequate nutrient intakes during periods of 
pregnancy and lactation, or delivery of infants by forceps, and premature deliveries. 
These are only a few examples of circumstances, or "injury", known to develop into 
disorders ranging from mild learning difficulties to aggressive behavior as children grow 
into adolescence. The increasing demands required by families and communities, to cope 
with problems of learning disabled children and juvenile delinquency, have necessitated 
the specialty of child psychiatry (McDermott, 1977). A number of disorders, ranging 
from organic brain dysfunction to psychosis, have been attributed to a failure of primary 
development, or an arrest at very early stages of development. Because children have not 
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matured into their personalities as adults, children express the earlier symptoms of 
disorders differently. The symptoms most often observed are "hyperactivity, 
impulsiveness, distractibility, and shortened attention span"(McDermott, 1977), all of 
which have described astronomical proportions of children in various communities. To 
what degree these symptoms are actually attributable to developmental circumstances 
needs to be determined. Many of the developmental consequences of poor nutrition, or 
early cortical injury, are known to manifest themselves into a variety of disorders into 
adolescence and adulthood. 
Valenstein (1998) has documented theories of circumstances that provide 
behavioral and cognitive patterns of psychiatric disorders. For example, "prenatal errors 
in brain development, birth trauma, incompatible immune systems between mother and 
fetus, slow acting viruses, and genetic factors" have been included in the etiology of 
mental disorders (Valenstein, 1998). The primary treatment intervention to date is a 
pharmacological approach to treating a class of diagnosed behavioral and cognitive 
disorders. Although many of these agents have proven very useful, rarely are some of the 
consequential effects of nutritional depletions addressed, as a result of a long-term 
ingestion of a various drugs. The drug effects in the body are known to interfere with 
nutrient metabolism as secondary malabsorption (Zeman, 1991). As a result, many 
psychological, or psychiatric disorders can become exacerbated as a result of poor 
nutritional status, especially inadequate long-term intakes. For example, depletions of 
various B vitamins due to either inadequate nutrition intakes and/ or using drugs that 
interfere with the normal metabolism of nutrients, result in numerous peripheral and 
central nervous system dysfunctions (Groper, Groff, & Hunt, 1995). 
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As an alternative to pharmacotherapeutic drugs that are currently on the market 
for treatment, an open-label study on professionally diagnosed bipolar adults using a 
vitamin and mineral supplement, EM Power +, has been documented. (Kaplan, Simpson, 
Ferre, Gorman, McMullen, & Crawford, 2001). These studies have inspired interest for 
the therapeutic application of the same vitamin and mineral supplement toward the 
treatment for early cortical injuries that can predispose individuals to similar behavioral 
and cognitive patterns found in many disorders. 
Brain injury, and/or early cortical injury, not only affects anatomical structures of 
the brain, but also the neural circuits that have a specific purpose for the normal 
physiological functions of the brain. Damage very often has interfered with the learning 
abilities of the affected individuals. Some of the main effects from brain damage 
documented include interferences in attention and memory processes (Kolb & Whishaw, 
2003). Either perceptual attention of the posterior brain regions, or the control of 
attention in the prefrontal regions are commonly known to suffer from the effects of brain 
injury (Kolb & Whishaw, 2003). Attention, in turn, provides the appropriate substrates 
for mnemonic processes and the ability to learn. A variety of disorders, such as bipolar 
disorder, attention deficit disorder, and associated comorbid disorders, usually share 
symptomatologies of deficits of attention (American Psychiatric Association, 1994). If 
the vitamin supplement treatment intervention can improve behavioral deficits of 
attention, learning, and memory, there are then reasons to suspect that it can provide the 
fundamental substrates necessary to support processes of neural plasticity that underlie 
such behavioral and cognitive improvements. 
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The goal of nutrition is to correct any nutritional deficiencies, prevent disease and 
disorders, and to promote maintenance of optimal health. The effects of a well-
formulated vitamin and mineral supplement as treatment intervention for brain injury 
have not been extensively studied, if at all. Similarly, the nutritional requirements for 
brain injury have barely been addressed in research studies of neuroscience. 
The goal of this thesis is to begin to address the potential effects of nutritional 
intervention as a therapeutic approach to reduce the effects of early cortical injury. 
The first experiment used choline as a therapeutic intervention, which also 
provided a template for which to apply the supplement study, as this supplement has not 
yet been tested in rats. The second experiment in this study has applied the same vitamin 
supplement used in the clinical studies, at approximately the same dosages, to determine 
the potential benefit for treatment intervention. The behavioral tasks used are intended to 
measure various levels of recovery, or improvement, that can be offered from nutrition 
intervention. They also take an approach towards a better understanding of attentional 
processes that are necessary for learning and memory, cognitive deficits that are so 
commonly seen in people with various forms of brain damage. 
Brain Plasticity 
The experiences that an individual will endure throughout a lifetime are many and 
varied, and can be presumed to affect the brain, although likely in different ways. As a 
result, such various exposures have been proposed to sufficiently enable an individual to 
adapt to new changes in their environment. The ability to make appropriate behavioral 
changes in response to a changing environment is considered to be a form of learning, 
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and learning have been proposed to be accompanied by structural and chemical changes 
in the brain (Kolb, 1999). If an individual has at some time during their lives suffered 
from injury to the brain, the behavioral outcome generally changes over time, presumably 
in association with changes in brain structure and/or activity. These subsequent changes 
in the brain are known to depend on factors such as locus of lesion, age at injury, extent 
of injury, gonadal hormones, growth factors, pre- and postinjury experience, and so on 
(Kolb, 1995). 
The idea that brain plasticity might vary with age at injury arose from 
observations of the effects of early childhood brain injury (Kolb, 1995). Broca noted that 
his young patients with damage to the language areas of the brain rarely developed 
aphasia later in life. This led Broca to suspect that there was something different about 
the effects of brain injury in the infant compared to effects seen in the adult. Kennard 
supported this hypothesis with her research of brain lesions in monkeys. Infant monkeys 
with motor cortex lesions showed improved behavioral recovery as opposed to similar 
injury in adulthood. The argument posed by Kennard (1942), namely that brain injury 
during childhood has a more favorable behavioral outcome than similar injury later in 
life, was presumed to be due to the fact that the brain is still developing during these early 
years. Responses to injury in the early years could be different, possibly by some form of 
reorganization of neural circuitry. It was therefore postulated that "earlier is better" for 
recovery from brain injury. In contrast to Kennard's views, Hebb (1949) later suggested 
that there may be certain periods during development of the cortex that would result in 
more deleterious effects than that produced by similar injury later in life. Hebb studied 
children with damage to the frontal lobes and noted that if this damage occurred at certain 
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Control NGF 
Oblique 
Fig. 1. Example of measures of dendrites, axons, and spines demonstrating neural 
growth. Illustration reveals the effect of the infusion of nerve growth factor into the 
lateral ventricle of adult rats. (Extracted from Kolb, 1999). 
periods during development, there were severe cognitive and behavioral consequences in 
adulthood and considered significant (Hebb, 1949). 
To understand these cognitive and behavioral consequences of brain injury, Kolb 
and colleagues have performed extensive research in rats to determine critical periods for 
recovery and plasticity in the mammalian brain and to investigate the effects of various 
treatment interventions. Results of cortical plasticity after brain injury can be quite 
significant, quantified with measurements taken for changes in the axons, dendrites and 
glia (see Fig.l). From these data, Kolb and colleagues have constructed charts (see Fig.2) 
to identify growth periods during cortical development, as well as time dependent periods 
of maximal and minimal periods of cortical plasticity throughout the lifetime of a rat. 
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Fig. 2. Cortical plasticity of the developing rat brain. Top- approximate time period of the 
main cellular events. Bottom- Summary of the time dependent processes of plastic 
cortical periods during the life of the rat (Extracted from Kolb, 1999). 
Development of the vertebrate central nervous system 
During early embryonic life, embryo cells differentiate into three germinal layers: 
1) the ectoderm (skin, nails, brain, and central nervous system) 2) the mesoderm (skeletal 
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structures, voluntary muscle, heart, kidneys, gonads) and 3) the endoderm (digestive 
system, respiratory system and glandular organs) (Barr, S, 1998). 
During development of the nervous system, the ectoderm differentiates into the 
neural plate, and further into the neural tube, neural crest, and ectodermal placodes 
(Steward, 1989). The neural plate folds into the neural tube, giving rise to the brain and 
spinal cord. The neural crest gives rise to the sympathetic and parasympathetic system, 
glial cells of the peripheral system, and some non-neural tissue, such as melanocytes. The 
rostral end of the neural tube develops three vesicular swellings that give rise to the 
forebrain, midbrain, and hindbrain of the central nervous system (see Fig.3). 
During formation of the neural tube, the epithelial cells that line the wall of the 
tube become pseudostraufied, becoming the germinal neuroepithelium, or the ventricular 
layer. The cells at the luminal surface of this pseudostraufied cell layer are known as 
precursor, or progenitor cells (Reid & Walsh, 1996). During the earliest stages of cortical 
development, progenitor cells undergo processes of mitosis and extensive cellular 
proliferation, prior to migration during the formation of the cerebral cortex (Reid & 
Walsh, 1996; Steward, 1989). 
Cortical cell lineage models of retroviral labeling and in vitro observations have 
suggested that some progenitor cells do not migrate widely into cortical regions, but 
undergo multiple rounds of cell division. Other progenitor cells however, are migratory 
and produce daughter cells of a multipotential migratory cell, and a non-migratory cell in 
stem-cell fashion (see Fig.4) (Reid & Walsh, 1996). 
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Reproduced with the permission 
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of Anatomy, University of 
Leyden. 
Fig. 3. Development of the central nervous system. (Extracted from Kolb and Whishaw, 
2001. Introduction To Brain and Behavior). 
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A hypothetical model of cell lineage in the mammalian cerebral cortex is depicted along a schematically rendered saggital 
section through the E22 rat forebrain. Cerebral cortical cells are derived from the two proliferative tones (VZ, SVZ) and most neo-
cortical neurons migrate radially from the proliferative zones'to the cortex proper. The behavior of one muhipotentia! cell is illus­
trated. The multipotential cell (m) migrates as it divides, sequentially producing three non-migratory progenitors at spatio-temporal 
intervals and regenerating a multipotential cell in "stem cell" fashion. Each non-migratory progenitor then behaves essentially in­
dependently, dividing multiple times (shading), directly differentiating (stippling) or dividing once (cross-hatching), to form three 
distinct cell clusters. Since cells in the rodent cortex are added in a roughly inside-out sequence, the oldest non-migratory progeni­
tors would tend to form deeper neurons, and the newer non-migratory progenitors would tend to form more superficial neurons. 
Infection of the multipotential precursor at E15 would result, with equal probability, in integration of the viral DNA into the migra­
tory or the non-migratory daughter integration into the non-migratory daughter would label a single clustered clone (or single cell), 
whereas integration into the migratory daughter would label a widespread clone consisting of several subunits. In contrast, infection 
at E17 would label a progenitor with fewer remaining cell divisions. Therefore widespread clones would be rare and small follow­
ing E17 injections. 
Fig. 4. Cell lineage model (Extracted from Reid & Walsh, 1996). 
The formation of the cortex requires migrating cells to follow an inside-out 
pattern, while forming distinctive cortical layers. The most superficial layer of the cortex, 
the preplate is the first layer formed, which differentiates into the subplate and marginal 
zone. New migratory cells of neurons and glia then form a cortical plate and 
progressively follow an inside out pattern forming layer six, then five, and so on, until 
layer two is complete (see Fig.5)(Reid & Walsh, 1996). 
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A summary of cerebral cortical development represented schematically by drawings of cortical cross-sections at very early 
(left), intermediate (center) and late stages of development (right). These drawings correspond roughly to the E12 (left), E16 
(center), and adult rat (right) sections. The cerebral cortex arises from progenitor cells within the germinal zone (GZ) lining the 
lateral ventricles. Early in neurogenesis these cells divide to form the preplate (PP) cells. These early formed neurons eventually 
differentiate to become subplate neurons and the Cajal-Retzius neurons of layer I, also known as the marginal zone (MZ). Over the 
course of development, other neurons arising from the germinal layer migrate to a position within the preplate, eventually splitting 
the preplate into layer 1 (I) superficially and the subplate (SP) subjacently. The intervening neurons arrive to form the cortical plate 
(CP) in an inside-out fashion. Layer six (6) neurons arrive first, then layer five (5) and so on. 
. 5. Summary of cerebral cortical development (Extracted from Reid & Walsh, 1996). 
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Fig. 6. Lateral migration (Extracted from Bayer & Altman, 1995). 
Three-dimensional reconstructions and labeling patterns of the newly generating 
neocortex indicate that young neurons and glia migrate along radial glia, or co-migrate 
with glia radially, to reach their destinations. Depending on the distance required for 
migration and the placement of selective neurons, some neurons are also considered to 
migrate laterally to reach their destinations (see Fig.6)(Bayer & Altman, 1995). 
Most of the newly formed cortical neurons in rats are generated between 
embryonic days fourteen and twenty (Bayer & Altman, 1995). The Cajal-Retzius neurons 
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of layer I, originate mainly on embryonic day fourteen, followed by the subplate neurons, 
originating on embryonic days fourteen and fifteen. Bayer and Altman (1995) consider 
this time frame of neurogenesis the first epoch. The neurons that form layers VI and V 
are generated in the second epoch and the final layers, IV to II are generated in the third 
epoch (Bayer & Altman, 1995). 
Critical periods for recovery from brain injury during development 
Cerebral neurogenesis in the rat begins on embryonic day twelve and continues 
until the day of birth, on embryonic day twenty-one. The period of neurogenesis has been 
designated as the first critical period of development. From the first day of birth to 
postnatal day six or seven, is a period of neural migration. Astrocyte proliferation occurs 
through this time period and peaks from around day fifteen to day thirty, depending upon 
the cortical region examined. This second peak in activity can be considered the second 
critical period of development and time at which the cerebrum is the most plastic. Shortly 
after the peak of synapse formation at around day twenty synapse pruning and 
programmed cell death (apoptosis) begins and stabilized neurons begin to mature. 
If the rat cortex is injured during neurogenesis at around embryonic day 18, 
complete functional recovery is observed in behavioral test results (Kolb et al, 1998). 
Regrowth of cortical tissue is apparent, although not original in shape. Injuries during the 
period of intense neural migration, roughly postnatal days one to six, generally results in 
dendritic atrophy, decreases in brain weight, and poor functional outcome. This period of 
early life is the least plastic time period for cortical development. 
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Damage to the brain during postnatal days seven to twelve occurs during a time of 
astrocyte proliferation, and dendrite and synapse growth. This period is more favorable 
for recovery of cortical lesions by growth in dendrites and spines in existing neurons, the 
generation of new neurons at least under some circumstances, and the recovery of 
function behavioral ly. 
Injury during adulthood, around postnatal days one-hundred twenty, an initial 
decrease in dendritic growth is found, but thereafter increases slightly, with a partial 
recovery of function (Kolb, 1999). 
These age-related effects of cortical injury can be seen after lesions across the 
cerebral cortex with similar effects after lesions of the prefrontal cortex, motor cortex, 
occipital cortex, temporal cortex, and the posterior parietal cortex of the rat (Kolb, 1995). 
Some of the principal mechanisms that influence plasticity appear to be especially 
active at certain times during development. By enhancing these mechanisms after brain 
injury it should be possible to make some improvements for recovery processes. 
Treatment interventions for recovery of function might include pharmacological agents, 
nutritional support, environmental enrichment or a direct application of growth factors. 
Glial cells likely play an important role in supporting brain plasticity after injury. 
Nutritional support comes from glial cells, which form "end feet" that are attached to 
blood capillaries, and presumed to derive nutrients through the blood stream. Nutrients 
that are necessitated by neurons at any given time can then be transferred. Similarly, 
neuromodulators and nutrients in excess after neural transmission can be absorbed by 
astrocytes. Astrocytes accompany neurons to provide both structural and nutritional 
support and express receptors for chemicals, neurotransmitters, and neuromodulators, as 
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well as produce and respond to trophic factors (Kolb, 1995). Astrocytes are also known to 
store glycogen and fatty acids to provide the energy sources for metabolic processes of 
both neuronal and glial cells that are required to operate normal functions (Rouach & 
Giaume, 2001). The presynaptic influx of calcium, necessary to generate neural 
transmission, is a response of astrocytes to the extracellular environment produced from 
the depolarization of neurons. Astrocytes communicate with each other, thereby 
increasing the neural signals across neighboring astocytes into long-range signaling 
pathways. These mechanisms increase the modulating capacity of glial cells, which 
inadvertently result in plastic influences with neural cells (Rouach & Giaume, 2001). 
All of these factors are known to increase activity in neural cells, which increases 
the activity of glial cells and trophic factor production, which in turn, increases the 
metabolic processes necessary for neurotransmitter synthesis in neural cells. An increase 
in the number of glial cells generally signifies an increased requirement for neuronal 
support and therefore, increases in neural activity. 
The frontal cortex: Functions in humans and in rats 
One of the simplest ways to describe the functions of the frontal lobe is probably 
as the anterior region of the brain that temporally integrates neuronal input from all 
regions of the brain, records it into memory, organizes it, and prepares the individual for 
the execution of a behavioral response. The frontal lobe as a whole consists of the 
prefrontal cortex, the premotor cortex, and the primary motor cortex. The prefrontal 
cortex in humans is considered the highest intellect of the mammalian species. The 
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complexity in connectivity and function gives this area of the brain a recognized 
characteristic of executive function, which implies that all complicated decisions 
regarding appropriate behavioral outcome, are assessed in the prefrontal cortex. Another 
section of the prefrontal cortex, the orbital cortex, is dominant for social awareness and 
behavior. The premotor cortex prepares the motor cortex for action, which is contingent 
on the decision-making processes from the prefrontal cortex, during complex and novel 
experiences. 
Injury to the motor cortex in humans is known to cause difficulties in fine finger 
movements and losses in speed and strength (Kolb & Whishaw, 2003). The premotor 
cortex provides adequate preparation of voluntary motor movements. It does this as it 
simultaneously receives and sends signals to the parietal and temporal association areas. 
An injury to this area of the brain often results in disturbances of voluntary eye gaze, and 
speech, as well as disturbances with messages to the posterior areas to accommodate for 
planned movements (Kolb & Whishaw, 2003). Injuries to the orbital frontal region have 
revealed impulsive, disinhibited behaviors as a result of poor response inhibition, some of 
which develop into social and sexual disorders (Kolb & Whishaw, 2001; Cummings, 
1995). The orbital frontal cortex has also been proposed to contribute to the attention 
processes by filtering out unnecessary information before entering processes of executive 
function (Fuster, 2002; Cummings, 1995). 
The ventral areas of the prefrontal cortex, as part of a frontoparietal network, have 
revealed activity during in vivo neuroimaging, when subjects were required to redirect, or 
shift, their attention to locations of salient, or unexpected stimuli (Corbetta & Shulman, 
2002). This area has reciprocal connections to the temporal-parietal junction of the 
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posterior cortex and is called the ventral frontoparietal network. The parietal connection 
enables the ventral frontal areas to make spatial shifts of attention. Although the ventral 
cortical areas are not specialized to focus attention spatially, it is considered to share this 
feature with the dorsal regions of the frontal cortex. 
Prefrontal cortex injuries to the dorsolateral region are known to cause executive 
dysfunction. Because this set of cognitive functions is very complex, impairments result 
in an array of behavioral deficits, namely, large deficits in the supervision of attentional 
control (Fuster, 2002). 
The human dorsolateral prefrontal cortex selects and recruits sensory information 
from the posterior regions of the brain, to integrate and process this information 
sufficiently. Attention is required to select the appropriate, or relevant, features of a task, 
which uses working memory to keep information "on line". These processes are 
necessary for an individual to focus their attention. During working memory processes, 
the prefrontal cortex can organize and manipulate information to prepare for an 
appropriate behavioral response according to the task requirements. Impairments with 
these attention processes generally result in a disorganized plan and inappropriate 
preparation of actions. In addition, these processes all require monitoring of ongoing 
cognitive processes and activities to continue producing appropriate behavioral activity 
and filter out any inappropriate behavioral urges (Fuster, 2002). Fuster's model of 
executive function operate within long-term memory processes, he calls executive 
memory. Previously performed actions necessitate past memories for reference, which 
would progress as an updated version with the present action, and returned back into 
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long-term memory. Newly acquired behavior would need to undergo processes of 
rehearsal using working memory. 
Cognitive and behavioral inflexibility is common in prefrontal cortex injuries and 
revealed by individuals having difficulty in shifting attention set. Inflexibility can be seen 
when an individual has achieved an attention set with a particular rule for a task, but then 
is unable to shift to another rule. For example, some people who are accustomed to 
cooking a meal one particular way, with the same seasonings and methods, struggle to try 
a new recipe with new flavor combinations. They may want to try a new recipe and 
understand what is required to go through with a new plan of cooking, but cannot shift to 
a new method. Rules can also be considered as plans necessary to adapt to a new desired 
behavior. 
Injury to the frontal cortex in rats indicates some similarities to that of humans 
(Kolb, 1984). Brain lesions including the motor cortex impair the serial ordering of digit 
and forelimb movements and the execution of a chain of voluntary movements. Effects of 
damage can also be seen in tasks requiring strength or speed. 
Injury of the orbital regions, or the ventral portions of the rat prefrontal cortex, 
produces abnormal social interactions, hyperactivity, and an inability to initiate 
spontaneous behaviors, such as in generating new strategies for task solutions. Defective 
odor discriminations are also characteristic of orbital frontal lesions, and Kolb (2003) 
recently proposed that orbital lesions interfere with processes that integrate olfactory 
information into working memory. Maintaining stimuli "on line" is necessary to make the 
appropriate associations among stimuli and to attach the appropriate meanings to stimuli. 
This type of deficit could provide numerous complications for rats, as olfaction is one of 
19 
their primary sensory modalities necessary for orientation within their environment and 
among peers (Kolb. 1984). Lesions to the orbital frontal cortex in rats have also indicated 
impairments in delayed response of low reinforcement tasks that measures bar-pressing 
extinction (Kolb, Nonneman, & Singh, 1974). Deficits in extinction behaviors have been 
considered as impairments in shifting response strategies. The rat is required to 
extinguish a previously rewarded response that was no longer rewarded on subsequent 
trials. Spatial reversal tasks also indicate some problems for rats with orbital lesions, but 
the impairment is actually one of perseverative tendencies to the previously rewarded 
arm, not one of solving spatial problems. Brain lesions of the medial frontal regions of 
the prefrontal cortex do reveal spatial problem solving deficits and delayed-response type 
solving tasks, but not in bar-pressing extinction tasks (Kolb, Nonneman, & Singh, 1974). 
The serial ordering, or temporal integration, of movements has been determined 
to be a function of the medial frontal cortical areas in the rat (Kolb, 1984). Measures 
associated with the serial organization of behavior have been determined in delay-
response type tasks that determine capabilities in working memory, or in spatial aspects 
of that task (Kolb, 1984). 
In humans, these processes are considered as executive functions, housed in the 
dorsolateral areas of the prefrontal cortex. In consideration of the possibility that rats 
might possess executive functions, many researchers have devised various experiments in 
attempts to isolate certain functions with particular regions of the prefrontal cortex. Kolb 
(1984) has defined impairments in behavior of temporal ordering of movements, response 
inhibition, spatial processing, and habituation as a result of prefrontal cortical damage. 
20 
Although these impairments have not been labeled as "executive dysfunction", the 
resulting behavior may be comparable. 
Fuster's (2002) model of executive function, or supervision of attention, includes 
four contingencies of known prefrontal cortex functions: 1) attention, 2) working 
memory, 3) prepatory set, and 4) monitoring. These processes however do not function in 
a linear form from the first to the last process, but rather operate in an overlapping 
manner (Fuster, 2002). To adequately respond to a stimulus, one must first be able to 
attend to the relevant aspects of that stimulus, while disregarding the irrelevant aspects of 
the stimulus. During this time, working memory would be required to maintain "online" 
information to determine necessary preparation for behavioral responses. Monitoring 
records the feedback of information held online in working memory for prepatory set of 
the next behavioral response. Attention throughout these overlapping contingencies 
determines appropriate encoding of information and planning of responses. 
Researchers who have attempted to delineate the separate effects of executive 
processes in rats have isolated certain aspects of these functions through brain lesion 
experiments. A "supervisory attention system" residing in the prefrontal cortex of rats has 
been proposed by Delatour and Gisuet-Verrier (2000). Attention, behavioral flexibility or 
attention shift, spatial attention and working memory were examined. By using 
chemically induced excitotoxic lesions of the prelimbic-infralimbic region, they were 
able to determine behavioral deficits of these executive functions defined by attention and 
working memory abilities. One paradigm tested for flexibility was navigation on a 
circular arena. Starting positions changed with each trial to assess the ability of rats to 
shift with each new starting position (Delatour & Gisuet-Verrier, 2000). Birrell and 
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Brown (2000) maintain that executive function of attention shift does exist in the rat, and 
resides in the prelimbic-infralimbic region of the prefrontal cortex. This was 
demonstrated using excitotoxic lesions and a behavioral task that did not require spatial 
shifts of attention, but was intended to measure only a shift of attention, using inhibition 
of previous responses. (Birrell and Brown, 2000). Behavioral tasks measuring spatial 
attention and working memory have been indicated as part of the prelimbic functions, as 
determined by Fritts et al (1998). Fritts, performed studies of cortical lesions from 
surgical removal of the medial frontal cortical region, some or which included the 
prelimbic areas, some did not. The results of this experiment suggests that the anterior 
cingulate, infralimbic and medial precentral (premotor) areas are required for attention 
with working memory, and temporal sequencing of information in rats (Fritts, Asbury, 
Horton & Isaac, 1998). 
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Table 1. Summary of effects of medial frontal and orbital frontal lesions in rats 
Behavioral Impairment Basic Reference 
Medial Frontal: 
(including motor) 
Serial ordering of digit and 
forelimb movements, 
Excecution of a chain of 
voluntary movements, 
Decreases in strength and speed. 
Kolb et a l , 1984 
Medial Frontal Spatial problem solving, 
Delay-response type solving tasks, 
Working Memory, Habituation. 
Spatial attention, Attention shift, 
or behavioral flexibility. 
Non-spatial attention shift. 
Attention with working memory. 
Temporal sequencing of 
information. 
Kolb, Noneman & Singh, 
1974 
Delatour & Gisett-Verrier, 
2000 
Birrell & Brown, 2000 
Fritts, Ashbury, Horton & 
Isaac, 1998 
Orbital Frontal Social interaction, Hyperactivity, 
Response inhibition, 
Inability to initiate spontaneous 
behavior, Defective odor 
discriminations, 
Extinction, Perseveration. 
Kolb, 2003 
Kolb, Noneman & Singh, 
1974 
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Functions of the parietal cortex in humans and in rats 
The primary function of the posterior parietal cortex is to provide sensory 
guidance of movements in space. The dorsal stream of visual information arrives to the 
parietal cortex directly from the occipital cortex. This information is known as the 
"where" stream of information. The ventral stream of visual information from the 
occipital cortex flows to the temporal lobes and provides the "what" stream of 
information. Reciprocal connections between the parietal and temporal lobes enable the 
individual to make associations of objects, or landmarks, in space with other objects or 
landmarks. 
The visual-spatial information of the posterior parietal lobe is that of 
extrapersonal cues, or landmarks, which enables the individual to monitor its place in 
space. It is believed by some that this lobe provides the individual with a "cognitive map" 
of representations of their environment, as was originally suggested by O'keefe and 
Nadel (1978). Recent research, however, suggests that the parietal lobes trace a series of 
representations (Kolb & Whishaw, 2003). These representations must be continually 
updated in memory, according to the changes within the environment as the individual 
moves from one location to another. A mental map would be formed to trace the previous 
path, but the individual would also need to consider what it is approaching. The 
prefrontal cortex monitors these cognitive processes, holds them in working memory, 
while new information is presented and kept on line to make a trace of spatial events. 
Both the posterior parietal and prefrontal cortexes also have reciprocal connections with 
the hippocampus in the medial temporal lobe, which plays an important role in the 
generation of certain forms of long-term memory. 
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Another approach to understanding spatial behavior is the accuracy of hand-eye 
coordination of movements within the proximal area of the individual. The parietal lobes 
are responsible for visually guided movements, which also require a continual update of 
behavioral actions just performed. The premotor cortex receives this information and 
prepares for the next behavioral action. This information is again projected to the 
posterior parietal cortex forming a re-entry loop. 
Injuries to the parietal lobes in humans and laboratory animals can seriously 
interfere with the normal updating processes necessary to maintain accurate 
representations in space. Whether these representations are of distal cues and landmarks, 
or of proximal movements of the individual, there is often a disorientation of 
extrapersonal space. 
An extraordinary example seen in humans is the experience of contralateral 
neglect with injury to the posterior parietal regions of the brain, particularly if the 
damaged area is in the right hemisphere. The resulting behavior indicates an inability to 
acknowledge the information presented to the visual field opposite the side of the brain 
lesion location. This tends to interrupt the formulation of associations with distal cues 
within their environment, but also of movements within proximal areas of the body. 
Many of these patients do not realize that they have the other side of their body to dress, 
or the other side of their plate of food to eat and so on (Kolb, & Whishaw, 2003). 
A number of researchers have proposed possibilities for the underlying deficits of 
behavior resulting from brain damage to the posterior parietal cortex. One primary deficit 
proposed is an inability to selectively attend to the relevant stimuli required to maintain 
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accurate representations and associations of environmental cues. The end result could be 
a confusion of appropriate and inappropriate representations into memory. 
Imaging of brain activity has revealed heightened activity in the parietal cortex 
during shifts of attention and has been implicated as a region for spatial attention control, 
as well as to maintain the current state of attention (Yantis et al., 2002). The extrastriate 
areas of the adjacent visual cortex are also proposed to be involved in attention-related 
changes by mediating the type of information that is communicated with the motor 
systems of the frontal lobe. During shifts of attention required to perform changes in eye 
movements, or arm reaches, the posterior regions of the brain perform the necessary 
shifts of attention (Yantis et al., 2002). 
The temporal-parietal junction is reciprocally connected to the ventral areas in the 
prefrontal cortex (Corbetta & Shulman, 2002). Activity in these areas is also heightened 
during periods of orienting attention towards oddball or infrequent stimuli that are 
distractors from relevant stimuli. If the distracting stimuli have similarities to the relevant 
stimuli, such as color, attention would transiently shift toward peripheral distractors, 
resulting in loss of attention at the relevant spatial location. For example, if you were 
looking for a friend wearing a red hat in a crowd of people, anyone wearing red would 
activate your attention. The activation, in this case, would reside in the temporal-parietal 
junction. It is suggested that this cortical area is differentially engaged by task-relevant 
stimuli and determines the their behavioral valence (Corbetta & Shulman, 2002). 
To determine the possibility that rats may have some similarities in behavioral 
deficits from posterior parietal lesions, to those experienced by humans, a region of 
similar characteristics in the posterior cortex needed to be identified (Kolb, & Walkey, 
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1987). Kolb and Walkey used tracer techniques to identify areas of the posterior cortex 
that would indicate the same characteristic connectivity patterns of the parietal cortex to 
that of primates. Kreig's area 7 was the area identified that closely resembles the primate 
posterior parietal cortex. Injections of tracer into area 7 indicated staining in the border 
areas of the precentral (premotor) and anterior cingulate. Similarly, injections into the 
frontal regions of the precentral and anterior cingulate produced staining in Kreig's area 
7. Counterstaining with another tracer revealed an overlap of neural connections in both 
of these regions, indicating reciprocal connectivity between the posterior parietal areas 
with the anterior cingulate and precentral (premotor) areas of the frontal cortex in the rat. 
The behavioral results of cortical lesions in Kreig's area 7 included tactile sensory 
impairments on a tactile discrimination task that required rats to chose the rewarded alley 
according to tactile textures. Impairments were also found in the Morris water task where 
rats were required to navigate their way to a hidden platform using distal cues. Their 
impairments in this task were of a poor heading angle, or trajectory, to find the platform 
after each new starting point. 
Some interpretations have extended poor initial trajectory as an impairment in the 
ability to use the extrapersonal cues as indicators necessary to orient the head and body in 
the correct direction before initiating a motor response (Ward, & Brown, 1997). To 
determine whether deficits are attentional in nature, Ward and Brown used a nine-hole 
apparatus, employing a covert orienting task, with rats tested before and after surgery to 
produce unilateral lesions in the posterior parietal cortex. There was no evidence for 
asymmetry of responses, but the incidence of incorrect responses toward invalid cues was 
higher. Ward and Brown concluded that using unilateral lesions of the posterior parietal 
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cortex do not reveal impairments in covert orienting, or in signal detection, or vigilance 
(Ward & Brown, 1997). The impairment in the attentional task of covert orienting was 
considered one of response impairment, which suggests impulsive responses if inhibition 
to respond to irrelevant cues was impaired. 
The neural circuit considered responsible for directing spatial attention in rodents 
thus involves the medial agranular insular cortex (Zilles Al), the ventrolateral orbital 
frontal cortex, and the posterior parietal cortex (Ward, & Brown, 1997). 
Disturbances in orientation that are necessary for maze solving in rats may also be 
due, in part, to impairments in the activity of head-direction cells. These cells have been 
proposed to aid the rat in maintaining awareness of direction according to a series of 
body orientations; therefore, if damage should include these cells, impairments in an 
innate form of orientation would ensue (Golob, Stackman, Wong, & Taube, 2001). 
Table 2. Summary of the effects of posterior parietal lesions in rats. 
Behavioral Impairment Basic Reference 
Tactile sensory 
Spatial navigation 
Poor initial trajectory 
Spatial attention 
Kolb & Walkey 1987 
Kolb & Walkey 1987 
Ward, Brown, 1997 
Head-direction cells for Golob, Stackman, Wong, 
& Taube, 2001 orientation 
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Choline Treatment 
Choline is an example of a vital amine. "Vital amine" was a term to describe 
organic compounds necessary in small quantities for normal health, coined by Casmuir 
Funk in 1912 (Blusztajn, 1998; Goff, Gropper, & Hunt, 1995). Although choline is 
synthesized naturally in the human body, this amount is too small to sustain optimal 
health and requires supplementation from sources of food. Choline has important 
functions in metabolic processes due to the interrelationship it has with methionine, 
folate, vitamin B6 (pyridoxine) and vitamin B12 (cyanocobalamin). It is essential for lipid-
cholesterol transport and metabolism in the liver, necessary for the synthesis of 
phospholipids in cell membranes and neural glia. Choline is also a precursor for two 
signaling lipids, platelet activating factor and sphingophosphorylcholine, as well as for 
acetylcholine, an excitatory neurotransmitter in the brain (Zeisel, 2000; Blusztajn, 1998). 
The Institute of Medicine recently has designated choline as an essential nutrient 
for humans and for animals (Zeisel, 2000; Blusztajn, 1998). Its essentiality as a nutrient 
has been determined from cases of choline deficient diets, which lead to liver 
dysfunction, growth retardation, renal dysfunction, and bone abnormalities in baboons. 
As a result, choline is generally added to animal feeds. In humans, liver damage has been 
reported in those receiving total parenteral nutrition devoid of choline. These effects are 
reversible with the addition of choline to the formulation. Dietary deficiency of choline in 
rats has revealed the development of hepatocarcinomas in the absence of any known 
carcinogen (Zeisel, 2000). 
Female rats have been noted to be less sensitive to choline deficiency than males, 
potentially due to the effects of estrogen with choline synthesis. Pregnant and lactating 
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female rats however, are considered as sensitive to deficiency as males, because large 
amounts of choline are delivered to the fetus via the placenta. These results could imply 
that choline is essential during critical periods of development. Studies in women, 
children and infants have not been carried out to determine recommended daily intakes 
for choline (Zeisel, 2000). 
Dietary choline administered prenatally and postnatally has revealed lifelong 
increases in attention, learning, and memory in rats (Meek, Smith, & Williams, 1988). An 
extension of this research found cognitive enhancements of working memory and 
reference memory to be correlated with neurochemical measures of brain activity. These 
results were found in both the frontal lobe and hippocampus of male rats tested in 
adulthood. 
Developmental factors are proposed to produce this enhanced effect of learning 
and memory into adulthood (Albright, Freidrich, Brown, Mar, & Zeisel, 1999). Changes 
in the timing of mitosis, differentiation, migration, and apoptosis as a result of maternal 
choline availability have been determined in the rat hippocampus and septum. Albright 
and colleagues suggests that interferences in the natural timing between stages of neural 
development could influence neural patterns of organization (Albright, Freidrich, Brown, 
Mar, & Zeisel, 1999). During the prenatal and postnatal periods of brain development, 
choline is metabolized in the maternal liver into phosphorylcholine and betain. These are 
the active forms of choline during periods of fetal brain development until migrating 
neurons reach their target cells and mature into cholinergic neurons (Garner, Mar, & 
Zeisel, 1995). According to Garner et al., choline in the form of phophorylcholine is the 
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essential messenger that can induce DNA synthesis, thereby increasing the rate of cell 
division. 
The effectiveness of dietary choline as a precursor for acetylcholine comes from 
the advantageous endogenous relationship that cholinergic neurons have with nerve 
growth factor (NGF). By increasing the plasma choline and the subsequent storage of 
choline as phosphatidylcholine in mature cholinergic neurons, neurons would have an 
available supply for acetylcholine synthesis, which increases nerve growth factor 
synthesis. Although NGF is largely committed to cholinergic neurons it may also 
enhance trophic activity for other neurons. 
The dietary and metabolic characteristics during the pre- and postnatal period of 
development that give long-lasting effects in learning and memory indicate that dietary 
choline could provide some benefit for the treatment of early cortical injury. 
Vitamin and mineral supplement treatment 
The discovery of vitamins came about in the early years of the twentieth century 
Researchers who became interested in diet composition realized that nutrients from food 
consist of more than fat, carbohydrate, protein, minerals and water (Goff, Gropper, & 
Hunt, 1995). 
The minerals identified as required for maintenance of normal health are 
numerous with various functions and are classified as macrominerals and microminerals 
(Goff, Gropper, & Hunt, 1995). The discovery of minerals began as knowledge of body 
fluid and body tissue composition, which eventually became more elaborate with the 
improvement of assay techniques. There is no concrete definition for either 
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macrominerals or microminerals. The two classifications can be distinguished by their 
occurrence in the normal healthy body, as a normal amount necessary to sustain health. 
Definitions used for macrominerals are: 1) present in a constitution of .01 % total body 
weight, or 2) present in a minimum quantity of 5 grams for 60 kilograms of body weight. 
A less ambiguous suggestion is a requirement of amounts greater than lOOmilligrams 
daily. Trace minerals are generally defined as a requirement of less than lOOmilligrams 
daily (Goff, Gropper, & Hunt, 1995). 
Vitamins and minerals are also a necessary dietary requirement for plants and 
animals (Morris, 1991). There is apparently a high degree of uniformity among all living 
organisms in their need of dietary essential minerals, although the necessary quantities 
vary between species. Morris (1991) has discovered the mineral requirement for most 
animals to be approximately five percent of dry weight food intakes. Vitamins, as well as 
essential fatty acids, are also nutrient requirements for animals with suggested intakes of 
approximately one percent and one to two percent dry matter, respectively (Morris, 
1991). 
The metabolic characteristics of vitamins and minerals and their effects on 
physiological function are well known for peripheral systems of the body. Their effects in 
the central nervous system, however, are not as well documented and many deficiency 
studies have been restricted to animal studies (Dreyfus, 1988; Goff, Gropper, & Hunt, 
1995). 
What is known and pertinent to the study of nutrition in the central nervous 
system, is that vitamin deficiencies generally result in bilateral "biochemical lesions", 
which affect certain cell populations as well as the neural connections associated with 
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them. The characteristic clinical signs of many deficiencies, such as dry hair, scaly skin, 
and brittle nails, are the late stages following already present neurological changes 
(Dreyfus, 1988; Goff, Gropper, & Hunt, 1995). 
A few of the known neurological dysfunctions caused by vitamin deficiencies 
have been attributed largely to deficiencies of the B vitamins (Dreyfus, 1988). Human 
studies of vitamin Bi, or thiamin, deficiencies have been numerous since its discovery. 
Beriberi results in polyneuropathy in the peripheral nervous system, characterized by 
progressive weakness and muscle wasting. Wernicke's encephalopathy has many 
characteristics of mental symptoms, such as global confusion, profound disorientation, 
inattentiveness and decreases in spontaneous speech. Korsakoff s psychosis is a known 
syndrome from excessive intakes of alcohol, characterized as an amnesic-confabulatory 
syndrome with impaired perceptual and conceptual mental abilities. 
Deficiencies of vitamin B6 (pyridoxine), has been reported to result in peripheral 
neuropathy in humans. In the human neonate, acute deprivation of vitamin B6 is known 
to lower the seizure threshold of the immature brain. Pregnant rats fed a vitamin B6 
deficient diet resulted in a delayed or reduced rate of myelination along with significant 
structural alterations in the brains of the offspring rats. 
Pernicious anemia has been commonly recognized in vitamin B12 
(cyanocobalamin) deficient humans. These signs of deficiency are generally treated 
before observations of neurological abnormalities become apparent. A severe deficiency 
of vitamin B12 has been noted as degeneration of cerebral white matter, optic nerves, the 
spinal cord and of the peripheral nerves. 
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Vitamin B3 (niacin) deficiencies have caused Pellagra, an encephalopathy that is 
associated with mental symptoms. Symptoms are also seen in peripheral nerves and 
spinal cord. Deficient humans and animals administered niacin have shown increases in 
nucleotide synthesis and increases of norepinephrine and dopamine tissue concentrations 
to well above normal (Dreyfus, 1988). 
Folic acid is probably the best known B vitamin that has deleterious effects if 
deficient during pregnancy. Folic acid is essential to complete the formation of the neural 
tube during development. Deficiency during pregnancy is known to cause spina bifida, or 
simply, neural tube defects. 
The neurological deficits mentioned as a result of vitamin deficiencies are only a 
few examples of the importance of vitamins and minerals for optimal physical, 
emotional, and mental health. 
Prenatal protein malnutrition, during neurogenesis, has been noted to interfere 
with the normal proliferation of cells and the normal subsequent enlargement of brain 
cells (Lewis, 1990). Among a number of deleterious effects of malnutrition postnatally, 
during late neurogenesis of the dentate gyrus and cerebellar cells, Lewis has reported a 
decrease of ten to twenty percent in cell population with severe deficits in total DNA. 
These findings revealed reductions in germinal cells, and an increase in the number of 
degenerated postmitotic cells, among other changes from normal developmental 
processes (Lewis, 1990). 
During the developmental processes cells require sufficient supplies of vitamins 
and minerals to sustain all of the nutritional demands of the growing fetus. All organs 
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have characteristic "critical periods" during development and are apparently very 
susceptible to nutrient alterations (McArdle & Ashworth, 1999). 
McArdle and Ashworth have reported Vitamin A as essential for reproduction, 
embryogenesis, development and growth. Vitamin E intakes are important to prevent 
peroxidation reactions and to maintain the integrity of newly formed cell membranes. 
Vitamin K supplementation improves the mineralization processes for bone, cartilage and 
tooth growth and development. Of the water-soluble vitamins, vitamin B6 is known to 
prevent alterations in brain N- methyl D- aspartate receptor function, necessary for 
learning and memory. Folic acid increases nucleic acid sysnthesis, necessary for cell 
growth and replication during gestation and for rapid tissue growth periods. Vitamin B12 
is necessary for the myelination processs in the brain (McArdle & Ashworth, 1999). 
The B vitamins, Bi, B3, and B6 in particular, are cofactors that are essential in 
metabolic pathways linked to energy and protein synthesis, which require increases in 
vitamin intakes for increases in energy and protein accretion. Vitamin C levels generally 
decrease during pregnancy and require vitamin increases to maintain pooled supply (Barr, 
1998). 
Aside from collagen synthesis and its antioxidant properties, vitamin C is also 
necessary to synthesize brain neurotransmitters serotonin, dopamine, and norepinephrine 
(Goff, Gropper, & Hunt, 1995). 
Vitamin D is often present in low (serum) amounts in infants, and is necessary to 
maintain neonatal homeostasis. Vitamin D aids in the prevention of bone malformations 
(rickets) during growth periods. During pregnancy iron is necessary for red blood cell 
expansion. Zinc is also essential, as it is part of enzyme complexes in numerous 
35 
metabolic pathways. Protein synthesis requires zinc, and therefore is necessary for 
normal weight gain during pregnancy (Barr, 1998). 
The studies mentioned exemplify the importance of a nutritionally balanced diet 
that reflect the body's present physiological status and metabolic requirements. Hence, 
during sensitive periods of pregnancy and lactation, maternal nutrient requirements 
change to prevent any unnecessary consequences. Importance has also been stressed on 
interactions among nutrients. Higher levels of one vitamin and/or mineral could interfere 
with the absorption of others. For example high magnesium intakes could affect the 
absorption of zinc and calcium. Similarly, synergistic effects could occur with other 
nutrients. Vitamin C is known to enhance the absorption of iron. A properly balanced 
vitamin and mineral supplement, formulated for pregnancy would be highly 
recommended to prevent potential imbalances in the various nutrients. 
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2. General Organization of the Thesis Experiments 
Two experiments were conducted to investigate the role of choline (Experiment 
1) and a vitamin/mineral supplement (Experiment 2) in facilitating recovery from early 
cortical injury in rats. In both experiments, rats were given suction lesions of the medial 
frontal or posterior parietal cortex on postnatal day 3 (Exp. 1) and postnatal day 4 (Exp. 
2). As noted earlier the functional outcome after injury at this age is very poor relative to 
similar damage oceuring one week later. The general hypothesis was that it ought to be 
possible to facilitate recovery from day 3 or 4 lesions by providing factors that either 
might potentiate the activity of endogenous factors necessary for plastic changes that 
could support functional recovery, or by some direct action of the factors themselves. The 
experiments were designed to run in parallel to other studies by Kolb and his colleagues 
that were looking at the effects the application of various pharmacological (eg., 
psychomotor stimulants, neurotrophic factors) and environmental (eg., tactile stimulation, 
complex housing) factors on recovery from similar brain injuries. 
Behavioral Measures 
The behavioral tasks chosen to study the effects of treatment intervention are 
summarized here. All animals in both experiments were tested on three behavioral tests; 
1) open field (to measure activity in a novel environment), 2) the Morris water task, (a 
spatial learning task), and 3) tray reaching, (a skilled forelimb motor task). A subset of 
each treatment group from both experiments participated in the attention shift task to 
measure proposed executive functions. 
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Fig. 7. Open Field Apparatus 
Open Field: 
The open field apparatus is commonly used to measure a variety of locomotor 
movements in rodents (see Fig.7). Using the open field as the first exposure to behavioral 
testing also gives this apparatus the opportunity to reveal activity in a novel environment. 
Sensors that surround the box for this test can measure horizontal and vertical activity, 
the distance covered and time spent in the margins, or the center of the field. Some 
experimenters also analyze fixed action patterns with the open field behavioral task. 
Habituation to a novel environment is generally indicated by a pattern of a decline in 
overall activity with each timed interval that is repeated for a designated time frame. 
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Morris Water Task: 
In their natural habitats, animals must learn to construct a cognitive map of their 
surroundings to remember specific locations, such as food sources, areas of safety from 
predators, and the route back to home base. 
The Morris water maze task has been a widely used behavioral task to measure 
spatial memory in rodents. It requires rats to form cognitive representations of their world 
by navigating within their local environment. To construct a cognitive representation, the 
rats must learn to make associations with distal cues in its environment with that of a 
hidden platform to escape the cool water (see Fig.8). The latency, or time, that the rat 
requires to find the platform is the most commonly used measure to indicate any learning 
deficits. Additional measures considered for testing in this task are: 1) heading angle, or 
initial direction of orientation towards the platform 2) speed, to assess motor capacity 3) 
path distance to determine the length of distance required for each trial, and 4) 
thigmotaxis to determine the amount of time an animal spends at the edges of the pool 
trying to get out, rather than learning to find the platform. 
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Fig.8. Morris Water Maze 
40 
Fig.9. Tray Reaching Apparatus. 
Tray Reaching: 
The tray-reaching task is useful to assess limb and grasp function of motor 
control. Rats are required to reach through the steel bars on the face of the cage to a tray 
which holds food pellets, grasp a pellet, and bring it back to their mouths to eat (see 
Fig.9). Once they are trained until consistently successful to their capacity, each rat is 
then filmed individually for assessment and scoring. Various lesions of the rat brain have 
revealed similar deficits to those seen in humans with brain damage in similar areas 
(Whishaw, Pellis, & Gorney, 1992). To assess a simplified form of a skilled reach, the 
tray-reaching task has been very useful to determine the effects of various treatment 
interventions under these conditions. 
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Attention Shift: 
The attention shift task for rodents is proposed to be somewhat analogous to the 
Wisconsin Card Sorting Test used in human neuropsychology studies. In the card sorting 
task patients are required to sort a deck of cards according to certain characteristics 
presented (Kolb, & Whishaw, 2003). These characteristics vary according to color, shape, 
and number of elements. The patient does not know the rule of the task, but is only 
informed whether or not the response is correct. For example, the first rule might be 
color. Patients must sort the cards according to color. Without notification, the rule 
changes to shape. The patient is then required to inhibit the previous rule of the task of 
color, and adopt the new rule of shape (Kolb, & Whishaw, 2003). It has been designed to 
assess prefrontal function of executive processes, or higher cognition, of patients with 
frontal lobe damage. 
This behavioral task proposes to determine the ability to maintain and shift 
attention set, when the rule of a task changes, without prior notification (Birell, & Brown, 
2000). Humans and monkeys with frontal lobe damage have difficulty with this task. 
Therefore, if rats also have difficulty shifting attention set it may be possible to presume 
that rats have the fundamental capability to learn and adapt to new situations, using 
executive functions of cognition. The main difference with this task used for rodents is 
that the stimuli for which to detect a rule change is within the rats' preferred modes of 
learning- olfactory or tactile. The paradigm for this task, with fixed dimension pairs, was 
based upon Birrell and Brown (2000). The differences between the paradigm used by 
Birrell and Brown, to the one used here were: 1) They used a maze that was not 
considered to have a spatial feature to it, this maze does have spatial features, 2) they 
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Fig. 10. Attention Shift Maze 
used three exemplars for rats to discriminate during each dimension, only two were used 
here, and 3) Birell and Brown used excitotoxic lesions to the prelimbic and infralimbic 
areas of the prefrontal cortex, this experiment used aspiration lesions of the entire midline 
frontal cortex. The apparatus used for this task has two arms for rats to enter to obtain a 
food reward (see Fig. 10). The baited arm is randomly chosen in such a way that it might 
also be possible to tease out any spatial reversal deficits. 
The purpose for the investigation of attention shift in these experiments was to 
determine the capacities of the rat's cognitive processes of attention, and potential 
executive function, and the underlying anatomical regions in the brain that rats use to 
solve difficult problems. 
43 
3. Experiment 1 
The experimental design used for treatment preparation was based upon one used 
by Richard Tees and Ehsan Mohammad! (1999). They introduced choline water solution, 
which was the only source of drinking water to females, two days prior to conception. 
Tees and Mohammadi then cross-fostered their rat pups at birth to mothers who no longer 
received choline water. The pups that had received prenatal choline also received 
postnatal choline by subcutaneous injections. The current experiment differed in that 
choline treatment continued in pups postnatal via their mother's milk for thirty days until 
weaned at postnatal day thirty. 
Preliminary studies (B. Kolb & R. Tees, unpublished observations) had shown 
that the new procedure was effective in altering neuronal morphology, so it was expected 
that it should be able to influence synaptic organization of animals with perinatal cortical 
injuries. 
In order to simplify the presentation of the results from the effects of the 
treatments on both frontal and parietal lesions, respectively, the frontal and parietal 
lesions are reported as separate experiments. 
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Experiment # 1 A 
The Effects of Choline Treatment on Recovery from Perinatal Medial 
Frontal Injury 
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Method 
Subjects 
A total of sixty-four Long Evans rats prepared using a crossed litter design were used for 
experiment 1A (see Table 3). This group of rats was used in three behavioral studies. Not 
all the rats were tested in the attention shift task. A subset of twenty-one rats from a total 
of fifty-eight, were selected for the attention shift task based on which rats were 
participating during the training session. 
Any sex differences that are significant to the experimental results are reported. 
Table 3. Number of rats used in experiment 1A. 
Untreated Choline Treatment 
Sex Female Male Female Male 
Unlesioned n = 5 n= 12 n = 7 ii=13 
Frontal Lesion n = 5 n= 11 n = 4 n = 7 
Treatment procedures 
Choline was added to regular tap water for drinking water ad libitum. 
Concentrations of choline are 5mL/L of 70% choline chloride in 0.02M saccharin 
solution. 
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Surgical procedures 
The animals were all anesthetized by means of cooling in a Thermatron set at -
5°C on postnatal days two and three. Cooling occurred for approximately 10 minutes, or 
until the rat pups were immobile and whitish in color. These parameters of immobility 
and color have been correlated with appropriate rectal temperatures, ranging from 18-
20°C by Kolb and colleagues. Once the skin was incised, the bone of the skull was 
removed from bregma to lambda using iris scissors. Frontal cortex lesions required 
removal of the midline region of the cortex, anterior to bregma, by gentle aspiration. 
Suturing of the wound was done using silk thread. The sham control animals underwent 
all procedures except for bone incision and lesion aspirations. After completion of 
surgery, animals were slowly warmed using body heat by holding the pups in warm 
hands until they began moving, then were returned to their mothers. 
Behavioral procedures 
Open field Activity: 
The open field test was performed in a plexiglass box (42 cmx42 cmx32 cm h), 
which has a lid on the top of the box. At the base of the box and approximately 1/3 in 
height, is a band of sensors around the perimeter of the box to record a variety of activity 
measures. A printer was connected to the open field apparatus, which resided in the same 
room, and was programmed to print activity behavior at two-minute intervals for ten 
minutes. At the end of the ten-minute period, the rats were placed back into their holding 
tubs and the number of defecations remaining in the apparatus were noted, which has 
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previously been used, in part, as observations of the stress response. Data collection was 
completed for each rat at the end of the ten- minute period. 
Morris Water Task: 
The maze used in the water task is a circular pool has a diameter of 1.5m and a 
height of 0.5m deep. The walls of the pool were painted white and the water rendered 
opaque with powdered milk. The platform (11x12 cm.) was placed in the northwest 
quadrant of the pool and submerged about 1.5 cm. below the water's surface. Each rat 
was placed into the pool facing the wall in one of four random starting positions (east, 
west, north, or south). 
All animals were selected randomly into groups of eleven, to prevent any 
potential litter effects. The animals swam four trials each day for five days. Each trial had 
a different starting position, using all four points of direction each day, and changed in 
order of direction each day. Each trial consisted of a maximum of ninety seconds during 
which the rats had to find the hidden platform. After ninety seconds, the trial ended and 
rats that did not find the platform within that time were placed on the platform for ten 
seconds. Rats who did find the platform within the ninety-second interval were able to 
stay on the platform for ten seconds before being removed from the pool. All swim trials 
were recorded by means of a video camera mounted from the ceiling directly above the 
pool. Data collected from the camera were analyzed by a computer program (Water 
2020). On the sixth day, a probe trial was given. During the probe trial, the platform was 
removed and the rats started at the north position. Rats swam for twenty seconds and each 
trial was recorded into the computer program for analysis. 
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Trav Reaching: 
The procedure for the tray reach task was devised from Whishaw's skilled 
reaching task (Whishaw, O'Connor, & Dunnet, 1986). The test cages consist of clear 
plexiglass walls with a closable iid (20x 28x 26 cm). The front wall and floor of each 
cage was constructed of stainless steel bars. The floor was cross-linked with 2mm bars, 
and the front had vertical 3mm bars, extending 9mm apart from one edge of the cage to 
the other. Mounted in front of each set of three cages was a stainless steel tray, which 
held small pellets of chicken feed. The tray was suspended on runners at the sides of each 
cage set, and is positioned about 5mm away from the faces of the cage. 
Rats were food deprived daily by feeding 15g. to each female and 20g. to each male. 
These food portions have been determined to slowly reduce body weight, which should 
not exceed in a loss of 15% body weight. The rats were fed a standard lab chow diet and 
were food deprived for six consecutive days. On the sixth day, after training, rats were 
fed ad libitum to prevent any potential further weight loss. Food deprivation began again 
after one day off. 
Reaches were considered unsuccessful if the rats did not maintain a successful 
grasp at the tray, or during transport of the pellet back to the rat's mouth. If the rat had . 
extended an arm towards the tray, but did not touch the food pellets, the reach attempt 
was not considered for scoring. When the animals had sufficiently learned to reach for 
the pellets, the rats were filmed by a video camera individually for ten minutes. Scoring 
of reach attempts and successes were determined by replay of the video for seven minutes 
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per rat. Attempts included both successes and failures. Overall success was determined as 
a percentage of successes verses attempts. 
Attention Shift: 
A wooden Y-shaped box (27 cm /xl4.5 cm wx21 cm h) was used and two glass 
octagonal bowls were placed at each of the two arms of what was designated the top 
portion of the Y maze. Each bowl contained sawdust during the training, or habituation, 
period. Rats were trained to dig for one half of a Froot Loop as a baited reward. The rats 
were then required to enter each arm to visit each bowl to learn to dig for a food reward. 
Once rats were trained to dig in bowls for a Froot Loop, the scent and medium in the 
bowls varied as the task progressed and only one of two bowls was baited. The baited 
arm was also randomly chosen, not exceeding more than two to three arm reversals 
throughout testing (Appendix B). Each rat was allowed four free visits to either of two 
bowls to determine which bowl was baited. Thereafter, errors were recorded as defined 
by a rat digging, or poking its head into the unbaited bowl, in an attempt to find the Froot 
Loop. A criterion of six correct consecutive trials was required to complete each 
discrimination combination. Approximately ten seconds was required to re-bait the 
bowls. The number of distractions were also recorded, because it seemed directly linked 
to the frequency of errors. A distraction was defined as having to remove the rat from the 
maze due to failure to participate in the task for that trial. The distracted trial was 
recorded as a distraction and another trial began after discontinuation. 
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Anatomical procedures 
At the completion of behavioral testing, rats were given an overdose of sodium 
pentobarbital (0.5ml-0.7ml) until they reached a comatose state. At this point, they were 
perfused intracardially, using 0.9 % saline solution. Rat brains destined for Cresyl Violet 
staining, perfusions of 4% paraformaldehyde followed saline. Removal of the brains were 
done using Rongeurs and weighed immediately following removal from the skull. Forty-
two rat brains were designated for Cresyl Violet stains. The remaining 22 male rats were 
perfused for Golgi staining. For Cresyl Violet preparations, the brains were placed in 
small bottles containing 4% paraformaldehyde in 30% sucrose solution. 
For Golgi preparations, brains were weighed at the end of saline perfusions and 
placed in small bottles containing Golgi solution. These brains were processed following 
procedures devised by Gibb and Kolb (1998). 
The brains for Cresyl Violet staining were sliced on a Cryostat 2800 Frigocut, 
which maintains tissue at -21 °C. Every 7 t h slice was taken at 40 u,m thickness and placed 
on slides fixed with a film consisting of 1.0% gel and 0.2% chromatin. Once the brains 
were dried to the slides, the slides were placed in slide trays, which hang on a Fisher 
Histomatic Slide Stainer (model 172). This apparatus runs through a programmed series 
of solutions required to complete Cresyl Violet staining. 
Brain Weight: 
The measures of brain weight are obtained by weighing each brain directly after 
removal from the skull of the perfused rat. Thereafter, brain weights are compared 
between groups to determine an estimate of tissue lost as a result of the lesions. Care was 
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taken to ensure consistency of brain removal before weighing. The spinal cord was cut 
along the caudal edge of the cerebellum, the cerebellar paraflocculi were removed, the 
optic nerve was cut 1-2 mm anterior to the optic chiasm, and remaining dura was stripped 
off the brain's surface. At the front end of the brain, the olfactory bulbs are cut at 1.5-2.5 
mm from the frontal cortex. 
Cortical thickness: 
After slide preparation, the brains were viewed and assessed at a magnification of 
17.5 x with a Zeiss DL 2 POL petrographic projector. 
Cortical measurements were made using a clear plastic ruler for both the choline treated 
group and the no treatment control group. Three different cortical measurements, for each 
hemisphere, were deterrnined at five planes. A standard technique was followed: 
Zillcs(1995) (seeFig.m 
Plane 1: AID, Pari , Fr2 
(most anterior plane 
of caudate putamen) 
Plane 2: Par2, Par l ,F r l 
(anterior commissure) 
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Plane 3: GI/DI, Pari , Frl 
(hippocampus) 
P lane4 :Te l ,Oc2L, RSA 
(posterior commissure) 
Plane 5: Tel , OIB, Oc2ML 
(hippocampus) 
Fig. 11. Zilles (1995) Lateral, central, and medial regions 
measured across five planes for cortical thickness. 
Thalamic width: 
Thalamic width was measured at two planes based upon previous studies by Kolb 
and Whishaw (1981). The first was the anterior plane, at the point of a predominant MD 
nucleus, and when the hippocampus CA fields and dentate gyrus had become full. The 
second plane was at the last slice that had a full thalamus, which is at the beginning of the 
posterior commissure. Degeneration of thalamic nuclei is commonly seen as a result of 
cortical injury. Degeneration is generally characterized by darker stained cells in thalamic 
nuclei, shrunken nuclear areas, as well as abnormally shaped cells. 
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Results 
Anatomical Results 
The frontal lesion consistently removed the midline region of cingulate 1 and 2 
(Cgl, Cg2) areas with primary motor regions Ml and M2, or Zilles Frl and Fr3. The 
prelimbic (PrL), or Zilles (1995) cingulate 3 (Cg3), and the infralimbic (IL) areas were 
usually gone, as well as variable amounts of the frontal association (FrA). or Zilles 
(1995) frontal (Fr2) areas. Sections of the medial orbital (MO), ventral orbital (VO) and 
lateral orbital (LO) cortex of the ventral frontal areas were also removed. A visual 
interpretation of comparisons between brains of animals with choline treatment, with 
brains of animals without treatment, suggests that some of the lesion cavities may have 
been slightly smaller in the choline treated rats. 
Thalamic degeneration was observed as a reduction in size of the thalamus, and 
an apparent increase in cell density, most likely from the compression of nuclei. The 
anterior areas most affected were the paraventricular nucleus (PVN) and possibly, to 
some mild extent the medial dorsal nucleus. Thalamic degeneration appeared more 
extensive in the no treatment group than that of the choline treatment group, indicating 
some beneficial treatment effects, although, this was not quantified (see Fig. 12). 
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Fig. 12. Frontal cortical lesions of the choline treated animals. 
Brain Weight: 
The overall result was that the choline treatment increased brain weight in female 
rats, whereas the frontal lesions decreased brain weight in both sexes. 
Because the Cresyl Violet and Golgi perfusion preparations yield different brain weights, 
they were analyzed separately. 
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Cresyl Violet Preparation: 
Increases in brain weight were observed in the female choline treatment groups 
and the animals with frontal lesions that showed the greatest benefit from the choline 
treatment (see table 4). 
A three-way ANOVA found a main effect of lesion (F(l,34)= 72.900, P< .0001), 
of sex (F(l,34)= 4.500, P=.0400), and of the interaction (F(l,34)= 9.900, P= .0030). 
There was a main effect of choline treatment (F(l,34)= 7.300, P= .0100), and for the 
interaction between sex and choline treatment (F( 1,34)= 5.900, P= .0200), but not for the 
interaction between lesion and choline treatment (F(l,34)= 3.700, P= .0600), or for the 
interaction among all three groups (F(l,34)= .4000, P= .5200). 
Table 4. Brain Weight for Cresyl Violet Preparations: 
Group Female Male 
Untreated lesion 1.706±.050 (n=5) * 1.768 ± .063 (n=5) * 
Choline lesion 1.940 ±.020 (n=4) 1.815 ± .045 (n=2) 
Untreated unlesioned 1.948 ±.024 (n=5) 2.162 ±.035 (n=6) 
Choline unlesioned 2.026 ± .024 (n=7) ** 2.131 ±.035 (n=8) 
* Denotes statistically different from the unlesioned groups (p< .05, or better). 
** Denotes statistically different from untreated groups (p< .05, or better). 
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Table 5. Brain Weight for Golgi Preparations: 
Group Male 
Untreated lesion 1.764 ±.024 (n=6)* 
Choline lesion 1.958 ±.121 (n=5) 
Untreated unlesioned 2.123 ± .033 (n=7) 
Choline unlesioned 2.142 ±.023 (n=5) ** 
Denotes statistical difference from unlesioned groups (p<.05, or better). 
** Denotes statistically different from untreated groups (p<.05, or better). 
Cortical thickness: 
The brains that were used to measure and analyze cortical thickness and thalamus were 
those that were prepared for Cresyl Violet staining. 
Data for all five planes were analyzed by a two-way ANOVA collectively to 
determine the overall effects on cortical thickness between treatment and no treatment 
groups. 
Golgi Preparation: 
It appears that male brains may have received some benefits of choline treatment 
when comparing with Golgi preparation brains, although the effect did not reach 
statistical significance. (Only male rats were prepared for Golgi). 
A two-way ANOVA indicated a main effect of lesion (F(l,19)= 21.600, P= 
.0002), but not of treatment (F(l,19)= 3.340, P=.0800), nor for an interaction (F(l,19)= 
2.250, P= . 1500). 
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A repeated measures ANOVA across the five planes measured found the frontal 
lesion groups to have the lowest cortical thickness, those with choline treatment showing 
the greatest benefit (see Fig. 13). A significant interaction was found between mean 
cortical thickness and lesion therefore, two-way ANOVAs between lesion and treatment 
groups were performed for each plane to determine the plane(s) affected. 
ANOVA for the first plane indicated a main effect of lesion (F(l,73)= 40.676, P< 
.0001), as well as for the interaction (F(l,73)= 4.304, P=.0415), but no significant effects 
of treatment (F(l,73)= 1.691, P=.1976). 
ANOVA for the second plane did not indicate any main effects of lesion 
(F(l,73)= 22.020, P< .0001), of treatment (F(l,73)= .302, P= .5842), nor for the 
interaction between groups (F(l,73)= 2.164, P=.1455). 
ANOVA for the third plane indicated a main effect of lesion (F(l , 73)= 8.416, 
P=.0049), but no effects of treatment (F(l,73)= 2.932, P=.0911), nor for the interaction 
(F(l,73)= 2.130, P=. 1487). 
ANOVA for the fourth plane indicated a main effect of lesion (F(l,73)= 14.785, 
P= .0003), but not of treatment (F(l,73)= .217, P=.6430), nor for the interaction 
(F(l,73)= 2.933, P= .0910). 
ANOVA for plane five indicated a main effect of lesion (F(l,73)= 4.796, P= 
.0317), but not of treatment (F(l,73)= 3.154, P= .0799), nor of the interaction (F(l,73)= 
1.104, P= .2969. 
Overall, the frontal lesion group treated with choline had thicker cortices than the 
animals that did not receive choline, throughout all five planes measured (see Fig. 14). 
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Fig. 13. Cortical thickness for each of five planes measured in animals with frontal 
lesions treated with choline. 
Fig. 14. Mean cortical thickness for the five planes measured in animals with frontal 
lesions treated with choline. * Denotes statistically different from unlesioned groups (p<. 
05, or better) 
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Thalamic width: 
The anterior portions of the thalamus of the lesion brains showed a trend to have 
increased in thalamic width with the choline treatment There was relatively high 
variance however, which prevented any statistical support for this impression. 
A two-way analysis of variance (ANOVA) for the anterior plane of measure 
between the lesion and treatment groups did not reveal a main effect of lesion (F(l,25)= 
.266, P=.6103), of treatment (F(l,25)= 2.441, P= .1308), nor for the interaction between 
groups (F(l,25)= 1.791, P=.1928). 
ANOVA for the posterior plane of the thalamus between the lesion and treatment 
group indicated a main effect of lesion (F(l,25)= 28.344, P< .0001), but not of treatment 
(F(l,25)= 1.042, P=.3172), nor for the interaction (F(l,25). P=3.319, P= .0805). 
Table 6. Mean measures of thalamic width. 
Anterior Plane (mm) Posterior Plane (mm) 
Untreated lesion 11.120 ±.282 12.940 ± .282 * 
Choline lesion 12.340 ± .223 13.660 ± .223 ** 
Untreated unlesioned 11.900 ±.400 14.750 ± .400 
Choline unlesioned 11.994 ±.239 14.547 ± .239 
* Denotes statistically different from unlesioned groups (p<.05, or better). 
Denotes statistically different from untreated lesion group (p<.05, or better). 
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Behavioral results 
Open Field: 
Both the frontal lesion and unlesioned groups that received choline treatment 
displayed less activity than the untreated groups in the measures of horizontal activity 
and distance, with both males and females showing a treatment effect. 
Horizontal activity: 
Because there was an effect for sex, a three-way ANOVA between lesion, sex, 
and treatment for horizontal activity was performed. ANOVA found a main effect of 
treatment (F(2,44)= 38.200, P< .0001), lesion (F(2,44)= 15.00, P< .0001), and sex 
(F(l,44)= 15.200, P< .0001).as well as for an interaction between lesion and treatment 
(F(2,44)= 23.900, P< .0001), but not between sex and treatment (F(2,44)= 3.200, P= 
.0823), sex and lesion (F(l,44)= 0.400, P= .8300), nor of an interaction among all three 
groups (F(2,44)= 1.00, P= .3200) (see Fig. 15). 
Distance: 
A three-way ANOVA for distance between lesion, treatment and sex groups 
indicated a main effect of treatment (F(2, 36)= 53.700, P< .0001), lesion (F(l,36)= 
19.100, P= .0001), sex (F(l,36)= 4.600, P= 0.400), and for an interaction between lesion 
and treatment (F(2,36)= 7.100, P= .0100), but not for an interaction between sex and 
treatment (F(2,36)= 2.200, P= .1500), nor for sex and lesion (F(l,36)= 2.400, P= .1283), 
nor among all three groups (F(2,36)= 1.100, P= .3100) (see Fig. 16). The interaction 
between treatment, sex, and lesion reflects that the choline treatment benefit was found in 
females with frontal lesions. 
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Mean Horizontal Activity 
3000 
Untreated Choline Frontal 
Unlesioned Unlesioned Untreated 
Frontal Choline 
Fig. 15. Mean horizontal activity of animals with frontal lesions treated with choline. * 
Denotes statistically different from unlesioned groups (p<05, or better). ** Denotes 
statistically different from untreated unlesioned groups (p<.05, or better). 
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Fig. 16.Mean distance in open field of animals with frontal lesions treated with choline. 
Denotes statistically different from unlesioned groups (p<05, or better). ** Denotes 
statistically different from untreated unlesioned groups (p<.05, or better). 
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Morris water task: 
A two-way analysis of variance (ANOVA) between lesion and treatment 
indicated a main effect of lesion (F(l,54)= 5.914, P= .0184), a main effect of choline 
treatment (F(l , 54)= 3.998, P= .0509), as well as for the interaction (F(l,54)= 6.866, P= 
.0114). The interaction reflected the selective effect of the choline treatment on the 
frontal lesion animal's performance (see Fig. 17 & Fig. 18). 
Fig. 17. Morris water task sums for frontal lesion choline-treated animals. * Denotes 
statistically different from unlesioned animals (p<. 05, or better). ** Denotes statistically 
different from untreated animals (p< 05, or better). 
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Fig. 18. Morris water task latency over the five-day trial period. Animals had frontal 
lesions and choline treatment. 
Probe trials at the end of training revealed that the choline-treated frontal lesion 
animals spent the most time in the correct quadrant, quadrant one. All groups did 
however, spend time in quadrant one, sharing time in quadrant four (see Fig. 19). 
A two way ANOVA indicated a main effect of lesion (F(l,34)= 4.718, P= .0369) 
and of treatment (F(l,34)= 7.400, P= .0102), but not for the interaction (F(l,34)= .850, 
P= .3630). 
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Morris Water Task Probe 
Ju 
I 
• Untreated 
Unlesioned 
o Frontal 
Untreated 
n Choline 
Unlesioned 
• Frontal 
Choline 
Quad 1 Quad 2 Quad 3 Quad 4 
Fig. 19. Probe trials of Morris water task for frontal lesion animals treated with choline. 
Quadrant 1 is the correct quadrant * Denotes statistically different from unlesioned 
animals ( rx. 05, or better). ** Denotes statistically different from untreated animals ( rx. 
05, or better). 
Tray Reaching: 
Rats with frontal lesions were impaired at the task, but treatment with choline 
successfully reversed the impairment (see Fig.20). In fact the success rate for the 
choline-treated frontal lesion group was similar to that of the unlesioned choline treated 
group. 
A two-way analysis of variance (ANOVA) for lesion and choline treatment 
indicated a main effect of lesion (F(l,30)= 11.246, P= .0022), as well as for the 
interaction between groups (F(l,30)= 10.714, P= .0027), but not of choline treatment 
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Fig. 20. Summary of tray reaching task for frontal lesion choline-treated group. * Denotes 
statistically different from unlesioned animals (p<. 05, or better). 
Attention Shift: 
Birrell & Brown (2000) proposed their task apparatus task to be different from 
those that have a spatial component to it, such as found in a Y-, or T-maze. Their purpose 
for not using a Y-, or T-maze is because it also measures spatial deficits that might 
confound the variable of attention shift. The anatomical area Birrell and Brown have 
claimed to house executive functions of cognition in the rat is in the prelimbic (Zilles 
Cg3) and infralimbic areas of the prefrontal cortex. This task did use a spatial Y-maze 
and midline frontal lesions in rats includes the cingulated cortex, which is known to be 
(F(l,30)= 1.194, P= .2831). The interaction reflects the selective effect of the choline 
treatment on the frontal lesion group. 
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responsible for spatial problem solving. Reversal of baited arm was also noted to account 
for spatial reversal deficits. Overall, this task proved to be difficult for all animals (see 
fig.20). For example, the unlesioned animals made errors at the beginning of the task 
during the simple dimension of odor, the complex dimension of odor and medium as well 
as during the first reversal (Revl) of odor-medium pairs (see Appendix B). It appears that 
learning of the dimension changes, as well as baited arm changes, provided some 
challenges during the beginning stages of the task. All animals eventually learned the task 
however, and towards the end of the task, were making fewer errors. The animals that 
indicated the greatest impairment were in the frontal lesion untreated group and seemed 
to perform less well throughout the series of dimensions. The greatest number of errors 
performed during the extradimensional shift (ED), were from the frontal lesion animals, 
particularly the animals treated with choline. The ED is the dimension proposed to 
measure the ability for rats to shift attention from the previously rewarded dimension of 
odor, to a new dimension of medium. All rats but the unlesioned animals expressed much 
confusion during the ED shift and required more time to solve this dimension indicating 
the possibility that rats are capable of solving complex tasks, and that this task possibly 
could measure attention shift. Both frontal lesion groups, especially the choline-treated 
animals, were the most distracted and inattentive, which was noted during testing. 
Surprisingly, the choline treatment did not indicate any statistically significant 
benefit as measured by decreases in errors throughout each dimension. It could be 
possible that choline treatment may have actually been detrimental to the performance of 
this task, but it also should be noted that the treated animals were run as a larger group, 
and for a longer period of food deprivation, potentially increasing the animals' tendency 
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for distraction. Anatomically, however, the rats indicating the greatest number of errors 
in the choline treatment group were also missing the proposed areas of the prefrontal 
cortex responsible for the ability to shift attention. The fact that the untreated group 
appeared to perform this task with fewer errors than the choline treatment group could 
also be attributed to the rats resorting to simpler modes of cognition to resolve this task. 
A visual inspection of the untreated animals indicated that they were missing larger 
portions of the prefrontal cortex, particularly the infralimbic/prelimbic region proposed 
responsible for attention shift. 
A two-way analysis of variance was performed for each dimension. ANOVA on 
the simple dimension found a main effect of choline treatment (SD) (F(l,38)= 6.265, P= 
.0167), but not of lesion (F(l,38)= .204, P= .6543), nor for the interaction (F(l,38)= .204, 
P= .6543). The choline treated animals exhibited the greatest number of errors in this 
dimension. 
ANOVA for the compound dimension (CD) also found a main effect of choline 
treatment (F(l,38)= 6.293, P= .0165) and no significant effects for lesion (F(l,38)= .400, 
P= .5309), nor an interaction (F(l,38)= 1.252, P= .2703). For this dimension, the choline 
treated animals exhibited the least number of errors. 
ANOVA for the first reversal (Revl) of exemplar pairs indicated no significant 
effects of lesion (F(l,38)= .869, P= .3572), treatment (F(l,38)= 1.496, P= .2289), nor the 
interaction (F(l,38)= .273, P= .6043). The statistical results suggest that all groups 
performed reasonably well in this dimension, although the frontal lesion group did make 
more errors. 
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ANOVA for the intradimensional shift (ID) also did not reveal any significant 
findings. Thus, there were no main effects of lesion (F(l,38)= 1.766, P= 1918), or of 
treatment (F(l,38)= .004, P= .9489), nor for the interaction (F(l,38)= .004, P= .9489). 
ANOVA for the second reversal (Rev2) found a marginal effect of lesion 
(F(l,38)= 3.960, P= .0538), but no significant effects of treatment (F(l,38)= 2.021, P= 
.1633, or an interaction (F(l,38)= 2.021, P= .1633). 
ANOVA for the extradimensional shift (ED) found no significant effects of lesion 
(F(l,38)= .845, P= .3639), of treatment (F(l,38)= .904, P= .3476), nor for an interaction 
(F(l,38)= 1.824, P= .1824). Errors were evident during this dimension, although not in 
substantial quantities. 
ANOVA for the third reversal (Rev3) also did not indicate any significant effects 
of lesion (F(l,38)= .845, P= .3639), treatment (F(l,38)= .904, P= .3476), or for the 
interaction between groups (F(l,38)= 1.824, P= .1848). The frontal lesion animals were 
the only group to commit any errors in this dimension (see Fig.20). 
Finally, I should note that although the measures of mean errors during the ED 
shift were not statistically obvious, all lesion animals in both treatment groups became 
very confused and distracted during this dimension, requiring much more time to figure 
out the changes. Unfortunately, time was not measured, but the behavior of the animals 
does suggest that the prefrontal cortex does play a role in the efficient solution of the 
task. 
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Attention Shift 
• Choline Unlesioned 
• Frontal Choline 
• Untreated Unlesioned 
• Frontal Untreated 
SD CD Rev1 ID Rev2 
Dimension 
ED Rev3 
Fig. 21. Summary of all dimensions measured in the attention shift task. Ariimals had 
frontal lesions and choline treatment. 
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Experiment # 1 B 
The Effects of Choline Treatment on Recovery from Perinatal Posterior 
Parietal Injury 
The methods used for experiment IB were essentially identical to those used in 1A. 
The differences were only in subject numbers and surgical procedures. 
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Method 
Subjects 
A total of seventy-three Long Evans rats were used for Experiment IB, all of 
which participated in three behavioral tasks (see table 7). A subset of twenty-two rats was 
selected for the attention shift task. At the age of 60 days the animals began behavioral 
testing. Any sex differences that are significant to the experimental results are reported. 
Table 7. Number of rats used in Experiment IB. 
Untreated Choline Treatment 
Sex Female Male Female Male 
Unlesioned n = 5 n= 12 n=7 n=13 
Parietal Lesion n = 5 n= 11 n = 7 n=13 
Surgical procedures 
The animals were all anesthetized by means of cooling in a Thermatron set at -
5°C as in Experiment 1A. Once the skin was incised, the middle third of the skull 
between bregma and lambda was removed using iris scissors. Laterally, the removal 
began about 1.5 mm lateral to the saggital suture and went laterally to make a square 
removal of the bone. The exposed tissue was removed by gentle aspiration. The skin was 
sutured with sterile silk thread. The sham control animals underwent all procedures 
except for bone incision and lesion aspirations. After completion of surgery, animals 
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were slowly warmed using body heat by holding the pups in warm hands until they began 
moving, then were returned to their mothers. 
Results 
Anatomical Results 
The lesions removed Kreig's area 7, in addition to the posterior part of the 
primary parietal cortex (Pari), and the anterior part of Zilles' occipital 2 areas (Oc2). 
Occasional unilateral damage was apparent in the posterior cingulate regions (RSA, 
RSG). There was no direct damage to the hippocampus, or to other subcortical regions. 
The hippocampus had an unusual shape however, as it often grew through the lesion 
cavity, leading to an appearance of a smooth cortical surface (see Fig. 21). 
Thalamic degeneration, as characterized by a reduction in nuclear size, was 
apparent in all brains observed and was variable in extent. Most posterior parietal lesions 
resulted in degeneration of anterior nuclei, especially the anterior dorsal (AD) and lateral 
dorsal (LD) and paraventricular thalamic nuclei (PVN). In some cases the cells of the 
medial dorsal (MD) nucleus also appeared to be sparse. 
The brains of rats in the untreated lesion group appeared to have more extensive 
damage than the choline treatment group. The lesions appeared larger, the remaining 
cortex was thinner, and degeneration in the thalamus was more obvious. 
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Choline Treatment 
Untreated 
Fig. 22. Posterior parietal cortical lesions of the choline treatment animals. 
Brain Weight: 
Posterior parietal lesions reduced brain weight in both sexes, but the choline 
treatment didn't have significant effects on brain weight. Differences in brain weight are 
usually found between fixation methods, therefore, the analysis has been done separately 
for each fixation technique (see Table 8). 
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Table 8. Brain Weight for Cresyl Violet Preparations: 
Group Female Male 
Untreated lesion 1.772 ±.055 (n=5) * 1.890 ± .040 (n=5) * 
Choline lesion 1.779 ±.040 (n=7) 1.776 ± .070 (n=8) 
Untreated Unlesioned 1.948 ± .024 (n=5) 2.162 ±.035 (n=6) 
Choline Unlesioned 2.026 ± .024 (n=7) 2.131 ±.035 (n=8) 
Denotes statistically different from unlesioned groups (p<.05, or better). 
Golgi Preparation: 
A two-way ANOVA indicated a main effect of lesion (F(l,19)= 38.300, P< 
.0001), but no effects of treatment (F(l,19)= .1300, P=.7300), or for the interaction 
(F(l,19)= .8400, P= .3700). (Only male rats were used for Golgi preparation) (see Table 
9). 
Cresyl Violet Preparation: 
A three-way ANOVA found a main effect of lesion (F(l,43)= 58.700, P< .0001), 
sex (F(l,43)= 10.100, P= .0030), but not for the interaction between lesion and sex 
(F(l,43)= 2.200, P= .1400). Choline treatment did not reach significance (F(l,43)= .2000, 
P= .6600), nor did the interactions between lesion and choline treatment (F(l,43)= 1.300, 
P= .2700), between sex and choline treatment (F(l,43)= 2.800, P= .1000), nor for the 
interaction among all three groups (F(l,43)= .0100, P= .9300). 
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Table 9. Brain Weight for Golgi Preparations: 
Group Male 
Untreated lesion 1.942±.010 (n=6) * 
Choline lesion 1.898 ± .060 (n=5) * 
Untreated Unlesioned 2.123 ±.030 (n=6) 
Choline Unlesioned 2.142 ±.020 (n=5) 
* Denotes statistically different from unlesioned groups (rx.05, or better). 
Overall, the lesion groups had thinner cortices than animals without lesions and 
choline treatment showed no beneficial effect on cortical thickness. The mean cortical 
thickness across all five planes was analyzed first. 
Repeated measures ANOVA for all five planes did not reveal any significant 
interactions between mean cortical thickness and lesion (see Fig. 22). 
A two-way ANOVA indicted a main effect of lesion (F(l,29)= 26.650, P< .0001), 
but no significant effects of treatment (F(l,29)= 2.846, P= .1023), or for the interaction 
(F(l,29)= .522, P= .4759) (see Fig.23). 
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Fig.23. Cortical thickness for each of five planes measured in animals with parietal 
lesions treated with choline. 
Fig.24. Mean cortical thickness for the five planes measured in animals with parietal 
lesions treated with choline. * Denotes statistically different from unlesioned groups (p< 
05, or better). 
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Thalamic width: 
The thalamus was smaller in both planes measured, and especially in the anterior 
plane. The choline treatment had no effect (see Table 10). 
A two-way analysis of variance (ANOVA) for the anterior plane of measure 
revealed significant effects of lesion (F(l,34)= 23.008, P< .0001), but not of choline 
treatment (F(l,34)= .254, P= .6175), or for the interaction (F(l,34)= .394, P=.5346). 
ANOVA for the posterior plane also found a main effect of lesion (F( 1,34)= 
32.246, P< .0001), but not of treatment (F(l,34)= 3.270, P=.0794), or for the interaction 
(F(1,34),P=1.150, P=.2910. 
Table 10. Mean measures of thalamic width. 
Anterior Plane (mm) Posterior Plane (mm) 
Untreated Lesion 8.720 ± .346 * 13.480 ±.128 * 
Choline Lesion 7.857 ± .651 12.686 ±.199 
Untreated Unlesioned 11.900 ±.400 14.750 ± .250 
Choline Unlesioned 11.994 ±.239 14.547 ±.132 
* Denotes statistically different from unlesioned groups (p<.05, or better). 
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Behavioral results 
Open Field: 
The choline treated animals displayed a lower amount of activity in horizontal 
activity and distance of movement than the untreated group; the largest effects were seen 
in the females. The parietal lesions also decreased activity and this was potentiated with 
the choline treatment, especially in the females. 
Horizontal activity: 
Because there were sex differences in activity, a three-way ANOVA was 
performed with lesion, sex and treatment factors. There was a main effect of choline 
treatment (F(l,36)= 61.900, P< .0001), lesion (F(l,36)= 11.700, P= .0020), and sex 
(F(l,36)= 5.300, P= .0300). There was no interaction between lesion and treatment 
groups (F(l,36)= 2.400, P= .1300), between sex and treatment groups (F( 1,36)= 2.400, 
P= .1300), between sex and lesion (F(l,36)= 2.600, P= .1200), or for an interaction 
among all three factors (F(l,36)= 1.300, P= .2600) (see Fig.24). 
Distance: 
A three-way ANOVA between lesion, sex, and treatment groups indicated a main 
effect of choline treatment (F(l,44)= 52.600, P< .0001), lesion (F(l,44)= 4.900, P= 
.0300), and sex (F(l,44)= 52.600, P< .0001), as well as interaction between lesion and 
treatment groups (F(l,44)= 11.100, P= .0017), and between sex and treatment groups 
(F(l,44)= 5.500, P= .0240). There was no effect of the sex by lesion interaction (F(l,44)= 
.0300, P= .6100), or for an interaction among all three groups (F(l,44)= .500, P= .4900) 
(see Fig.26). 
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Fig. 25. Mean horizontal activity in the open field task of parietal lesion animals treated 
with choline. * Denotes statistically different from unlesioned groups (p<. 05, or better). 
** Denotes statistically different from untreated groups (p<. 05, or better). 
Mean Distance 
Untreated 
Unlesioned 
Choline 
Unlesioned 
Parietal 
Untreated 
Parietal Choline 
Fig.26. Mean distance in open field task of parietal lesion animals treated with choline. 
* Denotes statistically different from unlesioned groups (p< 05, or better). 
** Denotes statistically different from untreated groups (p<. 05, or better). 
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Morris Water Task: 
The general finding was that the parietal lesion groups were impaired relative to 
the unlesioned groups and choline treatment was without benefit (see Fig.26). The lesion 
effect persisted to the final trial block as the animals with lesions asymptote at around 
twenty seconds on days four and five. 
A two-way ANOVA between lesion and choline treatment indicated a main effect 
of lesion (F(l,52)= 16.400, P=.0002), but not of treatment (F(l,52)= .400, P= .5300), or 
for the interaction (F(l,52)= 0, P= 1.0) (see Fig 27). 
Morris Water Task Latency Sums 
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Fig.27. Morris water task sums of animals with parietal lesions treated with choline. 
* Denotes statistically different from unlesioned groups (p<. 05, or better). 
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MWT Latency 
Fig.28. Morris water task latency over the five-day trial period. Animals had parietal 
lesions and choline treatment. 
The probe trials at the end of training revealed that none of the groups was very 
accurate in their swim patterns. It appears that all groups spent most of their time in both 
quadrants one and four (see Fig.28). 
A two-way ANOVA between groups for lesion and treatment did not reveal a 
main effect of lesion (F(l,52)= .020, P= .8891), or of treatment (F(l,52)= .289, P= 
.5936), or the interaction (F(l,52)= 1.784, P=.1887). 
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Morris Water Task Probe 
Q Untreated 
Unlesioned 
.•Choline 
Unlesioned 
• Parietal 
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i Parietal Choline 
Quad 1 Quad 2 Quad 3 Quad 4 
Fig. 29. Probe trials of Morris water task for parietal lesion animals treated with choline. 
Quadrant 1 was correct quadrant. 
Tray Reaching: 
No significant effects of lesion, or of choline treatment were found in the reaching 
task, for the parietal lesion animals (see Fig.29). 
A two-way ANOVA was used between the lesion and treatment groups, which 
did not indicated a main effect of lesion (F(l,40)= 2.631, P= .1126), of treatment 
(F(l,40)= 2.252, P= .1413), or of an interaction (F(l,40)= 2.575, P= .1164). 
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Tray Reach 
100 i 
Unlesioned Parietal 
Fig.30. Summary of tray reaching task for parietal lesion choline-treated group. 
Attention Shift: 
As in Experiment 1 A, the Attention Shift task did not reveal either lesion or choline 
treatment effects. The parietal animals did appear to be more impaired during the reversal 
of exemplars and distracted by baited arm changes, but this was not reflected in the 
statistical analysis of performance (see fig.31). 
Two-way ANOVA was performed between lesion and treatment groups for each 
dimension in the attention shift task, which did not reveal any significant effects of 
lesion, or treatment, nor for interactions in all dimensions. 
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ANOVA for simple dimension (SD) indicated no effects of lesion (F(l,36)= .353, 
P= .5561), treatment (F(l,36)= 2.454, P= .1260), nor for the interaction (F(l,36)= .353, 
P= .5561). 
ANOVA for compound dimension (CD) indicated no significant effects of lesion 
(F(l,36)= 1.990, P= .1669), of treatment (F(l,36)= 2.678, P= .1105), nor the interaction 
(F(l,36)= .385, P= .5387). 
ANOVA for the first reversal (Revl) indicated no significant effects of lesion 
(F(l,36)= 2.164, P= .1500), of treatment (F(l,36)= 3.133, P= .0852), or of an interaction 
(F(l,36)= 1.791, P = . 1892). 
ANOVA for the intradimensional shift (ID) indicated no significant effects of 
lesion (F(l,36)= .785, P= .3815), of treatment (F(l,36)= 1.426, P= .2402), or for the 
interaction (F(l,36)= .785, P= .3815). 
ANOVA for the second reversal (Rev2) did not indicate any significant effects 
(F(1.36)= 2.090, P= .1569), of treatment (F(l,36)= .354, P= .5554), for the interaction 
(F(l,36)= .354, P= .5554). 
ANOVA for the extradimensional shift (ED) did not indicate any significant 
effects of lesion (F(I,36)= .024, P= .8781), of treatment (F(l,36)= .230, P= .2748), or for 
the interaction (F(l,36)= .166, P= .6864). 
ANOVA for the third reversal (Rev3) did not indicate any significant effects of 
lesion (F(l,36)= 2.120, P= .1540, treatment (F(l,36)= 2.120, P= .1540), or for interaction 
(F(l,36)= 2.120, P = . 1540). 
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Attention Shift 
Rev1 ID Rev2 
Dimension 
• Choline Unlesioned 
a Parietal Choline 
• Untreated Unlesioned 
• Parietal Untreated 
i f I 
ED Rev3 
Fig. 31. Summary of all dimensions measured in the attention shift task. Animals had 
parietal lesions and choline treatment. 
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Discussion 
The main results of the choline treatment studies were: 1) the perinatal lesions 
produced a decrease in the thickness of the remaining cortical mantle following both 
frontal and parietal lesions, 2) treatment with choline increased cortical thickness in the 
frontal lesion animals, which was not apparent in the parietal lesion animals, 3) both 
perinatal medial frontal and posterior parietal lesions produced deficits in spatial 
navigation. Medial frontal lesions also produced deficits in skilled reaching, and, 4) the 
choline treatment partially reversed the behavioral impairments in the frontal, but not the 
parietal operates. I will consider the behavioral and anatomical results separately. 
Anatomical effects of early lesions and choline treatment 
A consistent finding of studies of the effects of early cortical lesions in rats is that 
there is always a reduction in cortical thickness across the remaining cortical mantle. The 
current study confirms this finding. It was also shown that choline partially reversed the 
cortical thinning in the frontal operates, but not in the parietal operates and was correlated 
with functional recovery in the former, but not the latter group. Thus, it appears that this 
increase in cortical thickness might represent some reorganization of cerebral circuitry 
that can support functional recovery. The most likely explanation for the increase in 
cortical thickness is an increase in dendritic arborization in the remaining pyramidal 
and/or stellate cells in the cortical mantle. Previous studies have shown increased 
dendritic arborization (and increased cortical thickness) in rats with early medial frontal 
lesions that were later placed in complex environments (Gibb, 2000). Kolb & Tees (in 
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submission) also found an increase in dendritic arborization in a preliminary study of rats 
with medial frontal lesions that were treated with the same regime of choline as that in 
the current study. 
An additional explanation for the improvement in behavioral performance of the 
choline-treated medial frontal lesion animals regards the visibly smaller lesion cavity 
size, which suggests that there potentially may have been a neurogenic response in the 
choline-treated rats. Previous studies have shown that basic fibroblast growth factor 
(FGF-2) does produce neurogenesis in the day three medial frontal lesion rats (Waite, 
2003), giving a precedent for postinjury treatments stimulating neurogenesis. 
Demonstration of this possibility will require studies using a mitotic marker to identify 
new neurons. In addition, studies will also need to demonstrate that new neurons 
integrate with the rest of the brain and are functional. 
In sum, the choline treatment, both prenatally and postnatally during lactation, 
facilitated functional recovery and morphological changes after perinatal medial frontal 
lesions, but not after posterior parietal lesions. 
Behavioral effects of early lesions and choline treatment 
If the cerebral cortex is injured during the first few days of life there is generally a 
poor functional outcome in adulthood, which is reflected in the impairments in a wide 
range of behavioral tasks (eg. Kolb, 1995). Although the behavioral analysis was limited 
to only a few measures in the current study, the present results generally confirm the 
findings of Kolb's group. One of the goals of the current study was to determine if 
treating infant rats with dietary choline could facilitate recovery from the early cortical 
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injuries. There is considerable literature showing that choline can influence cerebral 
organization and function in animals given choline during the pre- and postnatal periods 
of development. Meek, Smith and Williams (1988), and Kolb and Tees had shown in a 
preliminary unpublished study that choline treatment was beneficial to rats that had 
frontal lesions on postnatal day four. The current results showed a similar benefit in rats 
with day three frontal lesions, however, there was no significant benefit for animals with 
day three posterior parietal lesions. 
The failure to find a therapeutic effect of choline in animals with posterior parietal 
lesions was disappointing, but is consistent with parallel evidence that rats with perinatal 
injury to the posterior parietal region have more extensive behavioral deficits (eg. Kolb, 
Holmes & Whishaw, 1987). Furthermore, unlike day ten lesions elsewhere in the cortex, 
rats with posterior parietal lesions do not show increases in dendritic morphology, a result 
that may account for the relatively poorer functional outcomes (Kolb & Cioe, 1999). 
The reason for the differential effect of choline on the frontal- versus parietal-
injured brains remains a matter of speculation. It is known for example, that choline 
supplementation increases the endogenous production of nerve growth factor (NGF) and 
it is possible that the effect of choline on the frontal lesion animals is via its actions on 
NGF. Nerve growth factor is known to stimulate dendritic length and an increase in spine 
density after cortical lesions in adult rats (Kolb et al.. 1997), which could provide a 
mechanism for its beneficial effects after frontal lesions. It is not clear however, why 
animals with posterior parietal lesions did not show the same beneficial effects supported 
by NGF. Treating rats with perinatal lesions of the medial frontal, or posterior parietal 
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lesions with FGF-2 has shown to have greater recovery with medial frontal lesions than 
posterior parietal lesions (Waite, 2003). 
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4. Experiment 2 
The Effects of Vitamin Supplement Treatment on Recovery From 
Perinatal Cortical Lesions 
The general plan of Experiment 2 was similar to Experiment 1. Pregnant rats were 
to be given a vitamin supplemented diet prior to conception and continued throughout 
their pregnancy. As in Experiment 1, approximately half of the pups would receive 
medial frontal, or posterior parietal lesions on postnatal day 4. Unfortunately, this did not 
prove possible. The supplement appeared to retard pregnancy, as the initial pairing of 
males and females for two to three months did not result in successful pregnancies. 
"Plan B" thus was to introduce the supplement approximately one week after the 
introduction of males to females, potentially to allow conception to occur before 
treatment. The result of this plan was only one pregnancy and the litter consisted of only 
three pups (2males, 1 female). These animals were maintained on the supplement 
throughout life and as adults, the animals remained paired. This resulted in two 
pregnancies and two litters of animals. The second generation of animals remained on the 
supplement throughout their lives as well and one litter had behavioral testing in 
adulthood (see Appendix F). 
"Plan C" was to begin supplement administration on day of birth of the pups and 
continue the supplemented diet throughout the life of the pups (see Fig.31). 
This strategy was successful. As in Experiment 1, the analysis of the results for 
the medial frontal and posterior animals is presented separately. 
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Plan A: 2 pairs male/female. Introduced fortified diet 2 days prior to gestation 
— • No pregnancy 
Plan B: 2 pairs male/female. Introduce fortified diet approximately 1 week after gestation 
• 3 pups: 2 Males, 1 Female 
— • Pregnancy 1: 10 pups: behavioral tasks (Appendix F) 
—p> Pregnancy 2: 10 pups: Western Blot (Incomplete) 
Plan C: Introduce fortified diet on day of birth of full litters 
— • 4 full litters: 3 litters: brain lesions and behavior 
1 litter: no lesions and Western Blot (Appendix D) 
Fig. 32. Flowchart of subjects in the vitamin supplement experiment. 
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Experiment 2A 
Vitamin Supplement Treatment with Frontal Lesions 
The Effects of Diet Supplementation on Recovery from Perinatal Medial 
Frontal Injury 
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Method 
Subjects 
A total of seventy-seven Long Evans rats were used for Experiment 2A. This 
group of rats was used in three behavioral studies. At the age of 60 days the animals 
began behavioral testing. Any sex differences that are significant to the experimental 
results are reported. 
Table 11. Number of rats used in Experiment 2A. 
Untreated Unlesioned Supplement Treatment 
Sex Female Male Female Male 
Unlesioned n = 5 n=12 n=8 n=14 
Frontal Lesion n = 6 n= l l n=8 n=13 
Treatment preparation 
The vitamin supplement was incorporated into food pellets for the rats to eat as 
their regular diet ad libitum. The supplemented diet was the only food source available to 
the treatment groups. The concentration of the supplemented food pellets was determined 
according to a similar method used in the clinical studies. A mean daily intake of thirty 
capsules per day was applied to an average daily food intake of the human subjects, of 
approximately two to three pounds per day. This concentration was then extrapolated to a 
theoretical mean intake of a maximum of thirty grams of food per day, for each rat. 
(Hardy, 2002). The vitamin and mineral supplement was prepared into rat feed by the 
research laboratories at the Lethbridge Research Station. The standard laboratory rat 
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chow used is 5001 Rodent Diet, prepared by Purina Laboratories (see analysis in 
Appendix D). 
The percentage of dietary fat, carbohydrate and protein between both diets were 
very similar, both of which have sources of vitamins, minerals, and essential fatty acids. 
The main difference between the two diets is the additional vitamins and minerals, but 
importantly that the minerals in the supplement E.M. Power+ are chelated to increase 
their bioavailability. In addition to vitamins and minerals are amino acids and herbal 
ingredients. Grape seed (extract) is included in the formulation and known to provide 
essential omega-3 fatty acids (see Appendix D). 
Drinking water was regular tap water ad libitum. 
Surgical procedures 
The animals were all anesthetized by means of cooling in a Thermatron set at -
5°C on postnatal days two and three. Cooling occurred for approximately 10 minutes, or 
until the rat pups were immobile and whitish in color. These parameters of immobility 
and color have been correlated with appropriate rectal temperatures ranging from 18-
20°C. Once the skin was incised, the bone of the skull was removed from bregma to 
lambda using iris scissors. Frontal cortex lesions required removal of the midline region 
of the cortex, anterior to bregma, by gentle aspiration. Suturing of the wound was done 
using silk thread. The sham control animals underwent all procedures except for bone 
incision and lesion aspirations. After completion of surgery, animals were slowly warmed 
using body heat by holding the pups in warm hands until they began moving, then were 
returned to their mothers. 
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Behavioral procedures 
Open field Activity: 
The open field test was performed in a plexiglass box (42 cmx42 cmx32 cm h) 
attached to a Digiscan Analyzer, and has a lid on the top of the box. At the base of the 
box and approximately at 1/3 in height, is a band of sensors around the perimeter of the 
box to record a variety of activity measures. A printer was connected to the open field 
apparatus, which resided in the same room, and was programmed to print activity 
behavior at two -minute intervals for ten minutes. At the end of the ten-minute period, the 
rats were placed back into their holding tubs and the number of defecations remaining in 
the apparatus were noted. Data collection was completed for each rat at the end of the 10-
minute period. 
Morris Water Task: 
The maze used in the water task is a circular pool has a diameter of 1.5m and a 
height of 0.5m deep. The walls of the pool were painted white and the water rendered 
opaque with powdered milk. The platform (11x12 cm.) was placed in the northwest 
quadrant of the pool and submerged about 1.5cm. below the water's surface. Each rat was 
placed into the pool facing the wall in one of four random starting positions (east, west, 
north, or south). All animals were selected randomly into groups of eleven, to prevent 
any potential litter effects. The no treatment control group swam at a separate date. 
The animals swam four trials each day for five days. Each trial had a different 
starting position, using all four points of direction each day, and changed in order of 
direction each day. Each trial consisted of a maximum of ninety seconds during which 
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the rats had to find the hidden platform. After ninety seconds, the trial ended and rats that 
did not find the platform within that time were placed on the platform for ten seconds. 
Rats that did find the platform within the ninety-second interval were able to stay on the 
platform for ten seconds before being removed from the pool. All swim trials were 
recorded by means of a video camera mounted from the ceiling directly above the pool. 
Data recorded from the camera were analyzed by a computer program (Water 2020). On 
the sixth day, a probe trial was given. During the probe trial, the platform was removed 
and the rats started at the north position. Rats swam for twenty seconds and each trial was 
recorded into the computer program for analysis. 
Trav Reaching: 
The procedure for the tray reach task was devised from Whishaw's skilled 
reaching task (Whishaw, O'Connor & Dunnet, 1986). The test cages consist of clear 
plexiglass walls with a closable lid (20x 28x 26 cm). The front wall and floor of each 
cage was constructed of stainless steel bars. The floor was cross-linked with 2mm bars, 
and the front had vertical 3mm bars, extending 9mm apart from one edge of the cage to 
the other. Mounted in front of each set of three cages was a stainless steel tray, which 
held small pellets of chicken feed. The tray was suspended on runners at the sides of each 
cage set, and is positioned about 5mm away from the faces of the cage. 
Rats were food deprived daily by feeding 15g. to each female and 20g. to each 
male. These food portions have been determined to slowly reduce body weight, which 
should not exceed in a loss of 15% body weight. The rats were fed a standard lab chow 
diet and were food deprived for six days at a time. On the sixth day, after training, rats 
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were fed ad libitum to prevent any potential further weight loss. Food deprivation began 
again after one day off. 
Reaches were considered unsuccessful if the rats did not maintain a successful 
grasp at the tray, or during transport of the pellet back to the rat's mouth. If the rat had 
extended an arm towards the tray, but did not touch the food pellets, the reach attempt 
was not considered for scoring. When the animals had sufficiently learned to reach for 
the pellets, the rats were filmed by a videocamera individually for ten minutes. Scoring of 
reach attempts and successes were determined by replay of the video for seven minutes 
per rat. Attempts included both successes and failures. Overall success was determined as 
a percentage of successes verses attempts. 
Anatomical procedures 
At the completion of behavioral testing, rats were given an overdose of sodium 
pentobarbital (0.5ml-0.7ml) until they reached a comatose state. At this point, they were 
perfused intracardially, using 0.9 % saline solution. Rat brains destined for Cresyl Violet 
staining, were then perfused with 4% paraformaldehyde. Rongeurs were used to remove 
the brains and were weighed immediately following removal from the skull. Fifty-five rat 
brains were designated for Cresyl Violet stains. The remaining twenty-two male rats were 
perfused for Golgi staining. For Cresyl Violet preparations, the brains were placed in 
small bottles containing 4% paraformaldehyde in 30% sucrose solution. 
For Golgi preparations, brains were weighed at the end of saline perfusions and 
placed in small bottles containing Golgi solution. These brains were processed following 
procedures devised by Gibb and Kolb (1998). 
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The brains for Cresyl Violet staining were sliced on a Cryostat 2800 Frigocut, 
which maintains tissue at -21 °C. Every 4 t h slice of the treatment brains was taken at 40 
u.m thickness throughout the frontal lesion site. Thereafter, every 7 t h slice was taken. All 
slices were placed on slides fixed with a film consisting of 1.0% gel and 0.2% chromatin. 
Once the brains were dried to the slides, the sections were stained with Cresyl Violet. 
Brain Weight: 
The measures of brain weight are obtained by weighing each brain directly after 
removal from the skull of the perfused rat. Thereafter, brain weights are compared 
between groups to determine an estimate of tissue lost as a result of the lesions. Care was 
taken to ensure consistency of brain removal before weighing. The spinal cord was cut 
along the caudal edge of the cerebellum, the cerebellar paraflocculi were removed, the 
optic nerve was cut 1-2 mm anterior to the optic chiasm, and remaining dura was stripped 
off the brain's surface. At the front end of the brain, the olfactory bulbs are cut at 1.5-2.5 
ram from the frontal cortex. 
Cortical Thickness: 
After siide preparation, the brains were viewed and assessed at a magnification of 
17.5 x with a Zeiss DL 2 POL petrographic projector. 
Cortical measurements were made using a clear plastic ruler for both the supplement 
treated groups and the untreated groups. Three different cortical measurements, for each 
hemisphere, were determined at five planes. A standard technique was followed: 
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Zilles (1995^ (see Fie. 32) 
Plane 1: AID, Par l ,Fr2 
(most anterior plane 
of caudate putamen) 
Plane2:Par2, Par l ,F r l 
(anterior cornmissure) 
Plane 3: GI/DI, Par l ,Fr l 
(hippocampus) 
P lane4 :Te l ,Oc2L,RSA 
(posterior commissure) 
Plane 5: Tel , 01B, Oc2ML 
(hippocampus) 
Fig. 33. Zilles (1995) Lateral, central, and 
medial regions measured across five planes 
for cortical thickness. 
Thalamic width: 
Thalamic width was measured at two planes. The first was the anterior plane, at 
the point of a predominant MD nucleus, and when the hippocampus CA fields and 
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dentate gyrus had become full. The second plane, was at the last slice which had a full 
thalamus and at the beginning of the posterior commissure. 
Results 
Anatomical results 
The frontal lesion consistently removed the midline region of cingulate 1 and 2 
(Cgl, Cg2) areas with motor regions Ml and M2, or Zilles (1995) Frl and Fr3. The 
prelimbic (PrL), or Zilles (1995) cingulate 3 (Cg3), and the infralimbic (IL) areas were 
usually gone, as well as variable amounts of the frontal association (FrA), or Zilles 
frontal 2(Fr2) areas. Sections of the medial orbital (MO), ventral orbital (VO) and lateral 
orbital (LO) cortex of the ventral frontal areas were also removed. 
The vitamin supplement treatment had an obvious effect upon the lesion site, as 
most brains showed filling in of cortical tissue, including some of the most anterior areas 
of what was a presumptive FrA region (Zilles Fr2), PrL (Zilles Cg3) and IL (see Fig. 33). 
Very often, the ventral areas, containing portions of the orbital cortex, was present as a 
fuller cortex, than what is normally seen. The caudate putamen also appeared larger in the 
supplement treatment brains that regenerated large amounts of cortical tissue. 
Thalamic degeneration, observed as a reduction in size of the thalamus, was 
consistent in the anterior sections. Animals that had received the supplement however, 
had larger nuclear areas and many more cells than in the brains of untreated animals. 
Thus, cortical tissue loss and thalamic degeneration appeared less extensive in the brains 
of animals that received the supplement treatment. 
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f 
Untreated 
Supplement Treatment 
103 
Supplement Treatment 
Fig. 34. Examples of frontal cortical lesions in animals treated with the vitamin 
supplement 
Brain Weight: 
The vitamin supplement appeared to selectively increase brain weight in the 
lesion animals relative to the control animals in which there was little effect of the 
supplements. Differences in brain weight are usually found between fixation methods 
therefore, the analysis has been done separately for each method. 
Cresyl Violet Preparation: 
A three-way ANOVA with lesion, supplement treatment, and sex as factors 
showed a main effect of lesion (F(l,37)=41.7, P <.0001) and sex (1,37)=10.3, P <.003) 
but not of treatment (F(l,37)—1.35, P =.25. There was, however, a significant lesion x 
treatment interaction (F(1.37)=7.7, P=.009), a result that reflects the selective effect of 
the treatment on the lesion brains. The other interactions were not significant (p's>.2). 
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Table 12. Brain Weight for Cresyl Violet Preparations: 
Group Female Male 
Untreated lesion 1.730 ± .030 (n=6) * 1.768 ±.107 (n=5) * 
Supplement lesion 1.761 ± .030 (n=8) 1.843 ± .020 (n=10) 
Untreated Unlesioned 1.948 ± .020 (n=5) 2.162 ±.035 (n=6) 
Supplement Unlesioned 1.879 ± .040 (n=8) 1.970 ± .078 (n=9) 
* Denotes statistical significance from unlesioned groups (rx.05, or better). 
Golgi Preparations: 
The supplement treatment indicates an increase in brain weight in animals with 
frontal lesions. (Only male rats were prepared for Golgi-Cox staining). 
A two-way ANOVA indicated a main effect of lesion (F(l,19)= 61.100, P< 
.0001), as well as significant effects for the interaction (F(l,19)= 7.800, P= .0100), but 
not of treatment (F(l,19)= 1.670, P=.2100). These results reflect the treatment benefits 
were found in male animals with frontal lesions. 
Table 13. Brain Weight for Golgi Preparations: 
Group Male 
Untreated lesion 1.764±.020 (n=6) * 
Supplement lesion 1.902 ±.030 (n=5) ** 
Untreated Unlesioned 2.123 ± .030 (n=6) 
Supplement Unlesioned 2.072 ± .050 (n=5) 
* Denotes statistical significance from unlesioned groups (p<.05, or better). 
** Denotes statistically different from untreated lesion group (rx. 05, or better). 
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Cortical thickness: 
The brains that were used to measure and analyze cortical thickness and thalamus 
were those that were prepared for Cresyl Violet staining. 
Data for all five planes were analyzed by a two-way ANOVA collectively to 
determine the overall effects on cortical thickness between treatment and no treatment 
groups. 
Data for all five planes were analyzed collectively by repeated measures ANOVA 
to determine the overall effects on cortical thickness and lesion (see Fig.34). A significant 
interaction between mean cortical thickness and lesion was found in the analysis 
therefore, two-way ANOVAS were performed for each plane. 
A two-way ANOVA for the first cortical plane showed a main effect of lesion 
(F(l,83)= 51.256, P<.0001), and of treatment (F(l,83)= 4.419, P=.0386), but not for the 
interaction (F(l,83)= 2.748, P=.1011). 
ANOVA for the second plane revealed no main effect of lesion (F(l,83)= .891, 
P= .3479), a main effect of treatment (F(l,83)= 63.567, P< .0001), but not for the 
interaction (F( 1,83)= 1.032, P= .3126). 
ANOVA for the third plane indicated a main effect of lesion (F(l , 83)= 10.303. 
P=.0019), but not of treatment (F(l,83)= 1.874, P= . 1747), and not for the interaction 
(F(l,83)=.192, P=.6620). 
ANOVA for the fourth plane indicated a main effect of lesion (F(l,83)= 22.010, 
P<.0001), as well as for the interaction (F(l,83)= 5.356, P= .0231), but not of treatment 
(F(l,83)= 1.355, P=.2512). 
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Fig. 35. Cortical thickness for each of five planes measured in animals with frontal 
lesions treated with the vitamin supplement. 
ANOVA for plane five indicated a main effect of lesion (F(l,83)= 8.463, P= 
.0046), and of treatment (F(l,83)= 14.707, P= .0002), but not for the interaction 
(F(l,83)= 2.312, P= .1322). 
Overall, the frontal lesion group treated with the supplement had thicker cortices 
than the untreated animals throughout all five planes measured (see Fig.35). 
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Mean Cortical Thickness 
Fig. 36. Mean cortical thickness for the five planes measured in animals with frontal 
lesions treated with the vitamin supplement. * Denotes statistically significant from 
unlesioned groups (p<. 05, or better). ** Denotes statistically different from untreated 
groups (rx. 05, or better). 
Thalamic width: 
The frontal lesions produced a reduction in thalamic width in the posterior, but 
not the anterior plane. There was no effect of supplement treatment (see Table 14). 
ANOVA for the anterior plane of measure did not indicate any significant effects 
of lesion (F(l,27)= 2.032, P=.1655), of treatment (F(l , 27)= .305, P= .5850), or for the 
interaction (F(l,27)= .712, P=.4063). 
ANOVA for the posterior plane of the thalamus did indicate a main effect of 
lesion (F(l,27)= 25.167, P< .0001), but not of treatment (F(l,27)= .943, P=.3401), or for 
the interaction (F(l,27)= 1.455, P=.2382). 
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Table 14. Mean measures of thalamic width. 
Anterior Plane (mm) Posterior Plane (mm) 
Untreated Lesion 11.120 ±.282 12.940 ± .277 * 
Supplement Lesion 11.600 ±.284 13.008 ± .238 
Untreated Unlesioned 11.900 ±.400 14.750 ± .250 
Supplement Unlesioned 11.800 ±.284 14.117 ±.104 
* Denotes statistical significance from unlesioned groups (p<.05, or better). 
Behavioral results 
Open Field: 
The frontal lesion decreased the activity levels in the animals, which was further 
reduced by the supplement treatment. The supplement treatment reduced activity levels in 
the unlesioned group as well. 
Horizontal activity: 
ANOVA between lesion and treatment groups for horizontal activity did have a 
main effect of treatment (F(l,49)= 61.000, P< .0001), as well as significant effects for the 
interaction between groups (F(l,49)= 9.200, P= .0040), but did not indicate a main effect 
of lesion (F(l,49)= 2.800, P= .1000) (see Fig.36). 
Distance: 
ANOVA between lesion and treatment groups for distance also found main 
effects of treatment (F(l,49)= 76.800, P< .0001), as well as for interaction (F(l,49)= 
4.500, P= .0400). but not of lesion (F(l,49)= 0.700, P= .3900). The interaction reflects 
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Mean Horizontal Activity 
Unlesioned Frontal 
Fig. 37. Mean horizontal activity of frontal lesion animals treated with the vitamin and 
mineral supplement. * Denotes statistically different from untreated groups (p< .05, or 
better). 
the fact that the supplement treatment effects were significant for the lesion group, but 
there was no lesion effect because the supplement effect was larger in the unlesioned 
animals (see Fig.37). 
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Mean Distance 
1600 • Untreated 
1400 - I • VS 
1200-
1000 
• | 800 
600 
400 
200 -
Unlesioned Frontal 
Fig. 38. Mean distance of frontal lesion animals treated with the vitamin and mineral 
supplement. * Denotes statistically different from untreated groups (rx. 05, or better). 
Morris water task: 
The rats with frontal lesions were impaired at the task, and this impairment was 
reversed with the supplement treatment, suggesting a complete recovery of function (see 
Fig.38). 
Repeated measures ANOVA indicated significant effects of lesion (F(l,59)= 
9.531, P= .0031, treatment (F(l,59)= 12.018, P= .0010, and an interaction between lesion 
and treatment groups (F(l,59)= 4.868, P= .0313, as well as a main effect for the category 
of latency (F(4,236)= 89.004, P< .0001. All other interactions were not significant (p> 
.10). 
A two-way ANOVA found main effects of lesion (F(l,59)= 9.531, P= .0031, 
treatment (F(l,59)= 12.018, P= .0010 and for an interaction between groups (F(l,59)= 
I l l 
Fig. 39. Morris water task latency over five-day training period. Animals had frontal 
lesions and were treated with the supplement. 
4.868, P= .0313. The interaction reflects the greater treatment effects of the supplement 
in the animals with lesions (see Fig.39). 
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Morris Water Task Latency Sums 
Unlesioned Frontal 
Fig. 40. Morris water task latency sums of frontal lesion animals treated with the vitamin 
supplement. * Denotes statistically different from unlesioned groups (p<. 05, or better). 
** Denotes statistically different from untreated groups (p<. 05, or better). 
The probe analysis for the second experiment was not completed by the computer 
data processes due to computer malfunction in tracking of the rats' swim patterns. The 
probe was therefore graded from scores of one to four, according to a hand drawn trace of 
the swim path (see Fig.40). These results were analyzed by a two-way ANOVA, which 
indicated that both lesion groups spent less time than the control group in the correct 
quadrant, quadrant one. 
ANOVA for the lesion groups was significant and found a main effect of lesion 
(F(l,29)= 5.255, P= .0293, but no significant effects of treatment (F(l,29)= .250, P= 
.6206, or the interaction (F(l,29)= .730, P= .3999. 
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Fig. 41 . Probe trials of frontal lesion animals treated with the vitamin supplement. A 
grade ofl indicates least amount of time spent in correct quadrant, quadrant 1. A grade of 
4 indicates most time spent in quadrant 1. All animals are within the treatment group. * 
Denotes statistically different from unlesioned groups (p< 05, or better). 
Tray Reaching: 
Rats with frontal lesions were impaired with the reaching task and this deficit was 
partially reversed with the supplement treatment (see Fig. 41). 
A two-way ANOVA between revealed a main effect of lesion (F(l,59)= 88.740, 
P< .0001, and the interaction (F(l,59)= 10.437, P= .0020. There was no effect of 
treatment (F(l,59)= 1.676, P=.2004. The interaction reflects the selective effect of the 
supplement treatment. 
114 
Fig. 42. Summary of tray reaching task of frontal lesion animals treated with the vitamin 
supplement. * Denotes statistically different from unlesioned groups (p<. 05, or better). 
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Experiment # 2B 
The Effects of a Dietary Vitamin and Mineral Supplement on Recovery from 
Perinatal Posterior Parietal Injury 
The methods used for Experiment 2B were essentially identical to those used in 
2A. The differences were only in subject numbers and surgical procedures. 
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Method 
Subjects 
A total of seventy-four Long Evans rats were used for Experiment 2B. These rats 
participated in three behavioral tasks (see Table 15). At the age of 60 days the animals 
began behavioral testing. Any sex differences that are significant to the experimental 
results are reported. 
Table 15. Number of rats used in Experiment 2B 
Untreated Supplement Treatment 
Sex Female Male Female Male 
Unlesioned n = 5 n=12 n=8 n=14 
Parietal Lesion n = 5 n= l l n=8 n = l l 
Surgical, anatomical and behavioral procedures 
These procedures were identical to those in Experiment IB. 
Results 
Anatomical results 
The lesions removed Kreig's area 7, in addition to the posterior part of the 
primary parietal cortex (Zilles Pari), and the anterior part of occipital 2 area (Oc2). 
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Supplement Treatment 
Occasionally, unilateral damage was apparent in the posterior cingulate regions (RSG, 
RSA). There was no direct damage to the hippocampus or other subcortical regions. 
The hippocampus usually had an abnormal shape and often grew through the 
lesion cavity. A dorsal view of the cortex, therefore often indicated the appearance of a 
smooth exterior cortical surface (see Fig. 42). 
As in Experiment 2A, the lesion cavities appeared to be smaller in the 
supplement-treated animals with the hippocampus growing to the cortical surface in 
fewer brains^ 
Most posterior lesions resulted in some degradation in the anterior nuclei, but 
overall had larger nuclei and more cells than brains in the untreated group. An interesting 
effect observed in the caudate putamen of the supplement-treated brains was an increase 
in white matter, as well as cell density (see Fig. 43). 
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Untreated 
Fig. 43. Parietal lesions of the vitamin supplement treated group. 
Fig. 44. The caudate putamen in parietal lesion brains. 
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Table 16. Brain Weight for Cresyl Violet Preparations: 
Group Female Male 
Untreated lesion 1.772 ± .050 (n=5) * 1.890 ± .040 (n=5) * 
Supplement lesion 1.892 ±.038 (n=8) 2.077 ±.100 (n=6) 
Untreated Unlesioned 1.948 ±.020 (n=5) 2.162 ±.073 (n=6) 
Supplement Unlesioned 1.879 ± .040 (n=8) 1.970 ± .040 (n=9) 
* Denotes statistical significance from unlesioned untreated group (p<.05, or better). 
Brain Weight: 
The parietal lesion resulted in a decrease in brain weight, which was unaffected 
by the vitamin supplement. Differences in brain weight are usually found between the 
sexes, as well as with fixation method, therefore, the analysis has been done separately 
for each sex and fixation technique. 
Cresyl Violet Preparations: 
The parietal lesion resulted in a decrease in brain weight, which was reversed in 
both males and females that received the vitamin supplement treatment (see Table 16). 
A three-way ANOVA with lesion, supplement treatment, and sex as factors 
showed a main effect of lesion (F(l,38)= 4.8, P <04) and sex (1,38)=16.6, P <.0002) but 
not of treatment (F(l,38)= 0.24, P=.25). There was, however, a significant lesion x 
treatment interaction (F((1.38)=14.3, p=.0005), a result that reflects the selective effect of 
the treatment on the lesion brains. The other interactions were not significant (p's>.2). 
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Table 17. Brain Weight for Golgi Preparations: 
Group Male 
Untreated lesion 1.942±.010 (n= 6) * 
Supplement lesion 1.872 ±.040 (n= 5) 
Untreated unlesioned 2.123 ±.030 (n=6) 
Supplement Unlesioned 2.072 ± .050 (n=5) 
* Denotes statistical significance from unlesioned groups (p<.05, or better). 
The parietal lesion resulted in thinner cortices, which was significantly increased 
in the supplement-treated parietal lesion animals, (see Fig.44). 
An overall ANOVA on cortical thickness between lesion and treatment groups 
indicated significant effects of lesion (F(l,22)= 6.083, P= .0219), and treatment (F(l,22)= 
9.182, P= .0061), but not of an interaction (F(l,22)= 1.484, P= .2361). 
A repeated measures ANOVA for all five planes did not reveal significant 
interactions between mean cortical thickness and lesion (see Fig.45). 
Golgi Preparation: 
The parietal lesion resulted in lower brain weight, which did not indicate a benefit 
with the vitamin supplement. (All golgi analysis were done for male rats). 
ANOVA revealed a main effect of lesion (F(l,19)= 32.100, P< .0001), but not of 
treatment (F(l,19)= 3.210. P= .0900), or of an interaction (F(l,19)= .0800, P= .7800) (see 
Table 17). 
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Fig. 45. Cortical thickness for each of five planes measured in animals with parietal 
lesions treated with the vitamin supplement. 
Mean Cortical Thickness 
Unlesioned Parietal 
Fig. 46. Mean cortical thickness for the five planes measured in animals with parietal 
lesions treated with the vitamin supplement. * Denotes statistically different from 
unlesioned groups (p< 05, or better). 
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Thalamic width: 
Nuclear atrophy in the anterior plane of the thalamus was found for both parietal 
lesion groups with the appearance of less cell damage in the supplement treated brains 
(see Table 18). 
A two-way analysis of variance (ANOVA) of the anterior plane for thalamus 
indicated a main effect of lesion (F(l,23)= 57.820, P< .0001), but not of treatment 
(F(l,23)= .144, P= .7081), nor for the interaction (F(l,23)= .407, P= .5296). 
ANOVA for the posterior plane of the thalamus indicated a main effect of lesion 
(F(l,23)= 54.024, P< .0001) and of treatment (F(l,23)= 10.899, P= .0031), but not for the 
interaction (F(l,23)= .527, P= .4752). 
Table 18. Mean measures of thalamic width. 
Anterior Plane (mm) Posterior Plane (mm) 
Untreated Lesion 8.720 ± .346 * 13.480 ±.128 * 
Supplement Lesion 9.112 ±.651 13.075 ±.105 
Untreated Unlesioned 11.900 ±.400 14.750 ± .250 
Supplement Unlesioned 11.800 ±.129 14.117 ±.104 
* Denotes statistically different from unlesioned groups (rx.05, or better). 
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Behavioral results 
Open Field: 
The Parietal lesion resulted in decreased activity levels in the animals, which was 
further reduced by the supplement treatment. The supplement treatment reduced activity 
levels in the unlesioned animals as well. 
Horizontal activity: 
ANOVA between lesion and treatment groups for horizontal activity found main 
effects of lesion (F(l,47)= 4.800, P= .0400, of treatment (F(l,47)= 46.600, P< .0001), as 
well as for an interaction between groups (F(l,47)= 11.700, P= .0010) (see Fig.46). 
The main effect of the supplement treatment was evident in both the lesion and 
unlesioned groups, as well as having a direct effect with the parietal lesion animals. 
Mean Horizontal Activity 
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Fig. 47. Mean horizontal activity in open field of parietal lesion animals treated with the 
supplement. * Denoted statistically different from unlesioned groups (p<. 05, or better). 
** Denotes statistically different from untreated groups (p<. 05, or better). 
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Distance: 
ANOVA between lesion and treatment groups for distance also found main 
effects of treatment (F(l,47)= 61.600, P< .0001), as well as of interaction (F(l,47)= 
5.100, P= .0200), but not of lesion (F(l,47)= 0.960, P= .3300) (see Fig.47). 
The interaction reflects the fact that the supplement treatment effects were 
significant for the lesion group, but there was no lesion effect because the supplement 
effect was larger in the unlesioned animals. 
Mean Distance 
Unlesioned Parietal 
Fig. 48. Mean distance in open field of parietal lesion animals treated with the 
supplement. * Denotes statistically different from untreated groups (rx. 05, or better). 
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Morris Water Task: 
Rats with parietal lesions were impaired at the water task, which was reversed 
with the supplement treatment. 
A repeated measures ANOVA for the water task indicated many significant 
effects for all measures of lesion, treatment and category of latency (see Fig.48). 
There were main effects of lesion (F(l,42)= 12.560, P= .0010), and of treatment 
(F( 1,42)= 10.407, P= .0024), but not for an interaction between lesion and treatment 
(F(l,42)= 2.880, p= .0971). There was also a main effect of category latency (F(4, 168)= 
110. 754, P< .0001), an interaction between latency and lesion (F(4,168)= 3.338, P= 
.0108), and an interaction between latency and treatment (F(4,168)= 4.614, P= .0015). 
A two-way ANOVA between lesion and treatment for latency found main effects 
of lesion (F(l,42)= 12.560, P= .0010, and of treatment (F(l,42)= 10.407, P= .0024, but 
not for an interaction (F(l,42)= 2.880, P= .0971, indicating that the supplement treatment 
provided a benefit for all animals, especially those with parietal lesions in the water task 
(see Fig.49). 
The probe analysis for the second experiment was not completed by the computer 
data recording processes, due to a computer malfunction in tracking the swim patterns of 
the rats. The probe was therefore graded from scores of one to four, according to a hand 
drawn trace of the swim path (see Fig.50). These results were analyzed by a two-way 
ANOVA, which indicated that the no treatment parietal lesion group spent less time than 
the other groups in the correct quadrant, quadrant one. 
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Fig. 49. Latency in Morris water task over five-day training period. Animals had parietal 
lesions and treated with the supplement. 
Morris Water Task Latrency Sums 
U n l e s i o n e d Parietal 
Fig. 50. Morris water task latency sums of parietal lesion animals treated with the 
supplement. * Denotes statistically different from unlesioned groups (p< 05, or better). 
** Denotes statistically different from untreated groups (rx. 05, or better). 
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A two-way ANOVA between lesion and treatment groups did not reveal any 
significant effects of lesion (F(l,22)= 1.389, P= .2512, of treatment (F(l,22)= .008, P= 
.9314, nor for an interaction (F(l,22)= 1.103, P= .3051. According to this analysis, there 
were no significant effects with the parietal lesion group. 
Fig. 51. Probe Morris water task trials for parietal lesion animals treated with the 
supplement.. A grade of 1 indicates least amount of time spent in correct quadrant, 
quadrant 1. A grade of 4 indicates most time spent in quadrant 1. All animals are within 
the treatment group. 
Tray Reaching: 
The rats with parietal lesions were impaired compared to unlesioned animals. The 
supplement treatment partially reversed this impairment (see Fig. 51). 
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Fig. 52. Summary of tray reaching task of parietal lesion animals treated with the 
supplement. * Denotes statistically different from unlesioned groups (p< 05, or better). 
** Denotes statistically different from untreated groups (p<. 05, or better). 
A two-way ANOVA between lesion and treatment groups indicated a main effect 
of lesion (F(l,33)= 9.711, P= .0038), and of treatment (F(l,33)= 6.308, P= .0171), but not 
for an interaction (F(l,33)= .076, P= .7842). 
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Discussion 
The main anatomical findings of the current experiment were: 1) perinatal frontal 
and posterior parietal lesions produce a smaller than normal brain and reduced cortical 
thickness; 2) the supplement treatment significantly increased cortical thickness in both 
the lesion and control animals; 3) the supplement treatment may have reduced the chronic 
lesion size normally seen in the lesion animals. 
Behaviorally, the main findings of the current studies were: 1) both perinatal 
medial frontal and posterior parietal lesions reduced open field activity relative to 
controls and produced impairments in both spatial navigation and skilled reaching 
relative to controls, and; 2) the supplement completely reversed the spatial deficit in the 
medial frontal lesion animals and partially reversed the deficits found in spatial learning 
in the posterior parietal lesion animals. Partial reversals of skilled reaching impairments 
were found for both frontal and posterior lesion animals. 
Anatomical effects of the vitamin/mineral supplement treatment 
Over the past twenty years or so, Kolb and colleagues have repeatedly 
demonstrated that perinatal cortical lesions produce a reduction in brain size and cortical 
thickness (Kolb, 1995; Kolb & Whishaw, 1989). One goal of postinjury therapies is to 
stimulate an increase in cortical thickness because it can be presumed that this should 
facilitate behavioral outcome. Placing animals with perinatal lesions into complex 
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environments reduces the behavioral impairments, which is correlated with an increase in 
cortical thickness (Kolb & Elliott, 1987). The results of the current studies are consistent 
with the same general notion. The supplement treatment partially reversed the behavioral 
deficits and increased cortical thickness. The question is, why did this treatment have 
these effects? 
The thinner cortical mantle that invariably follows perinatal cortical injury is 
consistently associated with a reduction of dendritic arborization in cortical neurons, the 
actual cause for this however, is not yet established (Kolb, 1995). It is also likely that 
there are fewer cortical neurons than normal, possibly because of an enhancement in 
apoptosis (Kolb & Gibb, 1990). Thus, it seems reasonable to suggest that the supplement 
treatment may have stimulated dendritic growth, which is normally associated with 
synaptogenesis, and in addition, may have reduced apoptosis, or stimulated neurogenesis. 
A Golgi analysis is in progress to explore the first hypothesis. The second possibility has 
not yet been examined, but evidence suggests that this may be the case. 
The lesion cavities in both the medial frontal and posterior parietal experiments 
were visibly smaller in the supplement-treated lesion animals. Several studies have 
demonstrated that neurogenesis is possible after perinatal cortical injuries, although is 
normally seen only if the injury occurs during the second week of life in the rat (Dallison 
& Kolb, 2003; Kolb et al., 1998). Treatment with FGF-2 decreased cavity size in lesion 
brains and stimulated neurogenesis (Waite, 2003). As noted earlier, if the expression of 
FGF-2 is affected by the supplement treatment, this could provide a mechanism for 
stimulating neurogenesis. Naturally, a direct test for neurogenesis with respect to the 
findings of the supplement treatment is necessary for the identification of newly 
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generated neurons, and to determine if the new neurons integrate anatomically and 
functionally with the brain. 
One unexpected finding in the current study was that the supplements not only 
increased cortical thickness in the lesion animals, but also in the animals that did not 
receive lesions. Aside from the impressive results of the frontal lesion animals in the 
Morris water task, we do not have an obvious behavioral correlate with this increase in 
cortical thickness. It is likely that the behavioral tasks employed in the current studies 
were not particularly sensitive to determine these results, or perhaps not extensive enough 
to identify behavioral effects in the normal animals. If the animals were perturbed, or 
stressed, such as that seen during cerebral injury, or with a dementing disease, the 
behavioral advantages could appear. The thicker cortical mantle, with presumably more 
synapses, would be able to support a better functional outcome than that observed in 
untreated animals. 
Behavioral effects of the vitamin/mineral supplement treatment 
Rats with perinatal medial frontal or posterior parietal lesions typically have 
deficits in spatial navigation and the medial frontal animals also have deficits in skilled 
reaching. The current experiment further supports this finding. All of the lesion effects 
that are usually observed in lesion studies were reduced with the supplement treatment. 
Furthermore, even the unlesioned animals benefited from the supplement. The actual 
effect in the tray-reaching task is uncertain, as the results indicate that the supplement-
treated animals had lower success rates. This could be due to the rats not being hungry 
enough to make assertive attempts to reach and maintain a pellet grasp. The animals on 
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the supplement diet were more sensitive to food deprivation than those animals on the 
standard diet as observed by increases in inattentiveness and hyperactivity. 
The benefit of the supplement on functional recovery after perinatal cortical 
lesions is exciting because it is a simple treatment that can be initiated in a noninvasive 
manner. The critical time period for the administration of the supplement, however, is 
unknown because treatment was continued throughout the lifetime of the rat, since the 
day of birth in the current study. Future studies should determine if there are particular 
periods post-injury when the treatment is most beneficial. 
To date, there have been very few other post-injury treatments that have been 
shown to affect the outcome of early cortical injury. One treatment that has been found, 
however, is post-injury tactile stimulation (Gibb & Kolb, in submission). Gibb and Kolb 
have proposed that the mechanism for the tactile stimulation effect is via an upregulation 
of Fibroblast Growth Factor (FGF-2). Thus, the stimulation increases FGF-2 both in skin 
and in brain, and direct administration of FGF-2 has been found to stimulate functional 
recovery. Increases in FGF-2 expression have been associated with other forms of 
cortical plasticity as well, including the effects of psychoactive drugs (Flores & Stewart, 
2000). By administering psychomotor stimulant drugs, cocaine and amphetamine, the 
neural activity that is associated with sensitization to the drugs was found to produce 
long-lasting structural changes in the brain, which was correlated with increased FGF-2 
expression. It is therefore possible that the supplement treatment could act via some 
similar mechanism, either on FGF-2, as well as other neurotrophic factor(s). 
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5. General Discussion 
The fundamental goal behind the experiments performed was to enhance pre-and 
postnatal factors and mechanisms that are normal processes during the developmental 
stages, in an attempt to promote recovery of function following early cortical injury. Two 
different treatments were chosen, dietary choline and a vitamin and mineral supplement. 
Choline intervention has been studied for many years as therapeutic treatment during 
development. The majority of this research indicates that perinatal choline intervention 
can produce long-lasting behavioral benefits (Tees, & Mohammadi, 1999; Albright, 
Friedrich, Brown, Mar & Zeisel, 1999; Meek, Smith & Williams, 1988; Blusztajn, 1998; 
Zeisel, 2000). The vitamin and mineral supplement, on the other hand, has not previously 
been investigated as a therapeutic agent in laboratory animals. 
The principal findings of the experiments were that both the choline and vitamin 
supplement treatments facilitated functional recovery and reversed some morphological 
sequelae of perinatal medial frontal lesions. In contrast, only the vitamin supplement had a 
similar effect on these measures in rats with perinatal posterior parietal lesions. 
Furthermore, both treatment interventions appeared to exert some kind of an anxiolytic 
effect, as indicated by observed stress responses of behavior and defecations in the open 
field task. Subjective observations of the animals are they were calmer and had a more 
relaxed behavior with handling and with the task training. In addition, they displayed a 
reduction of activity in the open field test, possibly because they were less anxious. 
I should note parenthetically, that there were some initial difficulties in using the 
supplement in dams prior to conception, and possibly even during gestation, but it was 
possible to administer the diet postnatally. In addition, a second generation of animals 
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was successfully bred on the diet and the second generation of pups appeared healthy and 
performed normally on the behavioral tests (Appendix E). 
The focus of this discussion will be on the possible mechanisms underlying the 
beneficial effects of the dietary treatments, first at a molecular level and then at a 
behavioral level. I then consider how this research might be extrapolated to other 
disorders and where future research should head. 
Molecular Actions of the Choline and Vitamin/Mineral Supplement 
When the brain is injured there are both degenerative processes engaged as well 
as a continuation of the genetically prescribed developmental processes. To successfully 
treat injury of the developing brain, the progression of degenerative effects of the injury 
would need to be retarded and reversed as quickly as possible, in order to encourage the 
continuation of normal development and to promote the reparative processes. Treatments 
such as choline can be administered prenatally to counter some of the damaging effects of 
injury incurred at a later stage of development. Phosphorylcholine is a metabolite of 
choline found in the fetal brains of pregnant dams, which also shows higher 
concentrations in dams supplemented with dietary choline (Garner, Mar & Zeisel, 1995). 
Garner and colleagues have proposed that phosphorylcholine may serve as an essential 
messenger for the induction of DNA synthesis, thereby promoting cell division. 
Dietary choline and its metabolites have also been implicated in the prevention of 
apoptosis, a naturally occurring form of cell death and cell turnover in the brain (Holmes-
McNary. Loy, Mar, Albright & Zeisel, 1997). Cells deficient of choline show 
characteristic signs of cellular atrophy with intracellular degenerative processes, which 
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are known to occur prior to apoptotic cell death. The synthesis of choline metabolite, 
phosphatidylcholine (cell membrane phospholipid), has been proposed to be necessary to 
maintain the progression of the cell cycle, from the first growth phase (Gl) to the 
synthesis phase (S) of DNA nucleotide synthesis (Holmes-McNary, Loy, Mar, Albright 
& Zeisel, 1997). 
During the developmental period of neural migration at postnatal days one to six, 
cortical injury would result in losses of cortical target cells necessary to guide neuritic 
outgrowth, particularly in the case of cholinergic cells. In the brain, cholinergic neurons 
have an intimate relationship with nerve growth factor. Nerve growth factor is 
synthesized by the target cells in the cortex, which is then transported in a retrograde 
fashion to the nucleus basalis magnocellularis in the basal forebrain of the rat (Hefti, 
Hartikka, Knusel, LaPlume & Mash, 1990). Nerve growth factor is activated by neural 
activity, which could also promote cholinergic activity around the lesion site if sufficient 
growth factors exist in the area. Increasing the dietary choline content has been reported 
to increase the size of cholinergic cells, thereby preventing cell shrinkage as a result of 
cortical lesions. The subsequent effects of cholinergic activity increase growth factor 
activity to retard the degenerative processes of lesions, and potentially promote neuritic 
sprouting (Loy, Heyer. Williams & Meek. 1991). During development, neurite outgrowth 
is suggested to increase in activity from electrical activity occurring in neighboring cells 
(van Pelt, Ooyen & Corner, 1996). Cortical lesions remove a portion of cortical tissue, so 
any new tissue that could regenerate would need to rely on neighboring cells for electrical 
activation, trophic support, and guidance. There would also be a loss of neural and glial 
cells during migration. The cortex would suffer losses of early migrating neural cells. 
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which would not normally be replaced. Glia, on the other hand, can proliferate 
throughout development and the peak time for astrocyte genesis is not until the second 
week of life. Therefore, if treatment could enhance the proliferation of glial cells, there 
would be an increase in trophic support for neural cells. Furthermore, because it has been 
proposed that under some circumstances astrocytes can redifferentiate into neurons, it is 
possible that a treatment that enhanced glial proliferation could enhance the likelihood of 
neurogenesis. Radial glia that are proposed to guide neural cells during migration have 
been found to exhibit molecular characteristics that are typical of neural cells and express 
various transcription factors involved in cell fate in different brain regions (Reid, & 
Walsh, 1996). Any direct damage to migrating neurite elongation processes (axons) 
would result in losses of cytoplasmic constituents that are required to provide growth 
cones with cell signaling molecules, energy substrates and cytoskeletal constituents to 
continue elongating protrusions. 
The first two weeks of postnatal life in the rat begins a period of developing 
dendrites and synaptic connections. The firing patterns of immature cells are considered 
different from the patterns of their mature counterparts (Erzurumlu & Guido, 1996). 
Rather than a summation in electrical activity that produces a single burst of neural 
activity, as in mature neurons, immature neurons display smaller, but continuous firing 
patterns of electrical activity. Erzurumlu and Guido (1996) suggest that these new 
neurons have the capacity to generate a wide variety of responses based on the 
transduction pathways generated postsynaptically. These responses, in turn, could induce 
changes in neuronal differentiation, structurally at new synapses, and processes of 
plasticity (Erzurumlu & Guido, 1996). This concept of plasticity during development can 
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be applied to any type of treatment, provided that it could increase activation of neural 
cells. The supplement treatment would supply not only precursor amino acids for 
neurotransmitter synthesis, but also the necessary precursors for the enzymatic reactions. 
By influencing all systems, neural activity would experience a higher amount of electrical 
activity, which could recover some of the debilitating effects of a lesion. 
The activation of trophic factors that are necessary for neural support and survival 
depend upon the activity of the neurons supported by glial cells. Glial cells contain 
receptors for neurotransmitters, which can trigger trophic responses to support ongoing 
neurotransmission. Immature glial cells have also been identified as carriers of growth 
factors and extracellular proteins (Acarin, Gonzalez & Castanello, 2001). In the advent of 
injury to the brain, glial cells provide the injured area with factors necessary for repair 
and growth. One of the primary factors upregulated after injury is nerve growth factor 
(Acarin, Gonzalez & Castanello, 2001). Nerve growth factor then is important for injury 
repair, but has also been shown to provide mechanisms necessary for cortical plasticity. 
The direct infusion of trophic factors, particularly nerve growth factor, into the lateral 
ventricle (ventricular zone) has been correlated with functional plasticity (Kolb, 1999). 
Increases in dendritic arbor and spine density in neurons were observed after cortical 
lesions in rats, potentially as a result of stimulated neurogenesis to replace some of the 
lost cortical tissue. Removal of the newly grown tissue resulted in elimination of 
functional recovery, as measured in behavioral tasks, implying that this new tissue was 
functional. 
Cholinergic systems of the brain have a beneficial and endogenous relationship 
with nerve growth factor, giving dietary choline treatment a great advantage. Nerve 
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growth factor is suspect to support other neural systems, and there are a number of 
trophic factors in the brain aside from nerve growth factor. The vitamin supplement 
treatment could derive the benefits of other trophic factors, as well as nerve growth 
factor, through increases in neural activity of all neural systems postnatally. This increase 
in activity stimulates the growth in glial cells, which in turn provide additional 
neuroprotective factors and nutritive support. 
In addition to various beneficial factors necessary for the healing and reparative 
processes, such as antioxidants, a potential mechanism that has been considered 
advantageous postsurgery, is the vitamin A content of the supplemented diet. An increase 
in wound strength has been reported from supplementation in megadoses of retinyl 
acetate and beta-carotene (vitamin A) at five days after surgery (Gerber, Erdman, 1982). 
The mechanisms proposed to enhance wound strength are enhancements of normal 
processes during the initial phase of wound healing. Gerber and Erdman (1982) have 
suggested that the proliferative effect of vitamin A on cells could potentiate the mitogenic 
effects normally induced by epidermal and mesodermal growth factors, which would 
increase the fibroblast activity necessary to heal the wound. 
Enhancements of neurotransmitter system conductive abilities could potentiate the 
regenerative capacities in the damaged cortex and their functional outcome. The ability 
for neurons to synthesize neurotransmitters, and release neurotransmitters upon 
stimulation, is largely dependent on the availability of the amino acid precursors of these 
neurotransmitters (Heuther). Although the immature blood brain barrier is more 
permeable to nutrients during development, its destruction as a result of injury would 
further increase the amount of available supply of all nutrients via the blood stream. 
139 
The vitamin supplement provides amino acid precursors of neurotransmitters 
(choline, phenylalanine, glutamine), thereby providing large increases in overall neural 
activity and glial activity, into neural maturation. The functional consequences could 
potentially increase the processes of attention, learning and memory in rats. The 
catecholamines (norepinephrine and dopamine) have been previously implicated to 
influence alerting brain systems, but not orienting systems. Conversely, the cholinergics 
have been implicated to alter orienting abilities, but not alerting mechanisms (Marrocco 
& Davidson, 1998). 
During development some migrating neural cells can become differentiated 
depending on certain characteristics in their local extracellular environment. Cells that are 
initially designated to be noradrenergic cells have been suggested to change course to 
become cholinergic cells, if the conditions in their environment influence such a change 
(Purves & Lichtman, 1985). All neuotransmitter systems are known to modulate each 
other, and therefore, a higher increase of acetylcholine activity in the brain may depress 
the activity of other neurotransmitters, such as norepinephrine. A hypothesis for the 
treatment of anxiety using choline in the form of lecithin has been suggested to involve 
prostaglandin synthesis (Vergrosen, 1979). Based on a number of studies, the 
pharmacological effects of prostaglandins in the E series (PGE's) and F series (PGFct) 
are noted to include effects of "sedation, tranquilization, analgesia, reduction of brain 
catecholamines, and reductions in cardiac arrhythmia via a central action on brainstem 
neurons" (Vergrosen). A keynote with this hypothesis includes the fatty acid content of 
the source (lecithin), as well as the tissues stimulating prostaglandin synthesis. Grape 
seed has a high content of linolenic acid (omega-3 fatty acid) and is included in the 
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vitamin and mineral supplement. Omega-3 fatty acids contribute to the production of 
prostaglandin series 3, such as PGE3. According to Vergrosen's hypothesis, the 
prostaglandins produced by the grape seed might contribute to the anxiolytic effects seen 
in rats treated with the supplement. Anxiolytic effects have also been attributed to 
therapeutic quantities of gingko biloba, which is also included in the vitamin supplement 
and might have contributed to decreases in activity. Gingko biloba extract has been 
shown to restore restraint stress-induced elevations of catecholamines, norepinephrine, 
dopamine, serotonin, and plasma corticosterone levels to near normal in rats (Shah, 
Sharma, & Vohora, 2003). 
The increase in activity of newly formed excitatory acetylcholine is accompanied 
by natural increases in neurite outgrowth of the inhibitory neurotransmitter gamma-
aminobutyric acid (GABA). Cholinergic activation may thereby be accompanied with 
appropriate activations of GABA, dependent upon the circumstances requiring activation. 
Some drugs formulated as anti-anxiety agents are known to depress the stress-induced 
increases of norepinephrine and dopamine. The anxiolytic characteristics that counter 
these neurotransmitter actions are considered to be an effect of GABA, a predominantly 
occurring inhibitory neurotransmitter (Cooper, Bloom, Roth, 2001). 
The results seen in Experiments 1 and 2 of this thesis are valuable and could be 
applied for clinical treatment of injured patients. In the clinical setting treatment of injury 
also necessitates an aggressive nutrition intervention. The vitamin supplement used in 
Experiment 2 would be very beneficial for the treatment of injury through numerous 
mechanisms, and although only a few have been highlighted, many factors must be 
considered with treatment. The purpose of noting some of the physiological responses to 
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injury, or stress, is to emphasize the importance of an aggressive nutrition intervention 
for recovery. 
The body responds to a variety of signals within hours of injury to begin the 
healing and tissue regeneration processes. An increase in protein synthesis is paramount, 
as well as the energy required, to support the repair processes. Hormones are activated to 
meet the metabolic demands during the initial stages of injury and stress. Glucagon, 
insulin, catecholamines, glucocorticoids, and growth hormone are the primary hormones 
activated, based on the present level of circulating amino acids. Increases in protein 
turnover accompany stress, sepsis, surgery and trauma in attempts to synthesize all of the 
necessary proteins for repair. Unfortunately, the rate of protein degradation via amino 
acid catabolism is significantly higher than protein accumulation. The amino acid 
substrates from muscle protein catabolism are required for glucose production. In 
addition, adipocytes (fat cells) also undergo lipolysis to provide the body with glucose 
and ketones. The energy demands during the natural healing processes are very high, thus 
the increases in blood glucose is necessary to provide all active tissue with energy 
sources. Insulin secretion is generally increased during periods of stress to distribute the 
available increases of blood glucose. 
During prolonged periods of stress, however, tissues requiring glucose become 
resistant to insulin. Because tissues are not receiving glucose, the glucagon-to-insulin 
ratio changes to favor glucagon release, which signals a continuation of protein 
degradation and glucose synthesis. The brain can also utilize ketones for energy during 
periods of stress and starvation (glucose deprivation), but during prolonged periods of 
stress, ketones also become resistant to the effects of insulin. Cortisol (glucocorticoid) 
142 
concentrations generally remain elevated, further increasing degradation processes to 
synthesize glucose. 
The net result of these catabolic processes is a gradual and continual overload of 
blood glucose and a slow recovery of damaged tissue. Furthermore, if there is a 
considerable lack of digestible nutrient intake into the gastrointestinal tract as a result of 
prolonged periods of stress or injury the intestinal mucosa becomes susceptible to 
atrophy, which contributes to risks of sepsis. The demands for intestinal cell's needs are 
usually much higher than can be afforded from amino acid catabolism (Goff, Gropper, & 
Hunt, 1995). 
Cerebral metabolism after head injury has been noted to necessitate increases in 
glucose and amino acids for energy production to accommodate the metabolic demands 
during repair processes (Robertson et. al., 1988). Although the metabolic substrates of 
glucose are present in the blood stream, the brain cannot extract what it needs and some 
of the cerebral amino acids circulating, such as glutamate, may actually contribute to 
further neural damage. Other circulating aromatic amino acids that include tryptophan, 
phenylalanine, and tyrosine, apparently have not been equated to neurotransmitter 
production. Robertson and colleagues report that the initial purpose for these substrates 
would be for energy production to aid the reparative processes; however, they are rather 
associated with neuronal dysfunction, emphasizing the importance of regulating energy 
metabolism in the brain (Robertson, et. al., 1988). 
Head-injured children have even greater metabolic demands to ameliorate some 
of the physiological effects of stress, to prevent weight loss, and provide for increases in 
protein synthesis (Phillips, Ott, Young & Walsh, 1987). 
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The vitamin and mineral supplement provides a number of factors that could 
retard long-term effects of stress and begin supporting demanding metabolic systems 
with the appropriate substrates and enzymes. The antioxidants vitamins A, E, and C, and 
selenium, as well as, mineral complexes of antioxidant enzymes, copper-zinc superoxide 
dismutase and manganese-zinc superoxide dismutase would be essential to prevent neural 
excitotoxic reactions. Others worth mentioning are chromium, glutamine, and vitamin B6. 
One of many nutritional roles of glutamine is for the maintenance of the integrity 
of the intestinal mucosal cells, and is required in large amounts during periods of stress, 
which often leads to limited dietary intake. Aside from the prevention of sepsis, the 
necessity of healthy intestinal cells is to be able to absorb and transport nutrients across 
the intestinal barrier, as is necessary to provide the body with nutrients for the reparative 
processes and prevent malnutrition. 
After the initial period of tissue repair, when Cortisol release is beneficial by 
inducing neuroprotective factors, the debilitating activity of chronic Cortisol release is 
known to downregulate the expression of neuroprotective factors in the brain. 
Systemically, chronic Cortisol in circulation results in the continuous attempt to provide 
glucose for energy substrates, but instead begins accumulating in the blood stream. The 
debilitating processes of long-term Cortisol release could be reversed, by enabling insulin 
to transport blood glucose through capillaries into peripheral tissues and the brain. 
Glucose would then be oxidized, generating sufficient energy sources required to reverse 
catabolic (degrading) metabolism to anabolic (synthesis) metabolism that usually results 
with insulin activity. 
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A primary factor that could retard the chronic degradative processes of 
metabolism is vitamin B6 in its cofactor form pyridoxal phosphate (PLP) (Groff, Groper, 
& Hunt, 1995). Pyridoxal phosphate has been shown to prevent, or interfere with steroid 
hormone binding on target cells and can also bind to the steroid hormone receptors, thus 
diminishing the normal activities of steroid hormones on cells. The termination of 
glucocorticoid activity can then influence protein, carbohydrate, and lipid metabolism. 
Ironically, some drugs that are often prescribed post-surgery, such as corticosteroids, 
anticonvulsants, penicillamine, and isoniazid are known to deplete the body of vitamin B6 
(Groff, Groper, & Hunt, 1995). 
Chromium, as a glucose-tolerance factor, is provided in large amounts in the 
supplement, along with antioxidants to prevent the damaging effects of any surplus 
byproducts of oxidative metabolism. Chromium is known to enhance the effects of 
insulin. The subsequent clearing of high blood glucose levels should at some point trigger 
an appetite to provide the body with nourishment, particularly protein, to increase protein 
synthesis. Each metabolic pathway that is higher in activity during periods of stress, 
sepsis, injury, or trauma, requires a variety and abundance of vitamins and minerals with 
their diet to sustain prolonged nutrient depletion. The vitamins and minerals provide 
substrates and enzyme cofactors for the primary metabolic pathways, but also support a 
number of other pathways that are interlinked with these primary pathways to contribute 
to such a demanding task. 
Retardation of the chronic effects of stress, and subsequent reversal of catabolic 
metabolism associated with chronic stress could decrease the duration for healing and any 
nutritional losses could be significantly reduced. 
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Collectively, the metabolic demands that the body processes as a result of injury 
are numerous, complicated, and usually exceed the body's capabilities without nutrition 
intervention. Treatment of brain injury necessitates much more than caring for the wound 
alone. By addressing the issue using aggressive nutritional measures with a well-
formulated vitamin supplement and an adequate dietary intake, the body as a whole 
would receive substantial support to enhance the healing processes. 
If all the necessary substrates are available, through the diet and the vitamin and 
mineral supplement, the long-term effect of treatment in physiological systems of the 
brain and the body could possibly become balanced and operate under "normal" 
homeostatic circumstances. 
Behavioral Effects of the Choline and Vitamin Treatments 
Although I have considered a variety of molecular mechanisms whereby the 
treatments might influence brain function, it is not immediately obvious how these effects 
would translate into behavior. There are few clues about this in the existing behavioral 
literature so I have taken the liberty of speculating about possible ways that the 
treatments could alter behavior. I consider both the anatomical and cognitive substrates of 
the behavior. 
Anatomical Effects of Treatments 
The animals that showed beneficial behavioral effects of the treatments also 
showed several gross morphological correlates of the behavior. Thus, the lesions 
appeared to be smaller in the choline-treated frontal animals and in the supplement-
treated frontal and parietal animals. It would have been ideal to quantify the lesion 
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volumes in these animals but this is very difficult to do in neonatally injured brains 
because there is so much distortion of the brain (e.g., Kolb, Sutherland & Whishaw, 
1983). Nonetheless, the apparently smaller lesions are reminiscent of the brains reported 
by Kolb et al (1999), in which they showed partial regeneration of lost cerebral tissue 
after day 10 medial frontal lesions, and by Waite (2003) in her animals with prenatal 
injections of FGF-2 in rats who later received day 3 medial frontal or posterior parietal 
lesions. If we assume that the brains in the current study really are similar to those in the 
parallel studies in the Kolb lab, then it seems likely that the molecular changes discussed 
above could have stimulated neurogenesis and gliogenesis as proposed above. The new 
tissue would then be presumed to have influenced behavior. 
In addition to the lesion size, there was also a reduction in the shrinkage of the 
cortical mantle in the choline- and supplement-treated animals with lesions. Changes in 
cortical thickness can be presumed to reflect changes in the intrinsic organization of the 
cortex, which in turn can be presumed to influence cortical functioning (e.g., Kolb, 
1995). Although it is not known exactly how such changes influence cognitive 
processing, there is an extensive literature showing the relationship between changes in 
cortical organization and behavior (e.g., Kolb & Whishaw, 1999). 
Finally, although again difficult to quantify, it did appear that there was less 
extensive retrograde degeneration in the thalamus of the treated versus untreated lesion 
animals. If the thalami were in fact larger in the treated animals, then presumably there 
would be more thalamo-cortical and cortico-thalamic connections. These connections 
could be presumed to benefit cortical functioning. 
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Cognitive Effects of the Treatments in Cognitive Functioning 
Habituation to novel events is considered the basis of selective attention, which 
forms the fundamental processes for all forms of learning (Rose, & Rankin, 2000). In the 
open field task, selective and sustained attention would be required to filter out the 
distracting auditory stimulus throughout each interval in order to habituate to a novel 
environment. Rats that have difficulty with the suppression of distractions would have 
difficulty habituating in that each subsequent presentation of the auditory stimulus would 
be perceived as novel. 
One cognitive explanation for enhanced performance of animals in the water task 
is that there could be improvements in sustained and selective attention. In order to 
acknowledge and make associations with distal cues to a platform in the Morris water 
task, the rats need to be able to filter out irrelevant and distracting stimuli to make 
specific and relevant associations meaningful. For example, Delatour and Gisuet-Verrier 
proposed that navigation from different start positions as an ability to shift attention 
requires behavioral flexibility, which in turn, enables the animal to shift attention with 
novel starting positions (Delatour & Gisuet-Verrier, 2000). An extrapolation of this 
proposal would imply that the treated frontal lesion animals were successful in shifting 
their attention, by inhibiting previous responses from previous starting positions, and 
adapting to new starting positions. Parietal lesion animals in the supplement treated group 
may also have shown an improved ability to attend to relevant cues, although in this case 
to use them to choose an appropriate spatial trajectory towards the platform and inhibit 
previous responses. 
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One reason for using the attention-shift task was to test directly the idea that 
changes in the ability to shift and sustain attention might be influenced by the dietary 
treatments. Although subjectively it appeared that the treatments were beneficial to the 
brain-injured rats, the statistical measures used did not provide support for this 
impression. The task proved to be very difficult for all animals and the animals selected 
for the task may not have been a representative sample in each group. Specifically, a 
larger group of animals treated with choline were pretrained in the task and only those 
animals that were relaxed and adapted to the task well enough were chosen to perform in 
it. A subset of animals could have been selected and trained in smaller numbers. This task 
had previously not been performed at this laboratory; therefore, all rats were pretrained to 
select participants. In retrospect, this may have biased the results. The difficulty 
however, is that it seems likely that many of the parietal and frontal operates were not 
going to be able to succeed even in the early stages of the task. In addition, even with the 
preselection of subjects for the task in the subsequent groups tested, there was 
considerable intragroup variability, which made the statistical analyses very difficult. 
Broader Implications of Using Dietary Treatments for Behavioral Disorders 
Since the advent of magavitamin approaches for the alleviation of health 
symptoms by Linus Pauling, Abram Hoffer and others, a number of studies have been 
performed in humans using a variety of vitamins for treatment. Many results have 
indicated some short comings due to a lack of longitudinal studies, no significant 
treatment effects, or adverse effects of toxicity. The treatment interventions employed 
however, only used one, two, or a few vitamins, such as vitamin B6, vitamin Biz, vitamin 
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B3, Vitamin C, Vitamin A, or combinations of these vitamins. The problem with this type 
of intervention is that vitamins and minerals should not be used singularly for therapeutic 
purposes because they work together, in some cases synergistically. 
Using vitamin B6, for example, increases only one B vitamin, producing 
decreases in the levels of the other B vitamins, thereby potentially amplifying toxic 
effects. The B vitamins are interlinked metabolically therefore would operate more 
efficiently if all substrates and enzymes are present in relatively proportional amounts. 
With regard to using a vitamin supplement, in therapeutic quantities, having balanced 
proportions of all nutrients available would produce a more favorable outcome, as 
opposed to imbalances of nutrient intakes. 
For example, deficiency of vitamin B2 (riboflavin) rarely occurs in isolation, 
because it is accompanied by other nutrients (Goff, Gropper, & Hunt, 1995). Chronic 
deficiency of riboflavin however, has been known to impair the synthesis of vitamin B6, 
in its coenzyme form pyridoxal phosphate (PLP), as well as, the synthesis of vitamin B3 
(niacin) from tryptophan. Impairments in PLP synthesis could in turn, affect a number of 
necessary reactions involved in amino acid metabolism. Pyridoxal phosphate is also a 
required component for enzymatic activity in the catabolism of glycogen to form glucose. 
Neurotransmitter synthesis of dopamine and norepinephrine, as well as the conversion of 
glutamate to gamma-aminobezoic acid (GABA), also necessitate PLP as a cofactor to 
complete their respective reactions (Goff, Gropper, & Hunt, 1995). 
The vitamin and mineral supplement used for treatment intervention in the second 
experiment revealed significant effects both anatomically and behaviorally. The animals 
had a very calm demeanor, were easy to handle, and performed all tasks very well. Not 
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Future Directions for Research 
The present study supported the advantages of pre-and postnatal administration of 
choline treatment to enhance the learning and memory processes into adulthood. The 
vitamin supplement treatment was administered postnatally, and continuous throughout 
the lifetime of the rat. It would be interesting to determine any critical periods for 
treatment administration with the supplement also to see if pre-and postnatal 
administration would have similar functional outcome as the choline treatment. 
The female rats seemed to require some time to adapt to the supplement before 
becoming impregnated. It would therefore be very beneficial to be able to arrive at a 
dosage, or a time frame that would favor successful reproductive processes, and be able 
to deliver a therapeutic dosage of nutrients. 
one incidence of illness was observed in any rat that would have been an effect of vitamin 
toxicity, as measured by comparisons with animals that did not receive supplement 
treatment. This product (EM Power +) is different than most in that the minerals are 
chelated to provide for more efficient absorption and utilization. The minerals are 
generally a prosthetic (inorganic) component to enzyme complexes that are essential to 
fulfill biochemical reactions. By chelating minerals and increasing their bioavailability 
they could more effectively manage the metabolic demands of the higher amounts of 
vitamins ingested with them. In other words, if the enzymatic activity is not sufficient for 
the adequate metabolism of vitamins, a pooling of substrate could result, requiring the 
body to dispose of it, and/or resulting in toxic accumulations in tissues. 
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Kolb has pursued research in animal models of stroke. Because stroke is known to 
generally occur in adulthood, it would be interesting to see the effects of the vitamin 
supplement in the reparative processes of adult rats. The anatomical and behavioral 
effects could be measured, and would also be advantageous to determine the time 
required for recovery processes for functional recovery. 
The experimental use of bromodeoxyuridine (BrdU) and other mitotic markers 
could reveal some potential implications of neurogenesis for both choline and supplement 
treatments. Administering these markers at different time frames throughout 
development, and thereafter, could determine some of the growth patterns and changes 
that could be occurring during each period. 
The Western Blot technique is very useful for revealing the proteins that are 
expressed after cortical injury and the effects that choline and the supplement treatment 
have during the reparative processes. Glial fibrillary acidic protein (GFAP) and its 
receptor Fig are markers for glial cells. Proliferation of these cells is normal after cortical 
injury indicating reparative processes. Gluccocorticoid type 1 receptor (GR1) may be 
useful to reveal any increases, or decreases, in stress hormones the animals have been 
subject to. Basic fibroblast growth factor (bFGF) resides in glial cells and is known to 
increase in expression after cortical injury. Its increase is generally an indicator of factors 
supporting the process of neurogenesis. Structural proteins can also be assessed with 
microtubule associated protein-2 (MAP-2) to quantify the density of any newly formed 
dendrites. Synaptophysin is a marker for structural proteins that are associated with 
newly formed neural synapses. 
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Using a variety of lesions would also be useful to determine these treatment 
effects with various injuries to different areas of the brain. Hippocampal lesions are 
commonly used to measure treatment effects on memory; lesions of the occipital cortex, 
or visual system, can determine disturbances in visual functions. 
Dietary supplementation of the vitamin supplement into senescence would be 
very interesting to determine a potential treatment that could retard the aging processes of 
learning and memory, and possibly retard the overall effects of aging, as is proposed with 
anti-oxidants. 
Using a variety of behavioral tests is always advantageous to arrive at a clearer 
picture of what types of processes can recover functionally. The motor cortex appears 
somewhat resistant to full functional recovery, as is demonstrated in Whishaw's skilled 
reaching task. By improving motor function on this type of motor task, the supplement 
treatment may be able to contribute therapeutic benefit to people with motor disorders, 
such as Parkinson's Disease. 
I would also like to determine if the vitamin A content in the supplement could 
improve visual discriminations in the afoveate rat, using the visual discrimination maze. 
I also did enjoy working with my rats in the attention shift task. I do believe that it 
is possible to arrive at some accurate subjective judgments of rat behavior by carefully-
examining their moves and spending many days with them. The supplement did appear to 
improve attention processes in the attention shift task, but it should be repeated with 
several scoring techniques, such as filming, timing during each trial, etc. Other behavioral 
tests of attention, such as the five-hole task could support other findings. 
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The radial arm maze is often employed for tests of memory, which produces 
various results depending on the paradigm used, but also the lesion and treatments 
employed. 
If possible, it would be interesting and beneficial to observe differences in 
behavior and cognition in animals using different diets. By employing a diet that might 
resemble an imbalanced, or slightly deficient diet, in comparison with the vitamin 
supplemented diet, with a long duration of stress to determine the consequences of 
inadequate nutrient intakes might resemble a situation of chronic fatigue, or chronic 
burnout. Tasks would include the running wheel, and various cognitively demanding 
tasks, such as water maze, radial arm maze and others. Dietary intake and consumption 
would have to be carefully controlled to gain some insight into average caloric and 
nutrient intakes. The underlying proposal for this type of experiment is to provide a 
greater understanding of the determinants for depression. I believe that many cases of 
depression are due to nutritional burnout, and these people afflicted are being treated with 
antidepressants, while not seriously addressing nutritional issues. 
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6. Epilogue 
Aside from the advantages of therapeutic nutrition intervention for treatment of 
injury, studies in humans, such as adults with Bipolar Disorder also report to benefit from 
a this vitamin and mineral supplement, EM Power+ (Kaplan, Simpson, Ferre, Gorman, 
McMullen, Crawford, 2001). Kaplan and colleagues have reported patients' increased 
feelings of well being, as well as feeling more normal, while taking the vitamin 
supplement. Patients also have reduced their psychotropic medications by more than fifty 
percent since beginning treatment intervention with the supplement. 
Because my mother is bipolar and my academic background is in nutrition, I have 
been able to make careful dietary observations in relation to the characteristic mood 
swings of mania and depression, including the effects that perceived stressful events play 
into dietary behavior. Based on some known general characteristics of Bipolar Disorder 
and characteristics of my mother's behavior, I realize that there are some very important 
nutritional consequences of this disorder. Although this concept is basically an outline to 
the actual complexities that exist in Bipolar Disorder, I do feel that it can begin to provide 
some explanations for the benefits that this well formulated vitamin and mineral 
supplement has brought to many people who are presently receiving it for therapeutic 
intervention. 
One of the primary issues normally addressed in Bipolar Disorder is of a 
dysregulation of the hypothalamic-pituitary-adrenal axis (HPA axis). The stress response 
of the HPA axis is thought abnormal due to inappropriate feedback mechanisms in the 
brain required to turn off the HPA axis response. As a result of inefficient feedback to 
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glucocorticoids in circulation, increases in Cortisol begin to alter metabolic processes in 
the body and the brain, as has been discussed previously for injury treatment. Patients 
diagnosed with chronic (major) depression, or bipolar patients, not experiencing a manic 
episode, are considered to have a higher predisposition to experiences of stress. 
The limbic region of the brain contains a structure, the amygdala that is primarily 
associated with assigning the emotional significance to stimuli (Kolb, & Whishaw, 2003). 
Kolb and Whishaw have noted that in patients who have major depressive disorder the 
amygdala is unusually overactivated, even under resting conditions. Since the amygdala 
is also strongly connected to the hypothalamus, its activity has been proposed to stimulate 
Cortisol release, thereby activating the stress response of the HPA axis (Kolb, & 
Whishaw, 2003). 
If you can recall some of the metabolic consequences of stress mentioned earlier, 
the abundance of circulating hormones, including Cortisol and catecholamines, serve to 
mobilize metabolic processes necessary to meet the higher metabolic demands required 
to begin the reparative processes of stress and injury. The perceived stress of depressive 
patients would differ from injury responses in magnitude, at least initially, however, 
depressive patients generally are known to undergo chronic episodes of stress because of 
the length of time they must endure it. Bipolar patients have been known to endure a 
stressful episode for periods of weeks to months. I have seen my mother in serious 
episodes of stress for as long as one to two months. Her dietary intake is often limited, 
but more notably irregular and at times imbalanced nutritionally. Some of the metabolic 
consequences under stressful conditions lead to limited food intake and resemble the 
stress response (Groff, Groper & Hunt, 1995). 
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During periods of mania, bipolar patients are again undergoing these metabolic 
demands to provide the person with the energy used during this period, and to 
compensate for the lack of food and nutrient intake. My mother and undoubtedly many 
other bipolar patients love their manic and euphoric phases. Food intake is not a concern 
to her at this time; in fact, eating rarely crosses her mind. Periods of mania are known to 
occur for at least one week (American Psychiatric Association, 1999). Laboratory-
findings associated with mania include increases in Cortisol secretion and potential 
abnormalities in functions of neurotransmitter systems norepinephrine, acetylcholine, 
serotonin, dopamine and gama-aminobutyric acid (American Psychiatric Association, 
1999). The major depressive episodes are also characterized by decreases in appetite and 
nutrient intakes, and people are noted to lack the motivation necessary to perform regular 
daily chores including preparing regular and nutritionally balanced meals. During most 
every depressive period, my mother would engage in carbohydrate bingeing to provide 
the energy-depleted body with quick sugars that her body craved and restore some 
"normal" level of functioning. The large surplus of carbohydrates would bring her out of 
her depressive phases. 
To gain a better understanding of metabolic demands, the brain is the last organ in 
the body to be deprived of glucose, and with other central nervous system tissues, uses a 
very large amount of glucose to perform normal processes (Groff, Groper & Hunt, 1995). 
Groff et al. have indicated that during an overnight fast, nearly all liver and muscle 
glycogen has been depleted shifting the body into a fasting state after forty-eight hours of 
food deprivation (Groff, Groper & Hunt, 1995). Needless to say, Bipolar Disorder 
patients spend a lot of energy during their phases. 
157 
To summarize some of the potential nutritional consequences experienced by 
patients with bipolar disorder, the primary energy substrate required by the body and 
brain under various conditions in an attempt to maintain homeostatic conditions, is 
glucose. A number of catabolic processes of glycogen, protein, and fatty acids, can 
provide the organism with glucose for energy production. What is important however is 
that these metabolic processes are ongoing and also require the necessary vitamins and 
minerals to ensure activity of enzymes and their cofactors to support metabolism. The B 
vitamins in particular are noteworthy in this situation, as they are required for the final 
processes of glucose oxidation (see Fig. 53). 
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Fig. 53. The interconversion of nutrients required for energy metabolism (Extracted from 
Groff, Groper & Hunt, 1995). 
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An association of Bipolar Disorder and nutritional deficits may not seem likely, or 
significant, because after each phase of the cycle the individual begins to consume food 
again. Within time, the patient will overcome the event, and regain his/her appetite and 
energy. What should be considered however is that people with this disorder undergo 
these cycles for their entire lives. The B vitamins are very susceptible to depletion 
because they are water-soluble, have relatively quick clearance rates, and are in higher 
demands in people that are undergoing recurrent episodes of catabolic states. 
Furthermore, the numerous medications that are taken by these people every day also 
necessitate nutrients to metabolize these agents (see Fig. 54). 
To compound the potential imbalances of nutrient intakes in Bipolar Disorder 
these patients have been characterized as carbohydrate cravers, and unfortunately, some 
have developed Bulimia Nervosa. As I have previously mentioned, my mother would 
crave quick (refined) sugars, and eat only large amounts of carbohydrate, which 
inadvertently imbalances dietary intakes for a number of days. The carbohydrates in turn, 
have been shown to increase the effectiveness of tryptophan to cross the blood brain 
barrier for serotonin production (Chaftetz, 1990). 
Finally, it should be noted that niacin (vitamin B3) plays a number of important 
roles in this situation. Niacin is necessary to complete the oxidation process of glucose to 
provide the body and brain with energy sources. Tryptophan is also an amino acid 
precursor for the synthesis of niacin. If dietary intakes of direct sources (meat, fish) of 
niacin are low. the body will use tryptophan to produce niacin, which may initiate 
depletions of serotonin synthesis. Chaftez has also noted that the consumption of various 
proteins, such as that found in meats, provides competition for the transport of tryptophan 
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across the blood brain barrier making it more difficult for these people to obtain brain 
sources of tryptophan (Chaftetz, 1990). Also, during metabolically demanding periods of 
stress and mania, circulating amino acids are used for the production of glucose, 
compromising the availability of phenylalanine, tryptophan, and tyrosine for 
neurotransmitter synthesis (see Fig. 53). The long-term duration of nutrient imbalances 
and inadequate nutrient replenishment that are prone to result from recurrent periods of 
stress, mania, and depression, could produce a condition of "nutritional burnout". It is 
this type of nutritional imbalance then that could either initiate, or exacerbate, the 
chemical imbalances that contribute to some of the cognitive deficits that are 
characterized in mood disorders. 
Nutrients Used in Drug Oxidation and 
Conjugation 
Nutrient Oxidation Conjugation 
Carbohydrate Glucose 
Lipid Lecithin Acetyl (also 
from 
protein and 
carbohy­
drate) 
Amino acids Glycine Glycine 
and derivatives Protein Glutamic acid, 
glutamine 
Cysteine, 
cystine 
Methionine 
Serine 
Arginine 
Alanine 
Some peptides 
Minerals Iron, copper, 
calcium, 
zinc, 
magne­
sium 
Vitamins Pantothenate Pantothenate 
Niacin Niacin 
Riboflavin Folate 
Ascorbic 
acid(?) Vitamin B 1 2 
Fig. 54. Nutrients required for drug metabolism (Extracted from Zeman. F.J., 1991, in 
Clinical Nutrition and Dietetics). 
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Overall, nutrition is extremely important for recovery from illness, regardless of 
etiology; therefore, the therapeutic intervention of nutrition requires that all physiological 
and metabolic systems are effectively supported. Producing deficiencies at one stage of 
metabolism would most likely interfere with other metabolic processes, thereby 
beginning a cascade of effects as a result. Eventually, the catabolic processes of various 
nutrient sources are required, to "borrow" some necessary compounds and/or enzymes 
from other biological reactions to complete any further reactions. In this way the body 
can compensate metabolically for short-term duration of nutritional losses. Long-term 
duration however, could lead to a variety of deficiencies and result in some serious health 
consequences. 
A well-formulated vitamin and mineral supplement in therapeutic quantities could 
be a very beneficial agent for health care. The applications that have been noted for its 
use in the treatment of brain injury and bipolar disorder are only examples of its benefits. 
The body and brain is a unit that is integrated together. By keeping systemic 
systems functioning efficiently, and having the appropriate nutrient supply, the body can 
more effectively support the demands of central nervous system, which in turn effectively 
provides the organism with the appropriate learning capabilities to better adapt to its 
environment. 
162 
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Appendix D: Vitamin Supplement/ Standard Rat Chow Analysis 
Appendix E: Behavioral Results of the Second Generation Animals Treated with the 
Vitamin and Mineral Supplement 
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Appendix A 
Anatomy and Connectivity of the Rat Cortex 
The importance for an animal (or human) to be able to continually adapt to a 
changing environment requires the integrity of not only anatomical regions of the brain, 
but also the neural connections among them that makes the brain functional. 
In the mature rat cortex, some basic neural connections should be addressed between the 
two cortexes subject to lesions: the frontal cortex and the parietal cortex, along with some 
connections to other cortical regions. 
Zilles & Wree (1995) have revised previous editions of the rat cortical and 
subcortical connections and cytoarchitecture. To view past and present changes in 
nomenclature for the rat cortex, see table 19. 
The frontal cortex: 
The nomenclature for the frontal cortical areas are mainly from Zille's (1995) 
most recent research. 
The medial prefrontal cortex consists of cingulate areas, Cgl , Cg2, and Cg3, 
collectively make up the anterior cingulate cortex. The infralimbic region is also 
considered by some as part of the medial prefrontal cortex. The Cg3 is also known as the 
prelimbic (PrL) area. The infralimbic area (IL) lies ventral to Cg3 (PrL). The medial 
precentral area frontal 2 (Fr2) lies dorsal to the cingulate cortex (Cg2), and is an 
association area involved in premotor functions. 
Frontal areas Frl and Fr3 are situated dorsal to Fr2 (premotor) and are involved in the 
primary motor functions (see Fig.55). 
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Fig. 55. Anatomical areas of the frontal cortex in the rat. 
Connections of the frontal cortex: 
Frl (motor) receives neural afferents from Fr2 (premotor) and Parietal area 1 
(Pari) (sensory association) from both the contralateral (opposite) and ipsilateral (same) 
hemispheres of the brain. 
Frl (motor) also receives afferents from the contralateral (motor) and from ipsilateral 
forelimb (FL) and hindlimb (HL) areas (sensory association). Fr2 (premotor) receives 
additional afferents from the retrosplenial cortex, an area specific to the posterior 
cingulate cortex. 
Efferent connections from Frl and Fr3 (motor) terminate in Par 1 
(somatosensory). 
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Efferents from the infralimbic (IL) area terminate in the cingulate (Cgl-3), and 
agranular insular (AID/AIV) areas, as well as the piriform and perirhinal cortices of the 
limbic system. 
Efferent fibers from the Al cortex reach the prefrontal areas, IL, Cgl-3, the 
presubiculum, perirhinal, piriform, and entorhinal areas of the limbic system, and to the 
retrosplenial cortices of the posterior brain regions. 
The orbital frontal cortex has been called the transition zone by Krettek and Price 
and is the region of frontal cortex that lies dorsal to the agranular insular cortex (Al) and 
ventral to the cingulate cortex Cg3. The orbital cortex of the ventral frontal areas are 
difficult to identify by cronal (front to back) sections, and are usually viewed using 
horizontal and saggittal (lengthwise) sections. Efferents from many cortical areas have 
been identified as connected with the orbital regions. The orbital frontal cortex is also 
known to have connections with the limbic system (see Fig.56). 
56. Lateral, medial, and dorsal views of the rat brain. 
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The parietal cortex: 
Some anatomical correlates of the posterior parietal cortex in primates have been 
determined for rats using True Blue tracing techniques (Kolb & Walkey, 1987). Kreig's 
area 7 in the rat's posterior cortex is the region of the brain that has some of the same 
connectivity characteristics as the posterior parietal cortex in primates. 
Injection of True Blue tracer into Kreig's area 7 also revealed traces of dye into the 
adjacent somatosensory cortex (head and limb areas), extrastriate (association visual) 
cortical areas, (Vogt & Peters; 18a, 18b), striate (primary visual) areas (17), and frontal 
regions included the anterior cingulate (Cg2), the frontal eye fields in the precentral 
medial (PrCm/premotor) areas, and in some cases in the medial orbital, ventral orbital, 
and prelimbic areas (ventral frontal). To determine any reciprocal connections with 
Kreig's area 7, Nuclear Yellow was injected into areas in the frontal cortex. Labeling in 
area 7 was evident from connections with the anterior cingulate and the precentral 
(PrCm) region. The fronto-parietal connections labeled with True Blue overlapped with 
the parieto-frontal connections labeled with Nuclear Yellow, which indicated a 
convergence of connections in the same area (Kolb & Walkey, 1987). 
Zille's recent map of the posterior parietal cortex include Parietal 1 (Pari), forelimb (FL), 
and hindlimb (HL) areas as the primary somatosensory cortex, and parietal 2 (Par2) as 
the secondary somatosensory cortex. 
The surgical lesions performed in Experiments IB and 2B are from Kreig's area 
7, which is somewhat equivalent to Zille's occipital 2 lateral (Oc2L), therefore, 
connections involving Oc2L will be discussed (see Fig.57). 
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Fig. 57. Comparisons of Zilles and Kreig's areas of the rat brain. 
Target efferent connections from the Oc2L include the primary visual cortex Ocl 
(ipsilateral and contralateral), and the secondary Oc2M (medial) and the contralateral 
Oc2L areas. 
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The posterior cingulate areas of the retrosplenial granular cortex (RSG) and the 
retrosplenial agranular cortex (RSA) receive efferents from Oc2L 
Oc2L also extends efferents into the hindlimb (HL) area of the primary somatosensory 
areas, as well as, the secondary auditory cortex Te2 in the temporal regions. 
The Fr2 of the frontal cortex is the only area in the anterior sections of the cortex to 
receive efferents from Oc2L. 
Other cortical areas: 
The temporal and perirhinal cortices interlink many of the cortical areas 
discussed, all of which are necessary to carry out the numerous functions of the brain. 
The perirhinal cortex is part of the limbic system and receives efferents from the frontal 
cortical areas cingulate 1-3 (Cgl-3), frontal association Fr2, the agranular insular ventral 
and posterior regions (AIV,AIP), the secondary sensory area parietal 2, the agranular 
restrosplenial area (RSA), the secondary auditory cortex (Te2,Te3) and the lateral 
secondary visual cortex (Oc2L). 
Additional areas of the hippocampal proper innervate the perirhinal cortex, such 
as the presubiculum, parasubiculum, subiculum, and the CA1 region of the hippocampus. 
Efferent fibers from the perirhinal cortex are the entorhinal (ipsilateral), subiculum, and 
CA1 of the hippocampus. The CA1 and subiculum, in turn, project fibers to the 
infralimbic (IL) area of the prefrontal cortex. 
The temporal cortex lies dorsal to the perirhinal cortex. Most of the identified 
afferents to the temporal cortex are from various thalamic nuclei. Similarly many 
thalamic nuclei send projections to the temporal cortex. The cortical areas that have been 
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Fig. 58. Anatomical areas of the posterior regions of the brain in the rat. 
Fig. 59. Anatomical areas of occipital cortex and posterior regions of the rat brain. 
noted to project to the temporal cortex are the retrosplenial cortices; RSG and RSA (see 
Fig.58). 
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Table 19. Nomenclature of equivalent cortical areas. 
Zille's 1995 Zille's 1980 Krettek and Price, 
1977 
Kreig, 1946 
Cgl,Cg2,IL,CG3 C1,C2,C3,C4 ACd, Acv, IL Areas 23,24, & 
32 (IL/PL) 
Fr2 Prcm, Pre 3 PrCm Areas 4,6,8,8a, 10 
and 11 Fr l ,Fr3 Pre 1-2 PrCl 
P a r i SmI exclude 
dorsomedial section 
FL, HL SmI dorsomedial 
Par2 Smll 
Oc2MM Part of Rag Part of RsAg 
Oc2L Oc2L Area 7,18a 
The reciprocal projections between the frontal and parietal cortexes serve as a 
very important connection functionally. The posterior regions of the brain communicate 
certain messages of sensory information received from the body, which is communicated 
as ''bottom up" information to the prefrontal cortex. The prefrontal cortex operates at a 
"top-down" level of control over sensory input, as it must organize the information for 
behavioral output. Needless to say, brain injury to either of these regions disrupts a 
number of cognitive processes and behavioral responses related to both cortexes. 
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APPENDIX B 
Attention Shift 
Arm Baited Habituation Dimension Odor/Medium 
Left and Right Bait both bowls Sawdust 
Left Series of 2 
discriminations 
Odor Cloves vs. 
Rosemary 
Right Medium Styrofoam vs. 
Shredded paper 
Right Testing Simple (SD): Odor 
0 1 vs.02 
Cinnamon vs. Basil 
Left Compound (CD): 
Ol /Ml vs. 02/M2 
Cinnamon Sawdust 
vs. Basil Corncob 
Left CD: 
01/M2 vs. 02/M1 
Cinnamon Corncob 
vs. 
Basil Sawdust 
Right Reversal (Rev 1) 
02/M1 vs. 01/M2 
Basil Sawdust vs. 
Cinnamon Cob 
Right Rev 1 
02/M2 vs. Ol /Ml 
Basil Cob vs. 
Cinnamon Sawdust 
Right Intradimensional 
Shift (ID): 
03/M3 vs. 04/M4 
Cumin Beads vs. 
Thyme Glass Stones 
Left ID: 
03/M4 vs. 04/M3 
Cumin Glass Stones 
vs. Thyme Beads 
Left Reversal 2 (Rev): 
04/M3 vs. 03/M4 
Thyme Beads vs. 
Cumin Glass Stones 
Right Rev 2: 
04/M4 vs. 03/M3 
Thyme Stones vs. 
Cumin Beads 
Left Extradimentional 
Shift (ED): 
M5/05 vs. M6/06 
Curry Stones vs. 
Allspice Woodchip 
Left ED: 
M5/06 vs. M6/05 
Curry Woodchip vs. 
Allspice Stones 
Right Reversal 3 (Rev): 
M6/05 vs. M5/06 
Curry Woodchip vs. 
Allspice Stones 
Left Rev 3: 
M6/06 vs. M5/05 
Allspice Woodchip 
vs. Curry Stones 
Discrimination Pairs: 
1 2 3 4 5 6 
Odor Cinnamon Basil Cumin Thyme Curry Allspice 
Medium Sawdust Corncob Beads Glass 
Stones 
Stones Woodchip 
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Appendix C 
Western Blot 
Procedures: 
Brain tissue was removed from decapitated animals and placed on ice. Following 
rapid dissection of cortical regions, brain samples were placed in microcentrifuge tubes 
and frozen at -75° C, until ready for preparation. Preparation of a homogeneous sample 
consisted of sonicating the frozen tissue in the tubes with 800liL of 1% sodium dodecyl 
sulfate (SDS). Sample was then aliquoted into new microcentrifuge tubes and diluted 
1/20 to determine the protein concentration (Bradford Assay) before resolving labeled 
proteins on 12% acrylamide gels (5u.g of protein per well) using Sodium Dodecyl 
Sulfate- Polyacrylamide Gel Electrophoresis. Prepared gels were blotted on 
polyvinylidine difluoride (PVDF) membranes. 
The membranes were blocked for non-specific binding proteins for one hour with 
5% non-fat dry milk in Tris-buffered saline and 0.1% Tween 20. Primary antibodies to 
proteins of interest were diluted (1:1000) with the same solution used for blocking. 
The membranes were incubated in the primary antibody for two hours, followed 
by five more washes with PBS. Proteins of interest was revealed with an ECL + detection 
kit from Amersham (RPN2132) and the resulting image was captured on Hyperfilm ECL 
(Amersham #RPN1647K). 
The membranes were stained with 0.1% Coomassie Blue (Omnipure EM Science) 
to reveal all proteins in order to ensure pipeting consistency. Exposed film was imaged 
with a Kodak digital camera and the blot density was then analyzed using NIH Image 
software. 
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Primary anitibodies used: GR, Santa Cruz, SC-1004 
bFGF, Santa Cruz, SC-7911 
GFAP, Sigma, G3893 
Fig, Santa Cruz, SC-121 
Analysis was performed for proteins; glucocorticoid receptor type 1 (GR) 
Basic fibroblast growth factor (bFGF) 
Glial fibrillary acidic protein (GFAP) 
GFAP receptor protein Fig 
bFGF GFAP 
Fig GR1 
Fig. 60. Proteins analyzed by Western Blot technique. 
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Results: All brain tissue analyzed for specific proteins were present in normal quantities, 
as indicated by the control group (see Table 20). 
Table 20. Summary of Statistical Analysis for Western Blot. 
Protein Group F-value (i,ii) P-value Mean Std. Error 
GR Supplement .263 .6179 1.037 .081 
Control 1.087 .044 
bFGF Supplement .608 .4520 2.235 .181 
Control 2.422 .151 
GFAP Supplement .211 .6548 1.523 .297 
Control 1.690 .182 
Fig Supplement .379 .5415 2.012 .148 
Control 2.161 .187 
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Appendix D 
Analysis of Vitamin Supplement Diet vs. Analysis of Standard 
Laboratory Rat Chow 
The analysis of the vitamin supplement diet is a sample of some of the nutrients 
provided by the base diet, as well as the diet with the vitamin and mineral supplement 
added. 
Table 21. Nutritional analysis of the base diet composition in the vitamin supplemented 
diet. 
Analyte Units As Fed Dry Basis 
Moisture % 7.2 
Ash % 6.74 7.26 
Crude Protein % 22.9 24.6 
Crude Fiber % 7.4 7.9 
Total Digestible 
Nutrients (Crude) 
% 72.62 78.22 
Digestible Energy 
(Crude) 
Mcal/kg 3.27 3.53 
Gross Energy (Crude) Mcal/kg 4.3 4.63 
Metabolizable Energy 
(Crude) 
Mcal/kg 3.09 3.33 
Net Energy For Growth Mcal/kg 2.16 2.33 
Crude Fat % 5.5 5.9 
Nitrogen Free Extract % 54.3 
Analysis provided by Northwest Labs. 
Table 22. Mineral content of vitamin supplemented diet. 
Analyte Units As Fed Dry Basis 
Calcium % 1.02 1.10 
Phosphorus % 0.67 0.72 
Potassium % 1.08 1.16 
Magnesium % 0.22 0.24 
Sodium % 0.24 0.26 
Salt % 0.62 0.67 
Sulphur % 0.33 0.36 
Zinc ppm 78.7 84.7 
Manganese ppm 44.6 48.0 
Copper ppm 14.5 15.7 
Iron ppm 290 313 
Analysis provided by Northwest Labs. 
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The vitamin supplement provided approximately 1/2 to 2/3 of the mineral content 
in addition to the nutrients present in the base diet (Hardy, 2003). The minerals that are 
measured in parts per million (ppm), are a measure of milligrams per kilogram (mg/kg). 
The nutrient analysis of the standard lab diet fed to control animals is very similar to the 
vitamin supplement fortified diet in measures of crude protein, crude fat and crude fiber 
(see Table 23). 
The Amino acid and essential fatty acid composition of base diet of the vitamin 
supplement diet, and for the standard Rat Chow diet are also similar and present in 
similar quantities. The standard rodent diet (control) and the base diet for the fortified 
diet (supplement) differ in many of the vitamins and mineral contents. They are in higher 
quantities in the control standard diet than to those in the base diet of the fortified diet 
(see Table 25). Addition of the vitamin and mineral supplement to the base diet increased 
the amount of micronutrients (see Table 22) to levels just slightly above that in the 
control standard diet (see Table 24). 
Table 23. Nutritional analysis of the standard diet composition in the control diet. 
Analyte Units Dry Basis 
Moisture % 
Ash % 6.9 
Crude Protein % not less than 23% 
Crude Fiber % Not more than 6% 
Total Digestible Nutrients 
(Crude) 
% 76.0 
Digestible Energy (Crude) Mcal/kg n/a 
Gross Energy (Crude) Mcal/kg 4.00 
Metabolizable Energy 
(Crude) 
Mcal/kg 3.04 
Net Energy For Growth Mcal/kg n/a 
Crude Fat % 4.5 to 5.5 
Nitrogen Free Extract % 49.9 
Analysis provided by Purina Labs. 
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Table 24. Mineral content of control standard diet. 
Analyte Units Dry Basis 
Calcium % .95 
Phosphorus % 0.67 
Potassium % 1.10 
Magnesium % 0.21 
Sodium % 0.28 
Cloride % 0.65 
Sulphur % 0.36 
Zinc ppm 70.0 
Manganese ppm 64.0 
Copper ppm 13.0 
Iron ppm 270 
Analysis provided by Purina Labs. 
Table 25. Base nutrient profiles of the control and vitamin supplement diets. 
Dietary Constituents Standard Lab Diet (control) Base Diet for Supplement 
Amino Acids 
Arginine 1.38 % 1.47 % 
Cystein 0.32 % 0.72% (Met&Cys) 
Glycine 1.20% 1.19 % 
Histidine 0.55 % 0.57 % 
lsoleucine 1.18% 1.19% 
Leucine 1.70% 1.87 % 
Lysine 1.42% 1.42% 
Methionine 0.43 % 0.40 % 
Phenylalanine 1.03% 1.08% 
Tyrosine 0.68 % 
Threonine 0.91 % 0.93 % 
Tryptophan 0.29 % 0.30 % 
Valine 1.21 % 1.22% 
Serine 1.21 % 
Aspartate 2.83 % 2.94 % 
Glutamate 4.54 % 4.75 % 
* note: not all amino acids included in table. 
Fat 
Omega-3 fatty acids 0.33 % 0.24 % 
Omega-6 fatty acids 1.16% 1.23 % 
Arachidonic acid <0.01 % 0.11 % 
Vitamins 
Carotene 4.5 ppm. 0 
Vitamin K (menadione) 0.5 ppm. 0.54 ppm. 
Vitamin Bl (thiamine) 17.0 ppm. 7.01 ppm. 
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Vitamin B2 (riboflavin) 8.0 ppm. 3.23 ppm. 
Vitamin B3 (niacin) 124.0 ppm. 43.44 ppm. 
Pantothenic acid 24.0 ppm. 10.64 ppm. 
Choline chloride 2250.0 ppm. 0 
Folate 5.9 ppm. 1.21 ppm. 
Vitamin B6 (pyridoxine) 6.0 ppm. 4.18 ppm. 
Biotin 0.2 ppm. 0.2 ppm. 
Vitamin B12 22 mcg./kg. 3.52 mcg./lb. 
Vitamin A 22.0 I.U./g. 0 
Vitamin D3 4.5 I.U./g. 0 
Vitamin E 49.0 I.U./g. 11.85% 
Vitamin C 0 0 
Minerals 
Calcium 0.95 % 0.66 % 
Phosphorus 0.67 % 0.62 % 
Potassium 1.10% 1.16% 
Magnesium 0.21 % 0.21 % 
Sulfur 0 .28% 
Sodium 0.40 % 0.13 % 
Chloride 0.65 % 0.23 % 
Fluoride 18.0 ppm. 13.77 ppm. 
Iron 270 ppm. 238.73 ppm. 
Zinc 70.0 ppm. 40.98 ppm. 
Manganese 64.0 ppm. 28.86 ppm. 
Copper 13.0 ppm. 8.35 ppm. 
Iodine 0.8 ppm. 0.31 ppm. 
Chromium 2.0 ppm. 1.08 ppm. 
Selenium 0.27 ppm. 0.23 ppm. 
Cobalt 0.68 ppm. 
The vitamin supplement added to the base diet includes some ingredients that 
were not included in the base diet analysis. Listed in Table 6 are label claims of the 
vitamin and mineral supplement EM Power. 
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Table 26. Vitamin Supplement. Serving Size is 8 Capsules. (Label Claim) 
Dietary Constituent Amount Per Serving % Daily Value 
Vitamin A (retinyl palmitate) 2400 I.U. 4 8 % 
Vitamin C (ascorbic acid) 250 mg. 4 1 7 % 
Vitamin D (cholecalciferol) 400 I.U. 100% 
Vitamin E (d- a tochopherol 100 I.U. 3 3 3 % 
succinate) 
Vitamin Bl (thiamine mononitrate) 5 mg. 3 3 3 % 
Vitamin B2 (riboflavin) 5.5 mg. 3 2 4 % 
Vitamin B3 (niacinamide) 25 mg. 1 2 5 % 
Vitamin B6 (pyridoxine 
hydrochloride) 
7 mg. 3 5 0 % 
Vitamin B9 (folic acid) 400mcg. 100% 
Vitamin B12 (cyanocobalamin) 250 meg. 4 1 6 % 
Vitamin H (biotin) 25 meg. 8 % 
Vitamin B5 (d-calcium 6mg. 6 0 % 
pantothenate) 
Calcium (amino acid chelate) 550 mg. 5 5 % 
Iron (amino acid chelate) 6mg. 3 3 % 
Phosphorous (phosphorous 
complex) 
350 mg. 3 5 % 
Iodine (from kelp) 75 meg. 5 0 % 
Magnesium (amino acid chelate, 250 mg. 6 3 % 
magnesium complex) 
Zinc (amino acid chelate, zinc 20 mg. 1 3 3 % 
complex) 
Selenium (amino acid chelate, 100 meg. 1 4 3 % 
selenium complex) 
Copper (amino acid chelate, copper 
complex) 
3 mg. 150% 
Manganese (amino acid chelate, 4 mg. 2 0 0 % 
manganese complex) 
Chromium 250 meg. 2 0 8 % 
Molybdenum (amino acid chelate, 
molybdenum complex) 
66 meg. 8 8 % 
Potassium (potassium complex) 100 mg. 3 % 
The central nervous system proprietary blend as part of this supplement consists 
of dl-phenylalanine, glutamate, citrus bioflavinoids, grape seed, choline, inositol, ginkgo 
biloba, methionine, organic germanium, boron, vanadium, and nickel. 
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Appendix E 
Behavioral Results of the Second Generation Animals Treated with the 
Vitamin/Mineral Supplement 
One female and two males were born to a mother rat that received the vitamin 
supplement administration approximately one week after introduction to the male (Plan 
B). The three rats remained housed together until the birth of ten pups. Although this 
pregnancy was not planned, it had come as a pleasant surprise knowing that a second 
generation of rats on this supplement had been born. Two rats died during their early 
days, leaving eight rats to run on behavioral tests. Surgeries were not performed with this 
group. The new pups were calm and very easy to handle during behavioral tests. A few 
analyses were performed and compared to controls to measure the effects of this 
supplement with a second-generation litter. 
Method 
Subjects 
All rats participated in three behavioral tasks and were tested at 60 days of age. 
Table 27. Number of second-generation supplement treated animals. 
Animals 
Supplement Treatment N = 8 
Control N = 8 
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Treatment, and behavioral procedures 
Performed the same as for Experiments 1 and 2. 
Results 
Behavioral results: 
Open Field: 
As in the second experiment, the supplement treatment significantly reduced the 
activity level in both the horizontal activity measure (see Fig. 62), and in the distance 
measure (see Fig. 63). 
Analysis of variance for horizontal activity reveal a main effect of treatment 
(F(l,14)= 24.088, P= .0002), 
ANOVA for distance also indicated a main effect of treatment (F(l,14)= 25.667, 
P= .0002). 
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Fig. 61. Mean horizontal activity in the open field task of the second-generation 
supplement treated animals. 
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Fig. 62. Mean distance for second-generation supplement treated animals. 
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Morris water task: 
Latencies for the supplement-treated females were lower than males throughout 
the 5-day trial period (see Fig. 64). Of the 3 males that participated in this task, only one 
rat did not realize the goal of the task until day 3, possibly skewing good results of the 
other 2 males. 
Analysis of variance (ANOVA) between sexes for total sums of latency in the 
second generation group did not indicate a main effect for sex (F(l,13)= 3.019, P= 
.1059), latency (F(l,13)= 2.812, P= .1174), or for the interaction (F(l,13)= .988, P= 
.3384. The results indicate that the supplement treatment during pregnancy and lactation 
produces animals that function as normal as control animals on the standard diet. 
Fig. 63. Mean latency of second-generation supplement treated animals. 
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Fig. 64. Summary of tray reaching task for the second-generation supplement treated 
animals. 
Tray Reaching: 
The supplement-treated animals showed similar success rates to the control 
animals (see Fig. 65). A two-way ANOVA for treatment did not indicate a main effect 
(F(l,16)= 1.424, P= .2502). 
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